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ABSTRACT
Selection of larvae of Lucilia cuprina with ivermectin for over 60 generations 
resulted in a significant, though slight increase in tolerance (<10-fold). This 
resistance appeared to increase uniformly over the first 30 generations, then 
stabilised. Despite increased selection pressure the response did not 
increase markedly over subsequent generations. This resistance was not 
very stable, and the strain rapidly reverted towards susceptibility in the 
absence of selection pressure, although it did not return to total susceptibility. 
This slightly elevated basal-response (<2-fold) was probably due to selection 
for strain vigour rather than any specific resistance to ivermectin as this 
response was within the range of responses of the parental strain, and there 
was a similarly elevated response to diazinon roughly equivalent to the 
maximal response of the selected strain. The response of the selected strain 
to diazinon, cypermethrin, and moxidectin was examined; only the latter 
appeared to elicit a distinct cross resistance. Allowing for strain differences, 
the relatively small increase in tolerance to ivermectin following extensive 
selection to an apparent end point demonstrated that there was no specific 
mechanism for ivermectin resistance in the field population.
Metabolic inhibitors reduced the resistance to ivermectin in the selected 
strain by about 30%. Piperonyl butoxide caused the greatest reduction in 
tolerance, but also markedly affected the response of the unselected strain. 
Pretreatment with phénobarbital increased the tolerance of all three strains to 
diazinon, but had little effect on their responses to ivermectin. Aldrin 
epoxidase activity was significantly higher in the selected strain (2- to 3-fold), 
indicating that monooxygenases could have a role in the selected tolerance.
I
There was no suggestion of cross resistance to ivermectin in two 
organophosphate-resistant pooled field strains. The responses of nine 
distinct field strains, some with elevated monooxygenase levels, and with 
varying resistance to diazinon and butacarb, were similar and represented a 
susceptible population. However, a laboratory-selected pyrethroid-resistant 
strain was about 2.5-fold more tolerant of ivermectin than susceptible strains. 
This strain is extremely resistant to deltamethrin, highly cross resistant to 
butacarb, and is approximately twice as resistant to diazinon as most field 
strains of L. cuprina. A similar result was obtained with a highly-selected 
diazinon-resistant strain, which also had a low level cross resistance to 
ivermectin (about 4-fold). However, the susceptible responses of 
organophosphate-resistant field strains, and the low-order levels of 
ivermectin tolerance detected in both the deltamethrin- and diazinon-selected 
laboratory strains indicate that there is little likelihood of cross resistance to 
ivermectin due to any of the major mechanisms responsible for 
organophosphate or pyrethroid tolerance in L. cuprina larvae.
A cloth/wool/skin bioassay suitable for the assessment of responses of the 
sheep body louse to relatively slow-acting insecticides such as avermectins 
was developed. The addition of the wool/skin substrate enhanced survival of 
Bovicola ovis, and also provided a suitable medium for testing compounds 
which are more active through ingestion. While there was quite a range of 
responses in four field strains of lice to cypermethrin (up to a 4-fold 
difference), there was little difference between the responses of the four 
strains to ivermectin. Also, these responses did not correspond with the 
pattern for cypermethrin, indicating that all strains were susceptible to 
ivermectin and that there was no cross resistance from pyrethroid resistance.
II
Adults of the dung beetle, Onthophagus gazella, were relatively insensitive to 
both ivermectin and moxidectin in cattle faeces, and moxidectin was about 
ten times less toxic than ivermectin. O. gazella larvae were highly 
susceptible to both ivermectin and moxidectin. The LC^ values for both
compounds were three orders of magnitude less than the respective adult 
values. The responses of larvae of the dung-breeding fly, Tricharea 
brevicornis, to ivermectin and moxidectin were remarkably similar to those for 
O. gazella larvae. With moxidectin, pupal weight was strongly correlated to 
concentration, and this effect was noticeable well before any toxic signs were 
observed, indicating that moxidectin may have an anti-feedant effect. There 
was no correlation between pupal weight and concentration for ivermectin or 
abamectin.
Daily dosing with ivermectin was effective in preventing breech strike in 
scouring sheep, through the insecticidal effects of faecal residues. Thus a 
formulation developed for controlled-release delivery to control gastro­
intestinal nematodes could also effectively reduce the incidence of breech 
strike.
The movement of ivermectin on newly-shorn sheep was investigated using 
HPLC to detect residues in wool/skin biopsies. The recovery of significant 
amounts of ivermectin B1b only, away from discrete application sites indicated
a significant difference between the behaviours of the two components of 
ivermectin. Also, this implied that the observed movement was independent 
of dispersal due to the solvent, as this would be expected to distribute both 
components. This translocation was highly variable and animal dependent.
Ill
In an experiment using back-line treatments of ivermectin B1a and B1b on
newly-shorn lousey sheep, animal variation was again apparent as louse 
numbers were only slightly reduced on one of the B1b-treated animals, while
lice were rapidly killed on the other five treated animals. Difference between
the two ivermectin components was noticeable, with the louse numbers on 
two B1b-treated animals declining more rapidly than those for the B1a-treated
animals. HPLC analyses of wool/skin biopsies from four of these sheep 
indicated that both ivermectin components spread laterally with time. The 
high variability between sampling times masked any real temporal trends, 
although there was an indication of more rapid spread of the B1b component.
Examination of the relative toxicities of wool staple portions to L. cuprina 
larvae indicated that both hand jetting and tip spraying deposited ivermectin 
evenly along the wool staple. Residues remained highest in the middle 
portion, and depleted most rapidly from the portion of the staple closest to the 
skin indicating that there was little if any movement of ivermectin up or down 
the staple.
In vitro studies with pure lanolin showed that both ivermectin components 
permeated into, or bound with lanolin, and indicated that the B1b component
was more labile in or had a greater affinity to lanolin. The application of 
ivermectin to lanolin impregnated wool cloths showed that neither component 
would diffuse through lanolin. All dispersal was purely solvent driven. This 
indicates that the lateral movement on newly-shorn sheep was purely due to 
passive carriage in the yolk (lipid sweat mixture) as it moved through the 
stratum corneum. The differences in rate of spread of the two components of 
ivermectin, therefore, probably relate to their different affinities to lanolin.
IV
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1. INTRODUCTION.
The avermectins and milbemycins are the most recently introduced, distinct 
group of broad-spectrum pesticides. These macrocyclic lactones are 
fermentation products (or semi-synthetic derivatives of fermentation 
products) of actinomycètes in the genus Streptomyces which are active 
against nematodes, insects and mites. Avermectins were first introduced for 
use against a number of nematode and arthropod parasites of livestock, and 
as household insecticides and agricultural miticides in the 1980's. The mode 
of action of these compounds has not been clearly elucidated; however, they 
basically act as nerve poisons, primarily affecting chloride ion uptake in nerve 
membranes. Unlike other neurotoxic agents, avermectins have a relatively 
slow action with no quick knockdown effect. Mammals are relatively 
insensitive to these compounds.
In Australia avermectins have been widely used in the livestock industry, 
primarily as anthelminthic drenches in sheep and cattle with additional activity 
against some arthropod parasites. The compounds act when the parasites 
ingest them after the chemical's uptake into the host's blood. The majority of 
the host's dose is excreted unchanged in faeces, thus a number of insects 
may come into contact with varying concentrations of avermectins in both the 
blood and faeces of treated animals.
In this thesis I examine aspects of the toxicity of avermectins to some insects 
associated with livestock which may contact these compounds through either 
of these routes. Firstly, I determine the responses of the major ectoparasites 
of sheep, the Australian sheep blowfly and sheep body louse, as these may 
have been exposed to sublethal doses in animals treated for internal 
parasites over a number of years and ivermectin has recently been marketed
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for topical application to control these insects. Secondly, I investigate the 
toxicity of these compounds to some of the insects associated with cattle 
faeces, as the degradation of cattle dung, especially through the action of 
imported insects such as dung beetles, is very topical. Finally, I study the 
movement or disposition with time of ivermectin in the skin and fleece of both 
long- and short-woolled sheep, as the mobility of a compound in the fleece is 
extremely important in determining methods and strategies for the use of an 
insecticide for external parasite control in sheep.
The specific aims of this study are to:
- examine the response of the Australian sheep blowfly, Lucilia cuprina 
(Wiedemann), to avermectins and changes in susceptibility following 
laboratory selection,
- devise a method to determine dose response of the sheep body 
louse, Bovicola (Damalinia) ovis (Schrank), to avermectins and related 
compounds,
- define the responses of insecticide resistant populations of L. cuprina 
and B. ovis to ivermectin,
- examine responses of dung fauna to avermectins and related 
compounds in cattle faeces and determine the significance of this under 
practical usage patterns, and
- investigate the behaviour of topically applied avermectins on sheep, 
to relate this to the practical use of these compounds for parasite control and 
implications for the selection of resistance.
2
2. REVIEW OF LITERATURE.
2.1. Avermectins.
2.1.1. Discovery and Chemistry.
The naturally occurring avermectins are fermentation products of the 
actinomycete Streptomyces avermectilis, which was first isolated from a soil 
sample collected near a golf course in Japan (Campbell et al 1984). They 
are closely related sixteen membered macrocyclic lactones, which have 
structural similarities to antibacterial macrolides and antifungal polyenes but 
lack their antifungal or antibacterial activities and do not inhibit protein or 
chitin synthesis (Fischer and Mrozik 1989). Four homologous pairs of closely 
related compounds are produced through the fermentation of S. avermectilis, 
each pair comprising a major and minor component usually produced in the 
approximate ratio of 8 : 2 (Lasota and Dybas 1991). A mixture of one of 
these pairs, avermectin B1 (>80% B1a and <20% B1b) commonly called
abamectin was found to be active against nematodes (Burg et al 1979, 
Egerton et al 1980), insects (Ostlind et al 1979, James et al 1980, Wright 
1984) and mites (Putter et al 1981).
Ivermectin, the semisynthetic 22,23-dihydro derivative of avermectin B1 was
the first commercially produced avermectin, introduced in 1981 for use 
against a range of nematode and arthropod parasites (Jackson 1989). Like 
abamectin, ivermectin is a mixture of two homologs known as ivermectin B1a
(> 80%) and B1b (< 20%) (Campbell et al 1983). Abamectin was introduced 
as an antiparasitic drug and an agricultural insecticide and miticide in 1985 
(Campbell 1989). Another group of macrocyclic lactones with a similar 
spectrum of activity have also been developed as parasiticides. Known as 
milbemycins these fermentation products of Streptomyces hygroscopicus
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aureolacrimosus are structurally similar to the avermectins but lack the 
disaccharide substituent at C-13 (Tackiguchi et a /1980).
The chemical structure of avermectin B1a is given in Fig. 2.1. Ivermectin B1a
differs in the loss of the 22,23-double bond, thus 22 and 23 are dihydro 
carbons. The B1b components of each vary from the respective B1a structure 
by the replacement of a CH2CH3 group with a CH3 (Fischer and Mrozik 1989). 
Ivermectin is also commonly referred to as 22,23-dihydroavermectin Bv 
These compounds have strong ultraviolet absorption at 245 nm, a feature 
which is of value in analytical detection. Avermectins are highly lipophilic, 
soluble in most organic solvents but almost insoluble in water (Fisher and 
Mrozik 1989). Ultraviolet light rapidly decomposes avermectins and 
prolonged exposure results in a large number of products which lack any UV 
absorption (Mrozik et al 1988), and are less toxic (Halley et al 1989a). The 
half-life of ivermectin, exposed to sunlight as a thin film on glass is about 
3 hours (Halley et al 1989b).
2.1.2. Mode of Action.
The mode of action of avermectins has proved difficult to define (Jackson 
1989). While it is generally agreed that avermectins specifically increase the 
permeability of nerve membranes to chloride ions causing disruption to 
neurotransmission, there are clearly a number of different sites of action 
(Turner and Schaeffer 1989). Primary action was thought to be due to 
effects on the gamma-aminobutyric acid (GABA) mediated chloride ion 
channels (Fritz et al 1979, Mellin et al 1983, Albert et al 1986). Studies 
utilising the motor nervous system model of the nematode, Ascaris 
lumbricoides, indicated that avermectins could act as either a stimulator of 
GABA release from presynaptic inhibitory terminals or as a GABA inhibitor 
(Kass et al 1980, 1984). However, Duce and Scott (1983, 1985) studying the
4
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Figure 2.1. Chemical structure of avermectin B1a (the major component of 
abamectin), ivermectin differs in the loss of the double bond between carbons 
22 and 23. The B1b components of each vary from the respective B1a 
structure in the replacement of a CH2CH3 group (*) with a CH3.
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locust, Schistocera gregaria Forskal, showed that avermectins produced an 
increase in chloride ion conductivity in nerve tissues not mediated by GABA 
as well as in those that were. In contrast, Mellin et al (1983) found no effect 
on non-GABA neurons in the cockroach, Periplaneta americana (L.). More 
recently the effects of ivermectin on single chloride ion channels in muscle 
membranes of the nematode, Ascaris summ, have been examined (Martin 
and Pennington 1988). They found that non-GABA mediated chloride ion 
channels were irreversibly opened by ivermectin at concentrations much 
lower than those required to affect GABA-gated channels in the same 
preparation.
A number of avermectin binding sites have been identified in membrane 
preparations of the free living nematode, Caenorhabditis elegans, and a 
variety of neurotransmitters, including GABA had no effect on avermectin 
binding (Schaeffer and Haines 1989). Avermectins have been shown to have 
no effect on radio-labelled GABA binding at specific, high-affinity GABA 
binding sites, also identified in C. elegans (Schaeffer and Bergstrom 1988). 
However, avermectin-sensitive GABA-binding sites have been identified in 
P. americana (Lummis and Sattelle 1985) and avermectin acts as a partial 
agonist at a GABA-binding site in honey bees (Abalis and Eldefrawi 1986). 
Tanaka and Matsamura (1985) found that avermectin stimulated chloride ion 
uptake in leg muscle of P. americana; they suggested that this was not due to 
activity at the GABA binding site but direct action at the chloride ion channel. 
Tanaka (1987) determined that abamectin and milbemycin act directly on a 
chloride channel on the nerve plasma membrane of P. americana, and that 
this action was not mediated by GABA, picrotoxinin, or benzodiazepam 
receptors. Again in P. americana, Nicholson et al {1988) measured 
acetylcholine release in a central nervous system preparation. They 
concluded that avermectins acted on a non GABA-mediated chloride
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channel, with the resultant depolarisation of the nerve terminal leading to 
increased acetylcholine release. Deng and Casida (1992) examined the 
interactions of radio-labelled avermectin with nerve membranes from house 
fly heads and hypothesised that avermectins may have multiple binding sites 
at each chloride channel, or that they bound to GABA-gated channels at low 
concentrations and at other chloride channels at higher concentrations.
Of the vertebrates, only fish are uniformly susceptible to avermectin toxicity 
(Wislocki et al 1989). In mammals, GABA-mediated nerve transmission is 
confined to the central nervous system and avermectins do not readily 
penetrate the blood-brain barrier. Mammals are thus relatively insensitive to 
avermectins (Jackson 1989). Most studies of mode of action in vertebrates 
have thus concentrated on brain tissue preparations. Pong et al (1980) 
determined that avermectins stimulated GABA release from rat cerebral 
cortex synapses, and Pong and Wang (1982) identified specific avermectin 
binding sites in dog brain synaptosomes. They found the highest density of 
these sites in the region of the brain with the greatest concentration of 
GABA-binding sites, however, GABA was observed to have no effect on 
these avermectin binding sites. By contrast, Drexler and Sieghart 
(1984a,b,c) working with specific avermectin binding sites in rat brain 
membrane preparations found partial inhibition of binding in the presence of 
GABA. GABA agonists had similar effects, and avermectin binding was also 
blocked by chloride ions. Avermectins have been shown to increase chloride 
ion uptake in vertebrates (Sigel and Bauer 1987, Sonderland et al 1987) with 
enhancement of GABA-mediated chloride channels.
In summary, while a single mode of action cannot be assigned, the major 
effect of avermectins in susceptible invertebrates is mediated by a specific 
binding site. The physiological response is increased permeability of nerve
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membranes to chloride ions independent of GABA-mediated channels. The 
relative importance of the many other actions of avermectins is yet to be 
resolved. In vertebrates, activity is generally of a much lower order and is 
associated with GABA-mediated pathways (Lasota and Dybas 1991).
In comparison with other neurotoxic agents avermectins are considered to be 
relatively slow acting (Wright 1986, Strong and Brown 1987, Abro et al 
1988). Affected organisms usually die slowly, often over a period of days, 
and there is no quick knockdown effect like that achieved with the use of 
some pyrethroids and organophoshates (Jackson 1989). Death usually 
follows paralysis and immobility. Agee (1985) described symptoms of 
abamectin poisoning in Heliothis zea Boddie; insects showed a gradual loss 
of locomotor coordination followed by torpor with complete loss of locomotor 
activity. This slow action could possibly be due to progressive paralysis of 
the organism's feeding, resulting in slow accumulation of the toxin, or due to 
death resulting from starvation (Jackson 1989). However, it is apparent that 
there is a direct neurotoxic effect, as adults of H. zea died more rapidly from 
abamectin poisoning than from starvation (Agee 1985), and poisoned 
Blattella germanica (L.) ate less than controls, but starved controls did not die 
(Cochran 1985). The blood-sucking bug Rhodnius prolixus Stal, can survive 
for months after a blood meal, but die in 9 days after ingestion of ivermectin 
(De Azambuja et al 1985). While avermectins are effective through both 
topical and oral routes in lepidopteran larvae, toxicity is generally greater 
through ingestion than by residual contact (Wright et al 1985, Anderson et al 
1986, Bull 1986, Corbitt et al 1989).
8
2.1.3. Uses.
Worldwide, avermectins have generally been partitioned for use either in 
animals or against agricultural and household arthropod pests. Ivermectin is 
primarily used for the treatment of internal and external parasites of animals 
and man, while abamectin has been developed mainly as an insecticide and 
acaricide (Lasota and Dybas 1991). Avermectins registered for use in 
Australia include ivermectin as an oral drench for sheep and horses, and as 
an injectable and pour-on formulation for cattle, and abamectin as an 
injectable for cattle. All these products have claims against a range of 
gastrointestinal nematodes, lungworms, and a number of arthropod 
parasites. Ivermectin is also registered for the prevention of heartworm 
infection in dogs, and has recently been released for control of blowfly stike 
and treatment of lice in sheep. Ivermectin has been shown to be effective 
against a number of dipteran parasites of cattle when used as a systemic 
parasiticide. Uribe et al (1989) showed that a backline formulation of 
ivermectin controlled larvae of torsalo fly, in a similar fashion to subcutaneous 
injection. Miller et al (1986) demonstrated that the therapeutic anthelminthic 
(subcutaneous) dose of ivermectin would be effective against the blood­
feeding horn fly for more than 2 weeks. Similarly, the therapeutic dose has 
been demonstrated to kill implanted old world screw-worm fly larvae up to 
two weeks after treatment (Spradbery et al 1985). Standfast et al (1984) 
found that this same dose in cattle produced 99% mortality in engorged 
ceratopogonid midges 48 hours after feeding, for 10 days after treatment. In 
vitro studies have demonstrated that the subcutaneous dose of ivermectin in 
cattle kills 98% of buffalo flies fed for 7 days on blood taken 1 day after 
treatment (Kerlin and East 1992).
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2.1.4. Excretion in Mammals and Effects of Residues in Faeces.
While the route of dosage and the species treated may produce variation, 
blood levels of ivermectin generally peak within 3 days of treatment (Pritchard 
et al 1985, Marriner et al 1987, Bogan and McKellar 1988, Fink and Porras 
1989, Scott et al 1990). The majority of the dose is excreted in the faeces 
(Campbell et al 1983) with about 70% of the dose passed within 7 days of 
dosing (Chiu and Lu 1989). Chiu et al (1990) examined the metabolism and 
excretion of radio-labelled ivermectin. Following subcutaneous injection of 
ivermectin at 300 pg/kg, faecal residues peaked at approximately 800 pg/kg 
(wet weight of faeces) 2 days after injection, and declined slowly to about 
300 pg/kg at the end of the experiment, 5 days later. Sommer et al (1992) 
and Sommer and Steffansen (1993) used HPLC with fluorescence detection 
to quantify ivermectin levels in faeces of cattle following treatment by 
subcutaneous injection (200 pg/kg) or pour-on (500 pg/kg), and found that 
levels peaked at about 9 mg/kg 1 day after treatment for the pour-on, and 
about 4 mg/kg at the second day after treatment for the injection; both these 
values are per dry weight of faeces. These workers also determined that 
ivermectin residues did not markedly decrease as the pats aged. By 
contrast, Lumaret et al {1993) found that faecal residues of ivermectin 
peaked at 0.42 mg/kg (wet weight of faeces) 5 days after subcutaneous 
injection (200 pg/kg), and was rapidly degraded (to undetectable levels in 
under 6 days) in pats exposed to field conditions.
Avermectins excreted in faeces can have a significant effect on dung fauna. 
The species most studied have been dung-breeding Diptera and dung 
beetles. A number of workers have shown that ivermectin excreted in cattle 
faeces kill larvae of a number of muscid flies for up to 4 weeks after treatment 
(Meyer et al 1980, Schmidt and Kunz 1980, Miller et al 1981, Schmidt 
1983, Ridsdill-Smith 1988, Wardhaugh and Rodriguez-Mendez 1988,
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Wardhaugh and Mahon 1991, Marley efa/1993). Similarly, avermectin 
residues in faeces have been demonstrated to be toxic to larvae of dung 
beetles (Ridsdill-Smith 1988, Wardhaugh and Rodriguez-Mendez 1988, 
Sommer et al 1992, 1993, Sommer and Nielsen 1992). Wardhaugh et al 
(1993) found that insects feeding on the dung of sheep treated orally with 
ivermectin displayed similar effects to those reported for cattle dung, but 
observed that the duration of the adverse effects was much shorter.
The possible effects of avermectins and other "feed through" compounds on 
dung degradation is of some controversy. A number of workers have 
demonstrated that degradation may be delayed (Wall and Strong 1987, 
Madsen et al 1990, Sommer et al 1992, Strong 1992), while others have 
shown no difference in rates of breakdown of pats from treated or untreated 
cattle (Jacobs et al 1988, McKeand et al 1988, Ewert et al 1991, Schaper 
and Liebisch 1991, Wratten et al 1993). In either case there is no dispute 
that residues may affect some dung fauna, but long term effects of these 
compounds on pat decomposition and dung fauna are yet to be elucidated.
In a recent study of the field effects of ivermectin residues on dung fauna, 
Lumaret et al (1993) examined toxicity of excreted dung to a muscid fly as 
well as dung beetles. While they clearly demonstrated toxic effects they were 
unable to define potential environmental risk, which they concluded was 
variable and dependent on the region, climate, season and insect fauna. 
Scholtz and Kruger (1995) found that dung insect diversity was depressed 
1 month after treatment with ivermectin of cattle under intensive farming 
conditions, but 2 months later there were no differences in the fauna of dung 
of treated and untreated cattle.
Similar controversy may follow the recently released milbemycin, moxidectin. 
One published report (Fincher and Wang 1992) indicated that excreted
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residues of this compound did not affect dung beetles, and an in vitro 
comparison of moxidectin and abamectin (Doherty et al 1994) found that 
abamectin was about 50 times more toxic to larvae of a dung beetle and 
buffalo fly than moxidectin in spiked faeces. However, Miller et al (1994) 
reported significant mortality in horn fly larvae in dung for up to 28 days after 
oral or injectable treatment with moxidectin. Further, a recent comparative 
study of ivermectin and moxidectin in Western Australia showed that both 
compounds when excreted in cattle faeces adversely affected two species of 
dung beetle (D. Cook and I. Dadour, Pers. Comm.).
2.2. Ectoparasites of Sheep.
Blowfly strike is considered the most important disease of sheep in Australia, 
causing wool loss, reduction of wool quality, and death of sheep (Arundel and 
Sutherland 1988). The Australian sheep blowfly, L. cuprina, is the major 
myiasis fly, initiating around 90% of all strikes, although a number of other 
calliphorid blowflies contribute significantly to primary and secondary strikes 
(Watts et al 1976, Murray 1978). L. cuprina is dependent almost entirely on 
the living sheep. Although it can breed in carrion, larvae do not successfully 
compete for the available food with other flies which primarily breed in carrion 
(Fuller 1936, Waterhouse 1947). Currently, the major chemicals used for 
the prevention of flystrike are the triazine, cyromazine, and 
organophosphorus insecticides. While there has been no indication of 
resistance to cyromazine, resistance to organophosphates is wide spread in 
field populations of L. cuprina (Hughes and McKenzie 1987). Field 
populations of L. cuprina have also been demonstrated to be resistant to 
carbamates (Roxburgh and Shanahan 1973a, Hughes 1981), cyclodienes 
(Shanahan 1958a), and specifically malathion (Hughes et al 1984, Raftos 
and Hughes 1986). High level resistance to pyrethroid insecticides has been 
produced through selection of L. cuprina in the laboratory (Sales et al 1989).
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The sheep body louse, B ovis, is the next most important ectoparasite of 
sheep, and in many seasons may supplant flystrike as the main cause of 
economic loss in the sheep industry (Arundel and Sutherland 1988). B. ovis 
is a biting louse which feeds at the skin surface, sheep responding to the 
irritation by biting, scratching, and rubbing, resulting in damage to the fleece 
and skin (Wilkinson et al 1982). Currently, B. ovis is controlled or treated 
using pyrethroids in dips or as off-shears pour-ons, or organophosphorus 
insecticides in dips or by jetting. Resistance to pyrethroids is currently 
widespread in many flocks (Levot and Hughes 1990), and often causes the 
failure of pour-on treatments for lice control (James et al 1993, Johnson et al 
1993). Increasingly, these resistant populations are also failing to be 
controlled using pyrethroids in a dip application (Keys et al 1993, Morcombe 
and Young 1993), and populations with very high levels of resistance are 
being identified (Levot 1992, Martin 1993). Also a field population of sheep 
body louse resistant to the organophosphates, diazinon and coumaphos, yet 
very susceptible to pyrethroids has been detected (Levot 1991). Recently, 
Levot (1994) demonstrated high levels of synergism of pyrethroids with 
piperonyl butoxide, in strains of lice with varying levels of pyrethroid- 
resistance, and Kotze (1994) has reported enhanced monooxygenase activity 
in pyrethroid-resistant lice, implicating metabolism by monooxygenases as a 
major factor in resistance.
2.3. Avermectins and Ectoparasites of Sheep.
Ivermectin as a drench for sheep is used at a dose rate of 200 mg/kg. At this 
dose rate it is also effective against the nasal bot, Oestrus ovis L., (Roncalli 
1984) and the sheep itchmite, Psorergates ovis Womersly, (Hotson 1983), 
but is not effective against the major ectoparasitic insects, strike blowflies and 
the sheep body louse (Hotson 1983). However, East et al (1992)
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demonstrated that larvae of L. cuprina cultured in vitro on serum from sheep 
treated orally with ivermectin had significantly reduced growth. This effect 
though was only observed for serum collected 1 day after treatment, at 
6 days after treatment there was no significant result. James et al (1980) 
found that both crude and partially purified avermectins were active against 
L. cuprina both in vitro and on sheep. Hughes and Levot (1990) examined 
the dose responses of early instars of a number of strains of L. cuprina to 
three avermectins. They found that larvae were highly susceptible, LC50
values being around 3 pg/L in an in vitro assay. Adult female L. cuprina fed 
sheep dung containing ivermectin residues have been shown to have 
reduced fecundity, survival, and delayed reproductive development (Cook 
1991, Mahon and Wardhaugh 1991). Orton et al (1992) investigated the 
activity of avermectins as oviposition suppressants in L. cuprina. While the 
compounds tested were effective in suppressing oviposition this was related 
to general toxic effects and was only apparent at levels producing significant 
mortality. Recently, ivermectin has been demonstrated to be effective as a 
prophylactic treatment for blowfly strike of sheep when applied topically by 
hand jetting (Rugg et al 1992, Eagleson et al 1993b) and by automatic jetting 
machine (Thompson et al 1994a). Ivermectin was also shown to kill actively 
feeding larvae of the Australian sheep blowfly when when applied to struck 
sheep by hand jetting (Thompson et al 1994b). This topical application of 
ivermectin is also effective for the reduction of infestations of lice in long- 
woolled sheep (Eagleson et al 1993a, Thompson et al 1994c).
2.4. Avermectins and Resistance.
2.4.1. Arthropods.
The first confirmed incidence of field resistance to an avermectin was 
reported recently by Immaraju et al (1992). They found two resistant 
populations of western flower thrips in Californian glasshouses. Resistance
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ratios (LCqq) of 18-fold and 798-fold appeared to relate to intensive use of 
abamectin during the previous year (five and ten applications, respectively). 
An earlier report of resistance in citrus thrips (Morse and Brawner 1986) was 
based on very low differences in response (2- to 3-fold) and probably 
reflected inherent strain variation.
Previously, cross-resistance to abamectin from pyrethroids has been 
reported for field strains of house flies (Scott 1989). Abro et al (1988) 
proposed that there was a very low level of cross resistance to abamectin in 
a field strain of diamondback moth highly resistant to DDT, malathion and 
cypermethrin . However, Roush and Wright (1986) found no evidence of 
cross resistance to avermectins in house flies resistant to diazinon, dieldrin, 
DDT or permethrin, and Parella (1983) reported no cross resistance to 
avermectins in a pyrethroid-resistant agromyzid fly. Campanhola and Plapp 
(1989) determined that there was no cross resistance to abamectin in 
pyrethroid-resistant tobacco budworm, where both target site and metabolic 
resistances to pyrethroids were present. Similarly, Cochran (1990) 
concluded that pyrethroid-resistant field populations of German cockroach 
were not cross resistant to abamectin. Argentine and Clark (1990) examined 
a laboratory susceptible and a multiple resistant field strain of Colorado 
potato beetle, and found no difference in their dose responses to abamectin. 
No cross resistance to abamectin was observed in a laboratory-selected 
pyrethroid-resistant strain of citrus thrip, though cross resistance was 
detected to DDT and some organophosphates and carbamates (Immaraju 
and Morse 1990). Beeman and Stuart (1990) examined a number of 
pesticides against a field collected strain of red flour beetle resistant to 
lindane. It had been further selected with dieldrin in the laboratory. These 
workers found cross resistance to other cyclodienes, but not to abamectin or 
organophosphates. Resistance to cyclodienes usually extends to all
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insecticides which block chloride ion channels, and this resistance is not 
conferred to avermectins as these activate chloride channels (Bloomquist 
1993). Ismail and Wright (1991) examined the toxicites of a number of insect 
growth regulators, and abamectin, to a susceptible strain of diamondback 
moth and to strains selected with two growth regulators. They found that 
cross resistance to other growth regulators was variable and none to 
abamectin.
Scott (1989) proposed that cross-resistance to abamectin in pyrethroid- 
resistant houseflies was polygenic and due to decreased cuticular 
penetration and enhanced metabolism mediated by mixed-function oxidases. 
Subsequently, Scott et al (1991) reported laboratory selection of high-level 
abamectin resistance in these field-collected house flies; after seven 
selections resistance ratios of >60,000-fold (determined by topical 
application) and 36-fold (determined by residual exposure) were reached. In 
their study the synergists piperonyl butoxide, diethyl maleate, and S,S,S- 
tributylphosphorotrithioate did not affect the toxicity of abamectin, indicating 
that resistance was not due to enhanced metabolism mediated by mixed 
function oxidases, glutathion transferases or hydrolases. Konno and Scott 
(1991) found that resistance in this selected strain resulted from decreased 
cuticular penetration (>1,700-fold) and altered abamectin binding (35-fold). 
This strain was also cross-resistant to two abamectin analogues and 
resistance was highly recessive.
Laboratory selection of two strains of Colorado potato beetle with abamectin 
resulted in resistance levels at LD97 of 21-fold for a mutagen-induced
resistance and 38-fold by direct selection. Both resistance factors were 
incompletely dominant and polyfactorial (Argentine and Clark 1990). It was 
suggested that oxidative metabolism and possibly carboxylesterase activity
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could be partially responsible for abamectin resistance (Argentine 1991, 
Argentine et al 1992).
Laboratory selection (up to 15 generations) of two species of tetranychid 
mites produced no significant differences in responses of selected and 
unselected mites (Hoy and Conley 1987). However, 20 selections of a 
predatory phytoseiid mite resulted in a gradual and modest shift in 
susceptibility to abamectin (Hoy and Ouyang 1989). A recent survey of field 
populations of two spotted spider mite in California (Campos et al 1995) 
found that mites varied greatly in their susceptibility to abamectin, with up to 
658-fold variation in responses in a residual exposure assay. This resistance 
was correlated with the amount and time of abamectin usage, and laboratory 
selection of one population of these mites resulted in a greater than 100-fold 
increase in resistance over 38 cycles of selection. However, the selected 
mites still had a susceptible response in a direct contact assay, and despite 
the varying responses of field populations no field failures of the product were 
observed.
2.4.2. Helminths.
Ivermectin resistance has been detected in a number of strains of nematodes 
of sheep and goats, and the subject of ivermectin resistance in veterinary use 
has been reviewed recently by Shoop (1993). In summary, resistance has 
only been detected in nematodes of sheep and goats, and is generally a 
result of intensive use over a number of years. There is no evidence of cross 
resistance to ivermectin from other chemical groups, however, ivermectin- 
resistant nematodes have been shown to have cross resistance to other 
avermectins and milbemycins (Shoop et al 1993), even though moxidectin 
appears to be significantly more toxic to some parasitic nematodes (See 
Kieran 1994). Conder et al (1992) showed that the modes of action of
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ivermectin and moxidectin were qualitatively similar by examining changes in 
membrane conductance in crab muscle fibres. These workers also 
demonstrated cross resistance to moxidectin in an ivermectin-resistant strain 
of Haemonchus contortus. The mechanism(s) of resistance in nematodes is 
unknown, but not thought to involve target site modification (Rohrer et al 
1994).
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3. SELECTION OF LUCILIA CUPRINA AND RESPONSES OF FIELD AND 
SELECTED STRAINS TO IVERMECTIN.
3.1. Introduction.
The mass laboratory selection of organisms has been widely used as a 
predictive model for the development of resistance in the field. However, 
some concern has been expressed about the relevance of extrapolation of 
laboratory-derived resistances to field situations (Whitten and McKenzie 
1982, Roush and McKenzie 1987, Roush and Daly 1990). The major 
differences between the two resistances relate to genetic control. It is 
generally considered that insecticide resistance in the field is monogenic 
(controlled by a single gene), while polygenic resistance (multiple 
mechanisms controlled by a number of genes) is more often observed in 
laboratory-derived strains. The two factors that contribute to these results 
are thought to be the relatively small sample population in laboratory strains 
and the precise selection pressure applied in the laboratory (see Roush 
1990). However, laboratory selection is still used to investigate the possible 
development of resistance (eg. Hoy and Conley 1987, Hoy and Ouyang 
1989) and is considered to be the most practical method to develop resistant 
strains before the widespread use of a pesticide in the field (Immaraju and 
Morse 1990).
L. cuprina has rapidly developed resistance to the chemicals used to control 
fly strike in the field. Resistances have been detected to dieldrin (Shanahan 
1958b), diazinon (Shanahan and Hart 1966), and butacarb (Shanahan 1967). 
All of these resistances were detected less than 7 years after the widespread 
use of these chemicals for blowfly control. Laboratory selection of L. cuprina 
for 50 generations failed to select for diazinon resistance prior to its detection 
in the field (Shanahan 1965). However, laboratory selection has been shown
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to markedly increase the level of resistance of resistant field strains to 
diazinon (Harrison 1967, Hart 1969, Shanahan and Roxburgh 1974, O'Flynn 
and Green 1980), butacarb (Roxburgh and Shanahan 1973a), malathion 
(Hughes et al 1984) and propetamphos (Levot 1990). Also laboratory 
selection of a pyrethroid-susceptible field strain resulted in 25-fold resistance 
to deltamethrin (Sales et al 1989), and subsequent selection pressure has 
resulted in a resistance factor in excess of 1000-fold . Laboratory selections 
with diflubenzuron and butacarb have also caused resistances to these 
compounds of more than 1000-fold (Kotze and Sales 1994). These workers 
also found that metabolic inhibitors significantly synergised the three strains, 
indicating the involvement of both monooxygenases (mixed-function 
oxidases) and esterases in these resistances. Kotze (1995) found that the 
induction of monooxygenase and glutathione transferase enzymes with 
phénobarbital in insecticide-susceptible L. cuprina larvae resulted in 
increased tolerance to butacarb, diazinon and diflubenzuron. The laboratory- 
selected resistant strains of L. cuprina have been shown to have enhanced 
monooxygenase levels (Kotze 1993). Enhanced metabolism by 
monooxygenases has been proposed as a contributing mechanism to 
abamectin resistance in houseflies (Scott 1989). The major mechanism in 
diazinon resistance in L. cuprina is enhanced metabolism mediated by a 
number of carboxylesterases (Hughes 1982, Hughes and Devonshire 1982). 
Esterase synergism and elevated hydrolytic activity in an abamectin-resistant 
strain of Colorado potato beetle indicates the possibility of a 
carboxylesterase-based resistance in this insect (Argentine et al 1992).
Thus, both the major metabolic resistance mechanisms occurring in L. 
cuprina (i.e. monooxygenases and carboxylesterases) have been implicated 
in resistances to avermectins in other insects.
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Hughes and Levot (1990) reported that a laboratory-selected strain of 
L. cuprina resistant to organophosphates and carbamates exhibited low level 
cross-resistance (2- to 3-fold) to ivermectin when compared to susceptible 
flies. This strain was also slightly cross-resistant to pyrethroids (Sales et al 
1989). These workers also demonstrated that a laboratory-selected 
pyrethroid-resistant strain was cross resistant to diazinon and butacarb.
Cross resistance to abamectin in pyrethroid-resistant houseflies has been 
suggested (Scott 1989, Geden et al 1990), but other workers have found no 
evidence of this in houseflies (Roush and Wright 1986), agromyzids (Parella 
1983) or German cockroaches (Cochran 1990).
It has been proposed that selection for resistance to insecticides in L. cuprina 
may begin or be enhanced by exposure to residues following treatment for 
other parasites (McKenzie and Whitten 1984, Hughes and McKenzie 1987). 
Ivermectin has been widely used as an anthelminthic in sheep since 1987. 
While administration is oral, there are significant levels in the blood for some 
time after administration and plasma levels peak at about 20 pg/L 1 day after 
treatment then decline to around 5 pg/L by day 5, and to undetectable levels 
(< 0.5 pg/L) after 2 weeks (Marriner et al 1987). Thus there could have been 
significant exposure to larvae of L. cuprina of lethal and sublethal 
concentrations of ivermectin in the field over the past 7 years. This 
supposition is supported by anecdotal information from farmers claiming that 
blowfly larvae in sheep struck at the time of treatment with ivermectin are 
rapidly killed.
To determine if a mechanism for avermectin resistance was present in the 
field population or could be generated in the laboratory, I selected a 
composite field strain of L. cuprina for over 60 generations. The selected 
strain was tested for cross resistance to other insecticides and examined with
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metabolic inhibitors. The effects of phénobarbital induction on both selected 
and unselected strains were investigated, and monooxygenase levels were 
determined for both strains. To investigate the possibility of cross-resistance 
between pyrethroids or organophosphates and ivermectin the responses of 
two highly selected laboratory strains resistant to diazinon or deltamethrin 
were assessed. Further, the responses to ivermectin of nine individual field 
strains (including seven with known monooxygenase levels) collected during 
the 1992 - 93 and 1993 - 94 blowfly seasons were examined to indicate the 
range of field responses.
3.2. Materials and Methods.
3.2.1. Insects.
The initial culture for selection was obtained from the Biological and Chemical 
Research Institute (BCRI), NSW Agriculture in April 1990. This was a pooled 
field strain derived from larvae collected from over 30 separate field strikes 
during the 1989-90 blowfly season, and was termed CFS89. A laboratory- 
susceptible strain (LS) was obtained from the same laboratory. An 
organophosphate-resistant strain (Q20) was in culture at Merck Sharp and 
Dohme (MSD) Veterinary Research and Development Laboratory (VRDL) 
and had been maintained for at least 15 years under selection of each 
generation by immersion of newly-hatched first instars for 15 minutes in 
aqueous diazinon. This process had resulted in a population with a 
resistance factor to diazinon in excess of 80-fold, representing a level of 
resistance over two times greater than that seen in the most resistant field 
strains (G. W. Levot, NSW Agriculture, Pers. Comm.). Recently selection 
pressure had been relaxed and the strain was subsequently selected every 
four generations with diazinon at 1 mg/mL for 24 hours in the bioassay 
described below (see 3.2.3.) to allow reversion to a level more representative
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of high level field resistance. Assays with a laboratory selected pyrethroid- 
resistant strain (DL, selected by exposure in similar larval bioassays [Sales et 
al 1989]) were conducted at BCRI in comparison with the LS strain and a 
pooled field strain (F90) collected from 37 field strikes during the 1990-91 fly 
season. Seven field samples were obtained from BCRI which had been 
cultured from individuals collected from field strikes during the 1992-93 fly 
season. Two field strains were collected from struck sheep during the 1993- 
94 season by MSD field staff.
Adult flies were maintained in 30 x 30 cm aluminium-framed mesh cages and 
provided with cubed sugar and water. Approximately 6 days after emergence 
they were provided with sliced liver, as a source of protein for sexual 
maturation, over 2 days. Three days later liver was again introduced as a 
substrate for egg laying. Cultures were generally egged again after a further 
7 days. Liver and eggs held in a petri dish were wrapped in moistened 
absorbent paper and left overnight to hatch. About 5000 newly emerged 
larvae were placed on approximately 1 kg of chuck steak on vermiculite in a 
culturing tray in a vented cabinet to complete development. Pupae were 
sieved from the vermiculite and placed in a cage after 7 to 10 days. All 
stages were cultured at 27±2°C and 70% RH.
3.2.2. Chemicals.
General chemicals and solvents were analytical grade or better and obtained 
from commercial sources. Ivermectin was either commercially formulated 
product (Jetamec, 75 mg/mL in propylene glycol, MSD Aust. Granville, NSW) 
or an analytical standard (1 mg/mL in methanol) supplied by Merck and Co. 
Whitehouse Station, New Jersey. Diazinon (Topclip Blue Shield, diazinon 
200 g/L, Ciba-Geigy Aust. Pendle Hill, NSW), cypermethrin (Outflank Pour- 
On, cypermethrin 25 g/L, Cyanamid Aust. Baulkham Hills, NSW), and
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moxidectin (Vetdectin Injection for Cattle, moxidectin 10 g/L Cyanamid N.Z., 
Auckland) were commercially formulated product. The synergists/ metabolic 
inhibitors piperonyl butoxide (PBO, an inhibitor of monooxygenases), S,S,S- 
tributyl phosphorothioate (DEF, a putative inhibitor of esterases) (Bull and 
Pryor 1991), triphenyl phosphate (TPP, a carboxylesterase synergist) and 
tridiphane (TRI, a glutathione transferase inhibitor) (Lamoureux and Rusness 
1986), and the monooxygenase inducer, phénobarbital were obtained from 
Dr A. C. Kotze, NSW Agriculture. Newborn calf serum was obtained from 
Flow Laboratories, North Ryde, NSW. Yeast extract was purchased from 
Bacto Laboratories, Liverpool, NSW.
3.2.3. Bioassay and Selection.
The basic bioassay followed the method of Roxburgh and Shanahan (1973b). 
Insecticides were diluted in methanol or acetone; 1 mL of solution was 
applied to a 12 x 3 cm strip of blotting paper and allowed to dry. Individual 
strips were rolled lengthwise and flattened laterally to allow air spaces 
between the layers of rolled paper before being placed in a 8 x 25 mm glass 
or polystyrene vial. One mL of bovine serum (O'Flynn and Green 1980) 
fortified with yeast extract (2% w/v) and buffered with monobasic potassium 
orthophosphate (0.5% w/v) (Hughes and Levot 1990) was then added to 
each tube. Approximately 50 -100 newly hatched first instar L. cuprina were 
added to the tube which was plugged with cotton wool. Assay tubes were 
held at 27±2°C and 70% RH. For concentration-response assays 
approximately seven concentrations and a solvent control were used for each 
insecticide with from two to four duplicate tubes for each concentration. 
Mortalities were assessed by counting dead and live maggots after 48 hours 
for avermectins and moxidectin, and 24 hours for all other insecticides.
Probit analyses were performed on a personal computer using a fortran 
program which incorporates correction for control mortality (Davies 1971).
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Only those concentrations producing >0 or <100% mortality were used in the 
analyses. Significant difference between LC values was based on the non­
overlap of 95% Fiducial Limits.
Selection was carried out on newly-hatched larvae, using the bioassay 
system. More than 2000 larvae were placed in 20 tubes containing papers 
treated with a concentration expected to produce greater than 70% mortality. 
This dose was generally based on the response of the previous generation. 
After 48 hours the larvae were rinsed from the tubes and placed on chuck 
steak to complete development under standard culture conditions. Larvae 
from the selected line were also cultured without selection pressure each 
generation, and used to maintain the selected strain if there was unexpected 
high mortality due to selection. After 34 generations a parallel line of 
L. cuprina was cultured from the selected strain to allow examination of 
reversion (if any) in the absence of selection pressure. The parental strain 
(CFS89) was also tested whenever the concentration response of the 
selected strain was examined.
3.2.4. Effects of Synergists/ Inhibitors and Phénobarbital Induction.
The effects of synergists/ metabolic inhibitors were also assessed using the 
same bioassay system. Initially, this was by co-treatment using the 
compounds at the following concentrations, PBO 50 mg/L, DEF 10 mg/L, 
TPP 1 mg/mL, and TRI 500 mg/L. These solutions were applied to papers, 
which were allowed to dry before being treated with acetone (control) or 
dilutions of ivermectin. CFS89 and the selected strain at generation 25 were 
assessed using these conditions. In a later experiment CFS89 and selected 
larvae (generation 45) were pretreated with PBO at 100 mg/L, TPP at 2 
mg/mL, TRI at 1 mg/mL, or acetone (control) in the bioassay system for 6 
hours before being transferred to standard concentration-response assays.
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Phénobarbital induction experiments basically followed the method of Kotze 
(1995) and again involved pretreatment in bioassay tubes. Newly emerged 
larvae were exposed to 0.3 mg/mL phénobarbital in serum for 6 hours before 
being transferred to concentration-response assays. The LS strain was 
examined as well as the CFS89 strain, and the selected strain at generation 
42, as induction was expected to be greatest in the most susceptible strain.
3.2.4. Monooxygenase levels.
Aldrin epoxidase activity was determined as an indicator of relative 
monooxygenase levels of the selected and parental strains. The selected 
strain was assessed at generations 40, 41 and 42, and compared with 
CFS89. Assays were carried out by A. C. Kotze, NSW Agriculture.
Newly-hatched first instar larvae were transferred to bioassay tubes 
containing fortified, buffered serum, and allowed to develop for 24 hours. 
Larvae were then washed from the tubes, rinsed in distilled water, and dried. 
Five batches of approximately 30 larvae were weighed and counted to allow 
determination of mean larval weight. For each strain, two batches of 
approximately 500 mg of larvae were used for replicate enzyme preparations. 
Larvae were homogenised in 0.1 M sodium phosphate buffer (pH 7.5), 
containing glycerol (0.1 mLVmL), bovine serum albumin (BSA, 5 mg/mL),
1mM phenylmethylsulfonyl fluoride (PMSF) and 1mM 1-phenyl-2-thiourea 
(PTU) (both dissolved in 2-ethoxyethanol), ethylenediaminetetraacetic acid 
(EDTA, 1mM), and polyvinylpolypyrolidone (PVPP, 5% weight/larval weight) 
using a motor-driven glass homogeniser with a teflon pestle. The 
homogenate was then filtered through a single layer of polyester fibre.
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The filtrate was then centrifuged at 10,000 g for 10 minutes, the supernatant 
was filtered through glass wool and re-centrifuged at 100,000 g for 1 hour. 
The microsomal pellet was re-suspended in 0.1 M sodium phosphate buffer 
(pH 7.5), containing glycerol (0.2 mUmL), PMSF (1 mM), PTU (1mM) and 
EDTA (1mM). Microsomal protein in this enzyme preparation was 
determined using the method of Bradford (1976) with BSA as the standard.
Assays were carried out in 35 mL centrifuge tubes at 35°C. The 5 mL 
incubation contained from 0.5 - 1 mg microsomal protein in re-suspension 
buffer with BSA (5.0 mg/ml_), NADP (1.08 pmol), glucose-6-phosphate 
(12.4 pmol), and glucose-6-phosphate dehydrogenase (2 units). The 
reaction was initiated by the addition of aldrin (274 nmol in 100 pi of 2- 
ethoxyethanol). After 15 minutes the reaction was terminated by the addition 
of 3 M HCI (2 mL). Dieldrin was extracted with hexane and analysed on a 
Varian 2700 gas chromatograph using ECD detection (Column: 2 m x 2 mm 
i.d. glass, Matrix: 1.5% SP-2250 / 1.95% SP2401 on 100/120 Supelcoport 
(SGE Chromatography, Ringwood, Vic.), Carrier gas: nitrogen 90 mL/min., 
Injector: 220°C, Column: 215°C, Detector: 310°C). Determination was by 
peak height comparison with dieldrin standards.
The results were examined with analysis of variance using a randomised 
complete block design, with the results blocked by generation (date of 
assay), and the treatment comparisons being selected strain versus CFS89, 
for microsomal protein, and for aldrin epoxidase activity expressed per mg 
protein and per g larva. A random model was assumed for the analysis and 
F values were calculated using the experimental error mean squares. 
Analyses were conducted on a personal computer using Parastat (James 
1985).
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3.3. Results.
3.3.1. Selection Program.
Larvae of L. cuprina were selected for more than 4 years with ivermectin, with 
over 50 generations selected with concentrations ranging from 10 to 50 pg/L 
(Table 3.1.). The concentration-responses of the selected strain and the 
corresponding parental larvae are listed in Table 3.2. After the first selection 
the LCgo increased by a factor (selection ratio) of about 2-fold that of the
parental strain. With subsequent selections this selection ratio increased 
slowly to stabilise at approximately 8-fold (Figure 3.1.). The LC^ of the
parental strain remained stable at about 5 pg/L (range 2.9-10.8 pg/L) for the 
entire selection program, and a concentration of 25 pg/L reliably killed 95 - 
100% of CFS89 larvae. In most instances the LC^s of the two strains were
significantly different (based on non-overlap of 95% Fiducial Limits).
Following relaxation of selection pressure the selected strain reverted 
towards susceptibility fairly rapidly; within eight generations the LC^ value
dropped from 7-fold to 2-fold that of the parental strain, but stabilised at this 
slightly elevated level for subsequent generations (Table 3.3).
3.3.2. Cross Resistance to Other Insecticides
Moxidectin was the only compound tested to which the selected strain 
demonstrated any significant cross-resistance (Table 3.4). LCgo values of the
selected strain were generally significantly higher than those of the CFS89 
strain, and the resistance ratios were at least 60% of those for ivermectin.
The slopes of the concentration-response lines for moxidectin were relatively 
low (around 2) and generally similar for the selected and CFS89 strains 
indicating a definite population difference. By contrast both diazinon and 
cypermethrin produced only slightly increased responses in the selected
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strain, and generally these were not significantly different at LC^. For 
diazinon the increase in response was generally associated with a 
corresponding rise in the slope of the response line indicating the two 
responses may have been derived from the same population. For 
cypermethrin slopes were either similar or higher in the selected strain. 
Interestingly, relaxation of selection pressure did not result in any significant
reversion in response to diazinon; 29 generations after the cessation of 
selection, the selected strain (LC50 = 554.7 pg/L, 95% FL = 518.1-589.5 pg/L,
Slope = 6.7±0.6, n = 796) was still 1.9-fold more tolerant to diazinon than 
CFS (LCgo = 299.3 pg/L, 95% FL = 251.7-339.1 pg/L, Slope = 4.5±0.8, n =
648).
3.3.3. Effects of Synergists/ Inhibitors, and Phénobarbital Induction.
In initial experiments using co-treatment with synergists, DEF caused 100% 
mortality in both selected and unselected strains, and was not used in 
subsequent assays. PBO and TPP markedly increased the toxicity of 
ivermectin to both strains, while TRI appeared to synergise ivermectin 
against the selected strain but have little effect on CFS89 (Table 3.5., 3.6.). 
When the two strains were examined for their concentration-responses to 
ivermectin following pretreatment with synergists (Table 3.7.), only PBO
synergised both strains; this was most marked in the selected strain with a 
60% reduction in the LC50. TPP and TRI had no apparent effect on CFS but
a slight synergistic effect (-20%  reduction in LC50 values) on the selected
strain. However, due to the different strain responses all three synergists 
produced a similar reduction (-30% ) in the selection ratio.
Preliminary experiments indicated that induction with dietary phénobarbital 
had little effect on the responses of CFS89 and the selected strain to 
ivermectin and diazinon (no increased tolerance and about 2-fold increase
42
Table 3.5. Mortality (%) in unselected Lucilia cuprina larvae 
exposed to ivermectin, and co-treated with synergists.
Synergist* 
(cone., mg/mL)
Ivermectin (jjg/L)
0 2.5 5
0 0 5.0 42.0
PBO (0.05) 7.3 84.3 100
DEF (0.01) 100 100 100
TPP (1.0) 1.2 71.4 100
TRI (0.5) 0 5.6 63.4
*PBO = piperonyl butoxide, DEF = S,S,S-tributyl phosphorothioate, TPP = triphenyl phosphate, 
TRI = tridiphane.
Table 3.6. Mortality (%) in Lucilia cuprina larvae selected with 
ivermectin (generation 25) exposed to ivermectin, and 
co-treated with synergists.
Synergist* 
(cone., mg/mL)
Ivermectin (pg/L)
0 30.0
0 0 41.7
PBO (0.05) 2.1 98.9
DEF (0.01) 100 100
TPP (1.0) 4.5 86.2
TRI (0.5) 2.2 92.9
*PBO = piperonyl butoxide, DEF = S,S,S-tributyl phosphorothioate, 
TPP = triphenyl phosphate, TRI = tridiphane
43
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for the two compounds, respectively). When concentration-responses were 
determined, the susceptible LS strain and CFS89 showed induced tolerance 
to diazinon; with phenobarbital-treated larvae having LC^ values increased
by 5.2-fold and 1.8-fold, respectively (Table 3.8). The slopes of the 
responses of both strains were similar in both induced and non-induced 
larvae indicating a true shift in tolerance to diazinon. By contrast, the induced 
selected strain larvae while giving a 3.5-fold increase in the LC^ for diazinon
in comparison with the non-induced larvae, had a markedly higher slope of 
response (~3-fold) and higher LC values were closer (LC^s of 865.9 and
2189.1 pg/Lfor non-induced and induced larvae, respectively) indicating a 
lesser actual increase in tolerance. The responses of non-induced and 
induced larvae to ivermectin were basically equivalent within each strain 
(Table 3.8). While the LS strain induced larvae had a 2.2-fold increase in 
tolerance at LCgo this was again associated with a 2-fold increase in the slope
of the response line.
3.3.4. Monooxygenase Levels of the Selected Strain.
Monooxygenase activities were higher (about 2- to 3-fold) in the selected 
strain as determined by aldrin epoxidase activity, and whether expressed on 
the basis of microsomal protein or larval weight (Table 3.9.). The F values 
for experimental error in all three analyses were non-significant (P > 0.05) 
indicating that there were no significant treatment/generation interactions and 
that the assumption of a random model was correct (Table 3.10.). Similarly, 
there were no significant differences between generations in any of the three 
analyses (P > 0.05). There was no significant difference between the mean 
values (mean ± S.D.) of microsomal protein for the CFS (4.88 ± 1.44 mg/g 
larva) and selected (3.82 ± 1.05 mg/g larva) strains (P > 0.05). However, the 
mean aldrin epoxidase activities for the two strains were significantly different 
(P < 0.025) whether determined on the basis of microsomal protein or larval
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Table 3.9. Mean weight, microsomal protein, and aldrin epoxidase activity for 
larvae of an unselected and an ivermectin-selected strain of Lucilia cuprina.
Strain* Weight/larva
(mg)
Microsomal 
protein 
(mg/g larva)
Aldrin epoxidase activity
(pmol dieldrin/ 
min/mg protein)
(pmol dieldrin/ 
min/g larva)
CFS89 0.62 2.74 27.83 76.25
5.26 14.01 73.69
Sel40 0.58 3.21 47.80 153.44
2.70 50.91 137.46
CFS89 0.54 4.42 16.85 74.48
4.21 26.38 111.06
Sel41 0.49 3.10 66.78 207.02
5.02 55.66 279.41
CFS89 0.61 5.75 8.20 47.15
6.95 9.36 65.05
Sel42 0.79 3.66 48.32 176.85
5.20 29.77 154.80
*  CFS89 = unselected strain, Sel40 = selected strain, generation 40 etc.
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Table 3.10. Analysis of variance comparing microsomal protein, and aldrin 
epoxidase activity between larvae of an unselected and an ivermectin- 
selected strain of Lucilia cuprina.
Parameter Source of 
variation
Degrees of 
freedom
Sum of 
squares
Mean
square
F
Microsomal Combinations 5 12.32
Protein Generation 2 7.48 3.74 5.39
Treatment 1 3.46 3.46 4.98
Exp. Error 2 1.39 0.69 0.59
Samp.error 6 7.08 1.18
Totals 11 19.40
Pooled Error 8 8.46 1.06
pmol Dieldrin Combinations 5 3922.23
/min/ Generation 2 629.15 314.58 8.76
mg protein Treatment 1 3221.29 3221.29 89.75
Exp. Error 2 71.78 35.89 0.57
Samp.error 6 380.29 63.38
Totals 11 4302.52
Pooled Error 8 452.08 56.51
pmol Dieldrin Combinations 5 48429.78
/min/ Generation 2 8789.07 4394.54 2.75
g larva Treatment 1 36443.14 36443.14 22.79
Exp. Error 2 3197.56 1598.78 2.51
Samp.error 6 3823.47 637.24
Totals 11 52253.25
Pooled Error 8 7021.03 877.63
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weights. The means (± S.D.) for CFS were 17.11 (± 8.37) pmol 
dieldrin/min/mg protein and 74.61 (± 20.87) pmol dieldrin/min/g larva, and for 
the selected strain the respective values were 49.87 (± 12.09) pmol 
dieldrin/min/mg protein and 184.83 (± 52.22) pmol dieldrin/min/g larva. Thus, 
aldrin expoxidase activity was 2.9 times higher in the selected strain on a 
protein basis, and 2.5 times higher on the basis of larval weight.
3.3.5. Cross Resistance to Ivermectin from Other Insecticides.
The pyrethroid-resistant (DL) strain is extremely tolerant to deltamethrin. At 
the highest concentration examined (4 g/L) mortality was only 38% and was 
not apparently increasing to this point. The LCgo of the parental strain to
deltamethrin was 1.2 mg/L (Sales et al 1989) implying a resistance factor in 
excess of 3,000-fold. The DL strain exhibited a 2.5-fold increase in tolerance 
to ivermectin, when compared to either the LS or F90 strains which had 
similar responses (Table 3.11.) The slopes of the responses of all three 
strains were similar and this tolerance was consistent at LC^ indicating 
distinct population responses. The LCgo values for the F90 and LS strains 
were significantly different to that of the DL strain (based on non-overlap of 
95% Fiducial limits).
The diazinon selected Q20 strain was approximately 25 and ten times more 
tolerant to diazinon than the LS and CFS89 strains, respectively, but while 
CFS89 flies had a susceptible response to ivermectin, the Q20 strain was 
about four and nine times more tolerant at LC^ and LCgs, respectively (Table
3.12.). These values were significantly different at both response levels.
3.3.6. Responses of Field Strains.
All nine field strains had a similar response to ivermectin, LC^s ranging from 
4.1 - 9.7 pg/L and were within the range of 0.7 -1.5 times that of CFS89
49
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larvae assayed at the same time (Table 3.13.). These responses appeared 
to be independent of aldrin epoxidase levels, which in some strains were up 
to three times greater than those for CFS89. Also, the range of responses 
observed in these field strains was similar to the temporal variation detected 
in the CFS89 strain (see Table 3.2.).
3.4. Discussion.
3.4.1. Selection Program.
Selection of L. cuprina larvae for over 60 generations resulted in a significant, 
though only a slight increase in tolerance (<10-fold) to ivermectin. Similar 
slopes of the response lines for the selected and unselected strains indicate 
distinctly different population responses, and as the selected larvae survived 
concentrations lethal to 100% of the susceptible population these can be 
considered a resistant strain (O'Brien 1967). Under a relatively high selection 
pressure (a selective concentration generally producing > 70% mortality) this 
resistance appeared to increase fairly linearly over the first 30 generations, 
then stabilised at this level. Despite increased selection pressure resulting in 
mortalities up to 100% the response did not increase over the subsequent 
generations, implying that laboratory selection had reached an end point for 
the strain. This result is in contrast to the high level resistances selected 
from similar populations with deltamethrin, butacarb and diflubenzuron (Kotze 
and Sales 1994), but similar to the initial result for diazinon selection 
(Shanahan 1965), and the low levels selected for propetamphos (Levot 
1990). Although, once diazinon resistance developed in the field, laboratory 
selection produced a rapid increase in resistance levels (Shanahan and 
Roxburgh 1974). This indicates that none of the existing mechanisms for 
insecticide resistance in field populations are likely to markedly reduce the 
susceptibility of L. cuprina to ivermectin.
53
The resistance to ivermectin was not very stable and the strain rapidly 
reverted towards susceptibility in the absence of selection pressure, although 
it did not return to total susceptibility. This slightly elevated basal-response 
(<2-fold) was probably due to selection for strain vigour rather than any 
specific resistance to ivermectin as this response was within the range of 
responses of the parental CFS strain, and there was a similarly elevated 
response to diazinon roughly equivalent to the maximal response of the 
selected strain. The basal level of diazinon resistance remained stable in the 
CFS strain at about 10 times the response of the susceptible strain.
3.4.2. Cross Resistance to Other Insecticides.
Of the insecticides tested only moxidectin appeared to elicit a distinct cross 
resistance in the selected strain. This was expected to some extent as 
moxidectin and ivermectin are generally considered to belong to the same 
class of compounds and cross resistance to moxidectin has been 
demonstrated in some parasitic nematodes (Pomroy and Whelan 1993, 
Shoop et al 1993). This has been disputed, but it is most likely that 
differences in efficacy at therapeutic dose levels relate to the relative 
toxicities of the two compounds, rather than differences in mode of action 
(see Kieran 1994). Interestingly, moxidectin was markedly less toxic (50- to 
100-fold) than ivermectin to L. cuprina, yet moxidectin is claimed to have 
similar efficacy to ivermectin against parasitic arthropods (Strong and Wall 
1994) even though these same authors and others (Fincher and Wang 1993, 
Doherty et al 1994) claim moxidectin is much less toxic (1 to 2 orders of 
magnitude) to dung feeding arthropods. While demonstrated cross 
resistance between the two compounds indicates that either the modes of 
action are similar or they share susceptibility to the same resistance 
mechanism, it is obvious that the responses of arthropods and nematodes
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differ for the two chemicals. Although moxidectin appears to be at least two 
times more toxic to some nematodes than ivermectin (Shoop et al 1994), it is 
probable that ivermectin is intrinsically more toxic to arthropods than 
moxidectin.
3.4.3. Effects of Synergists/ Inhibitors, and Phénobarbital Induction.
The results of the synergist bioassays indicate that insecticide detoxification 
may be a factor in the tolerance observed in the selected strain. PBO, TRI 
and TPP all reduced the selection ratio by about 30%. PBO caused the 
greatest reduction in tolerance to ivermectin in the selected strain but also 
markedly affected the response of the CFS89 strain, while the other two 
compounds had no synergistic effect on this latter strain.
Metabolism by an esterase enzyme is the principal mechanism of 
organophosphate resistance in L. cuprina (Hughes and Devonshire 1982). 
Kotze and Sales (1995) have shown a significant correlation between 
monooxygenase levels and diazinon resistance in field strains of L. cuprina, 
and suggested this system may be an adjunct to carboxylesterase activity in 
resistance of this fly to diazinon. A similar relationship has been noted 
between butacarb resistance and monooxygenase activity (Kotze 1993), and 
it has been proposed that this enzyme system may have been responsible for 
the rapid failure of butacarb in the field (Kotze and Sales 1995). The fact that 
PBO had a synergistic effect on CFS89 larvae may indicate that 
monooxygenases could play a role in the metabolism of ivermectin.
However, selection with ivermectin did not markedly increase the level of 
oxidative metabolism in L. cuprina. Similarly, TPP and TRI had slight 
synergistic effects indicating possible metabolism by carboxylesterases and 
glutathione transferases. However, the facts that TPP did not synergise the 
CFS89 strain, which would have high carboxylesterase levels, and that the
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response of this strain was equivalent to that of the LS (susceptible) strain 
imply that the enzymes responsible for diazinon resistance do not have a 
major role in metabolism of ivermectin.
It is probable that the results for the selected strain indicate a small degree of 
enzymatic metabolism as these three synergists did not cause significant 
mortality in the absence of ivermectin. While there may be some metabolism 
by existing monooxygenases, the relatively small increase in tolerance 
observed and the lack of significant synergism implies that there were only 
slight increases in the activities of monooxygenases, carboxylesterases or 
glutathione transferases with prolonged exposure to ivermectin.
Pretreatment with phénobarbital increased the tolerance of all three strains to 
diazinon, but had little effect on their responses to ivermectin. Kotze (1995) 
found that phénobarbital significantly induced aldrin epoxidase (168-fold) and 
glutathione transferase (2.2-fold) levels in L. cuprina larvae. Further, the 
induced larvae showed increased tolerance to both butacarb and diazinon. 
The metabolism of diazinon has been reported for both glutathione 
transferases (Fukami 1980) and monooxygenases (Agosin 1985); also 
elevated monooxygenase levels have been demonstrated in L. cuprina larvae 
selected with diazinon (Terras et al 1983).
Although the increase in tolerance to diazinon in the phenobarbital-induced 
LS strain observed in this study was about half that obtained by Kotze (1995), 
the responses in all three strains indicated significant induction. However, 
the lack of any significant change in response to ivermectin in any induced 
larvae indicates that the induceable monooxygenase and glutathione 
transferase systems play little or no role in metabolic degradation of 
ivermectin.
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3.4.4. Monooxygenase Levels of the Selected Strain.
Monooxygenase levels, as indicated by aldrin epoxidation, were significantly 
higher in the selected strain, indicating that selection with ivermectin had 
resulted in the increased activity of monooxygenases, and that these could 
possibly have a role in the tolerance observed. However, activity in the 
selected strain was only enhanced about 3-fold compared to the CFS89 
strain, and both strains were well within the range of activities that have been 
determined in field strains (Kotze and Sales 1995). Although the activities of 
the CFS89 and selected strains were approximately two and one half, and 
seven times higher, respectively, than the mean activity for the modal class 
(7.2 pmol/min/mg protein) in that study, the activity of the selected strain was 
less than half that of the field strain with the highest activity.
In isolation, the increased monooxygenase activity of the selected strain 
could support the conclusion of Scott (1989) who found that 
monooxygenases were implicated in the metabolism of abamectin in resistant 
houseflies. This will be further discussed in the general discussion at the end 
of this chapter.
3.4.5. Cross Resistance to Ivermectin from Other Insecticides.
The pyrethroid-resistant DL strain was about two and one half times more 
tolerant of ivermectin than the F90 and LS (susceptible) strains. DL is 
extremely resistant to deltamethrin; there was less than 40% mortality at the 
highest concentration tested (4 g/L). This strain is also highly cross resistant 
to butacarb (Sales et al 1989) and is approximately twice as resistant to 
diazinon as most field strains of L. cuprina. In view of the high level of 
pyrethroid resistance in the DL strain and the fact that it is highly selected (in 
culture under pressure since 1985 [Sales et al 1989]), it is likely that the slight
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cross resistance to ivermectin was due to fitness or strain differences rather 
than any of the main mechanisms responsible for pyrethroid resistance.
There was no suggestion of cross resistance to ivermectin in either of the two 
organophosphate-resistant pooled field strains (F90 and CFS89). However, 
there was a distinct tolerance or low level cross resistance to ivermectin 
(about 4-fold at LC^) in the diazinon-resistant Q20 strain. In general, these
results are consistent with those of Hughes and Levot (1990) who also 
demonstrated a cross resistance to ivermectin of about two and one half 
times in a similar diazinon-selected strain. However, in the present study the 
response of the Q20 strain to ivermectin was markedly different to those of 
the other two strains (LS and CFS89) which had concentration-response 
slopes at least twice that of the Q20 strain, while Hughes and Levot (1990) 
obtained similar concentration response slopes for their organophosphate- 
resistant field strains and the diazinon-selected Q strain. Both diazinon- 
selected strains were probably derived from the same initial culture, the "Q" 
strain of Roxburgh and Shanahan (1973b), but had probably been in 
separate cultures under different selection methods for over 15 years. Even 
though the resistance levels of the two diazinon-selected strains were similar 
(about 25-fold), the markedly different slope of the response of the Q20 strain 
probably relates to the heavy selection pressure over many years due to the 
immersion method previously used for selection (soaking in aqueous 
diazinon for 15 minutes), which would be expected to enhance general 
resistance mechanisms such as reduced penetration or behavioural 
modification e.g. feeding reduction.
The levels of ivermectin tolerance detected in both the deltamethrin- and 
diazinon-selected strains were both of a very low order and indicate that 
there is little likelihood of cross resistance to ivermectin due to any of the
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major mechanisms responsible for organophosphate or pyrethroid tolerance 
in L. cuprina larvae.
The results of the investigations with the pyrethroid-resistant strain have been 
published (Rugg efa/1995).
3.4.6. Responses of Field Strains.
The responses of all field strains were similar and represented a susceptible 
population (like the two pooled field strains, CFS89 and F90), even though 
they may have been exposed to ivermectin residues for a number of years. 
This result is consistent with those of Hughes and Levot (1991) who reported 
a susceptible response in field strains, though these were collected prior to 
the release of ivermectin drench in 1987. This susceptible response was 
apparent even in strains with elevated monooxygenase levels and with 
varying resistance to diazinon and butacarb (see Kotze and Sales 1995). 
There was no indication of any correlation between aldrin epoxidase levels 
and response to ivermectin in these strains implying that monooxygenases in 
the field population have little effect on ivermectin, even though this enzyme 
activity has been shown to correlate positively with resistance levels to 
diazinon and butacarb, and with tolerance to diflubenzuron (Kotze and Sales 
1995).
3.4.7. General Considerations.
The susceptible or baseline response of early instar L. cuprina larvae to 
ivermectin with an LC50 around 5 pg/L could be of some concern when use of
ivermectin as an anthelminthic in sheep is considered. Plasma levels 
following oral dosing at the therapeutic level are 10 pg/L and lower for about 
2 weeks (Marriner et al 1987). Thus sub-lethal or selective levels have been 
present in the environment since the release of ivermectin drench in 1987.
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However, the low level of resistance achieved over a lengthy period of 
selection, and the susceptible response of all field strains tested, indicated 
that there is little potential for the development of resistance in current field 
populations of L  cuprina. Although, this does not discount the possibility of 
resistance occurring rapidly following widespread field use. Laboratory 
selection of mites has resulted in similar modest resistance levels (Hoy and 
Ouyang 1989) or no change in susceptibility (Hoy and Conley 1987). Field 
resistance to abamectin (up to 798-fold) apparently developed rapidly in 
western flower thrips following intensive use of the chemical (5-10 
applications in a year) (Immaraju et al 1992), and laboratory selection rapidly 
resulted in high level resistance in field collected houseflies slightly resistant 
to abamectin (Scott et al 1991). Similarly, field resistance in two spotted 
spider mites is correlated with amount and time of abamectin use, and 
laboratory selection resulted in the rapid increase of resistance levels 
(Campos et al 1995). These resistances were apparently already in the field 
populations and the levels were rapidly increased with the application of 
selection pressure, indicating that a specific resistance mechanism to 
avermectins was present. In houseflies this specificity was reinforced as 
selection with abamectin did not result in any increase in resistance to any 
other insecticides (Scott et al 1991). It is thus probable that L. cuprina does 
not currently possess any avermectin specific resistance mechanism as this 
would have rapidly responded to laboratory selection. This supposition is 
further supported by the fact that the susceptibility of field strains has not 
changed (even though larvae would have been exposed to significant 
ivermectin residues since 1987), and this response is comparable with the 
results of Hughes and Levot (1991) who assessed field populations collected 
prior to the release of ivermectin (G. W. Levot, NSW Agriculture, Pers. 
Comm.). Currently the majority of sheep are drenched for internal nematode
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parasites in spring-summer and summer-autumn and if drenched with 
ivermectin would probably have sub-lethal levels of ivermectin in plasma for 
about 2 weeks in what could easily be suitable blowfly conditions.
Cross resistance from pyrethroids has been proposed as a precursor of high 
level abamectin resistance in houseflies (Scott 1989) and this worker 
proposed that metabolism by monooxygenases was partially responsible. 
Argentine et al ( 1992) suggested that oxidative metabolism was partially 
responsible for resistance to abamectin in Colorado potato beetle, and also 
noted increased carboxylesterase activity. However, the lack of any 
significant cross resistance to ivermectin in the pyrethroid- and 
organophosphate-resistant strains examined here, indicates that existing 
monooxygenase and carboxylesterase systems are not effective 
metabolisers of ivermectin in L. cuprina. This conclusion is supported as a 
number of workers have found no indications of cross resistance to 
avermectins in insects resistant to a variety of insecticides (Roush and Wright 
1986, Abro et a /1988, Campanhola and Plapp 1989, Cochran 1990). Also it 
has recently been determined that monooxygenases were not implicated in 
high level abamectin resistance in houseflies (Scott et al 1991) but that 
resistance was due to reduced cuticular penetration and altered binding 
(Konno and Scott 1991).
The detection of elevated aldrin epoxidase activity in the selected strain could 
implicate monooxygenases in the low level resistance obtained. However, 
pretreatment with the monooxygenase inhibitor PBO resulted in only a slight 
decrease in tolerance to ivermectin. Also, treatment with phénobarbital 
apparently induced monooxygenases as evidenced by increased tolerance to 
diazinon, but had no effect on the toxicity of ivermectin to L. cuprina. Further, 
there was no apparent differences in susceptibility to ivermectin in field
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strains with quite widely varying levels of monooxygenase activity. Thus it is 
probable that the observed increase in aldrin epoxidase activity was a 
generalised response to the presence of a xenobiotic or the selection 
method itself rather than a direct response to ivermectin.
Similarly, the slight synergism of ivermectin by TPP in the selected strain 
could also indicate some metabolism by carboxylesterases; however, the 
lack of any tolerance or synergistic effect in organophosphate-resistant field 
strains implies that the enzymes responsible for diazinon resistance are not 
effective in metabolising ivermectin.
While it is not possible to ascribe a specific mechanism to the ivermectin 
resistance selected in L. cuprina larvae, it is probable that a number of 
factors, such as, enzymatic metabolism, decreased penetration, active site 
insensitivity and/or behavioural avoidance could be involved. The indications 
are that any significant resistance mechanisms are likely to be specific for 
avermectins and related compounds. Unfortunately, the level of resistance 
developed was not high enough to implicate a specific resistance or allow 
determination of mechanisms. Further selection may give rise to a specific 
resistance in the laboratory or chance may play its part with development of 
resistance in the field. In any case, ongoing study is warranted as the 
avermectins and related compounds, as a unique chemical group, are a 
valuable resource and are increasingly being used against a wide range of 
pests.
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4. RESPONSES OF THE SHEEP BODY LOUSE, BOVICOLA (DAMALIN I A)
OVIS TO AVERMECTINS.
4.1. Introduction.
The sheep body louse has developed resistance to the pyrethroid 
insecticides used as off-shears pour-ons for louse control (Boray et al 1988). 
Ivermectin applied as a jetting fluid has been demonstrated to successfully 
treat infestations of lice in long-woolled sheep (Eagleson et al 1993a, 
Thompson et al 1994c). However, the laboratory responses of lice to 
ivermectin have not been evaluated.
The resistance status of B. ovis to pyrethroids can be determined in a 
laboratory bioassay suitable for any fast-acting contact insecticide (Levot and 
Hughes 1990). This assay is based on exposure to an insecticide-treated 
linen substrate and is assessed at 16 hours; longer exposure results in high 
mortality in control insects. This assay is not suitable for testing avermectins 
since these compounds are generally slow acting (Strong and Brown 1987), 
and more effective through ingestion than by contact action (Lasota and 
Dybas 1991). It is possible to maintain B. ovis in laboratory culture; Scott 
(1952) reared lice in vitro on a mixture of skin scurf and baker's yeast at 
36.5°C and 70 - 90% RH, while Hopkins (1970) used skin scrapings as food 
at 37°C and 68% RH. Hopkins' (1970) method appeared to be the most 
successful, as he managed to increase his colony over a 10 month period.
To develop an assay suitable for avermectins, I investigated incorporating a 
feeding substrate into the contact bioassay system to enhance survival. I 
determined the survival of lice under the different systems, and examined the 
responses of lice to ivermectin and cypermethrin in the modified bioassay, 
and compared this to responses obtained using the contact assay of Levot
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and Hughes (1990). The responses of the MSD strain were also evaluated 
for abamectin and moxidectin, and responses to ivermectin of pyrethroid- 
sensitive and resistant populations of B. ovis were determined.
4.2. Materials and Methods.
4.2.1. Insects.
The strain used in most experiments was maintained on sheep at MSDVRDL, 
and will be referred to as MSD strain. A further two strains, Manildra and 
Dewrang, were obtained from NSW Agriculture (K. Dawson, Elizabeth 
McArthur Agricultural Institute, Menangle) and transferred to louse-free 
sheep at VRDL. A fourth strain (Tenterfield) was obtained on sheep 
purchased from a commercial property near Tenterfield, NSW, with a history 
of pyrethroid use and where ivermectin had recently been used for blowfly 
control and lice treatment. The Manildra strain was considered pyrethroid- 
susceptible (RF [Resistance factor] approximately 2) and the Dewrang strain 
pyrethroid-resistant (RF approximately 11) (A. C. Kotze, NSW Agriculture, 
Pers. Comm.). The MSD lice had been tested as moderately pyrethroid- 
resistant (RF approximately 5) (G. W. Levot, NSW Agriculture, Pers. Comm.). 
All of these strains were compared with the susceptible Peak Hill strain (Levot 
and Hughes 1990).
All strains were maintained on sheep, and the sheep with each strain were 
held isolated from contact with any other sheep. For the collection of lice, 
sheep were restrained in a sling, the fleece parted, and any lice observed 
were collected using a vacuum aspirator. Lice collected for bioassays were 
used within 2 hours of collection. Lice were handled using camel hair 
brushes or "soft-touch" forceps. Assays and culture experiments were
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conducted in a temperature and humidity controlled incubator (Hotpack, 
Philadelphia, Pa.).
All procedures for the handling of sheep and the collection of lice from sheep 
were carried out following a protocol (MSD 070) approved by an accredited 
animal care and ethics committee.
4.2.2. Chemicals and Assays.
Chemicals were as described previously (see 3.2.2.) with the addition of 
technical grade abamectin which was supplied by Merck and Co.
Whitehouse Station, N. J.
Bioassays were based on the method of Levot and Hughes (1990), in that 
lice were contained within a 2 cm section of 5 cm diameter stainless steel 
pipe on a 6 x 6 cm piece of pure cotton cloth (25 + 5 threads/cm). Their 
bioassay was modified by the addition of 100 mg of wool skin substrate 
prepared after Hopkins (1970). A portion of freshly shorn sheep skin was 
closely shaved using small animal clippers then frozen for 24 hours. The 
frozen skin was then scraped with a sharp knife, ensuring that only the outer 
cutaneous layer was taken. These skin shavings were dried for 24 hours at 
35°C before being finely ground using a coffee grinder. The prepared 
substrate was stored frozen until used. Initial experiments indicated that 
addition of yeast, as used by Scott (1952), promoted fungal growth and 
reduced survival of lice, and so was not used. Also, survival on this substrate 
was found to be optimal at 37°C and 68% RH; reducing the temperature did 
not enhance survival. Therefore, assays using this system were carried out 
under these conditions, which Hopkins (1970) had found to be the most 
suitable for in vitro survival of B. ovis.
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To compare survival of lice in both assays, untreated systems were set up 
and monitored regularly until mortality exceeded 30%. In cloth-only assays 
these were held at 34°C and 80% RH following the recommended methods 
of Levot and Hughes (1990).
For concentration-response assays, duplicates of six to eight concentrations 
of each test compound, plus solvent controls, were set up. Serial dilutions of 
the insecticides were made in acetone, and 1 ml_ of each dilution was evenly 
applied to saturate the wool/skin substrate and cloth, or plain cloth for each 
duplicate. Ten freshly aspirated lice were placed in each duplicate assay and 
mortality was assessed at 16, 24, and/or 48 hours. Moribund lice unable to 
move away when touched were considered dead. Results were examined 
using probit analysis (Davies 1971). Significant differences between 
LC values were based on non-overlap of 95% Fiducial limits.
The effect of varying assay conditions was evaluated using cypermethrin in 
both assays. To compare the two assays MSD lice were examined using 
both ivermectin and cypermethrin in the different assay systems and for 
different times. Where results are presented as corrected % mortality these 
values are adjusted for control deaths using Abbott's (1925) formula. The 
MSD lice were also assessed for their responses to abamectin and 
moxidectin in the modified assay. The other three strains were tested for 
their response to cypermethrin in the cloth-only assay, and susceptibility to 
ivermectin using the modified system.
4.3. Results.
Survival of control lice was enhanced markedly by the addition of the 
wool/skin substrate (Table 4.1.). With cloth only, survival was acceptable 
(> 75%) only at the 16 hour assessment; by 24 hours this had dropped to
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Table 4.1. Survival of Bovicola ovis in cloth-only or cloth/wool/skin bioassay 
sytems under different conditions.
Assay Conditions Duration
(hours)
n* % survival
Temp (°C) % RH
Cloth-only 34 80 16 120 93.3
24 60 66.7
68 16 60 81.7
24 60 66.7
37 68 16 60 81.7
24 60 66.7
Cloth/wool/ 34 68 16 60 96.7
skin 24 60 93.3
37 68 16 60 98.3
24 280 97.5
48 280 89.3
84 50 58.0
* Number of insects tested.
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66.7% independent of the assay conditions. At 16 hours survival was best at 
34°C and 80% RH, but at 24 hours survival was identical at the different 
conditions. In the cloth/wool/skin assay survival was higher at 37°C than 
34°C and both were higher than the corresponding results for cloth only. 
Survival was good (approx. 90%) out to 48 hours in this assay, though it 
dropped after this point. Higher humidities were not used as these resulted in 
fungal growth.
Responses of the MSD lice to cypermethrin in both assays, under different 
conditions and for varying durations, are given in Table 4.2. In the cloth-only 
assay there was only slight and non-significant variation between responses 
under different conditions, though assays conducted at 34°C and 80% RH 
appeared to give the most consistent responses and steepest slopes, and 
cypermethrin was possibly most toxic at this temperature. In the assays 
incorporating the wool/skin substrate there was again little difference in the 
responses of lice under different conditions, and there were no significant 
differences between any LC values (based on overlap of 95% Fiducial limits). 
Again it appeared that lice were slightly more susceptible to cypermethrin at 
the lower temperature. There was no difference between responses in this 
assay whether assessed at 16 or 24 hours. Indeed, when 40 lice were 
maintained for 48 hours in the assay system treated with cypermethrin at 
1.25 mg/mL there was no difference in mortality (<5% variation in corrected 
mortality) at 16, 24 and 48 hours. However, LC50 values in the cloth/wool/skin
assays were about three to four times higher than those obtained in the cloth- 
only assay, and in most cases these values were significantly different. The 
results achieved at 34°C and 80% RH in the cloth-only assay agreed well 
with an independent assessment carried out at NSW Agriculture where a 
LCgo of 1.73 mg/mL (slope = 3.4 ± 0.4) for cypermethrin using MSD lice was
determined (A. C. Kotze, Pers. Comm.).
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When ivermectin was used in the treated-cloth assay mortality was difficult to 
determine and highly variable at 16 hours. In four assays using 500 lice 
there was negligible mortality at concentrations below 1 mg/mL, and mean 
corrected mortality at 10 mg/mL was 73.2%, though this ranged from 0 to 
100% between replicates. In the modified bioassay (Table 4.3.) mortality was 
also difficult to determine at 24 hours because dead (or moribund) and living 
lice were often hard to differentiate. Twentyfour hour LCso values ranged
from 0.59 to1.15 mg/mL, but often these were not determined due to lack of 
convergence. Slopes of the 24 hour responses when determined were 
generally lower than those for 48 hour assays. Fortyeight hour LC^ values
ranged from 0.23 to 0.42 mg/mL, and the results had good reproducibility. 
Mortality was easily assessed; living lice were quite active, and dead or 
moribund lice were easy to differentiate. In many cases 24 and 48 hour LCso
values were significantly different (as indicated by non-overlap of 95%
Fiducial limits). Ivermectin at a concentration of 10 mg/mL reliably produced 
100% mortality within 48 hours.
Abamectin and moxidectin produced similar responses, with steeper slopes 
and tighter limits at 48 hours than at 24 hours (Table 4.3.). Abamectin had a 
similar toxicity to ivermectin, but moxidectin was about six times less toxic 
than both of these compounds.
The other three strains had differing responses to cypermethrin, with 
Manildra most susceptible and Dewrang the least (Table 4.4.). The pattern 
of the responses to cypermethrin was basically the same whether assessed 
in the cloth-only or the modified assay. Again, like the MSD lice LC^ values
were from two to four times higher in the modified assay. The results for the 
Dewrang strain were similar to those achieved at NSW Agriculture (LC^ =
5.33 mg/mL, slope = 2.4 [A. C. Kotze, Pers. Comm.]), but the response of the
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"susceptible" Manildra strain was markedly different to that achieved by Levot 
and Hughes (1990), the LC^ in this study being about five times the value
reported in their study. The responses of all three strains to ivermectin were 
similar and consistent with the range of responses for the MSD strain (Table
4.3. ), although the Tenterfield strain had a markedly higher slope.
4.4. Discussion.
The modified cloth/wool/skin bioassay is suitable for the assessment of 
responses of the sheep body louse to relatively slow-acting insecticides such 
as avermectins, because lice can be maintained for up to 48 hours with low 
control mortality. The addition of the wool/skin substrate enhances survival 
of B. ovis, possibly by the provision of nutrients and/or a more suitable micro­
environment. This system also provides a suitable medium for testing 
compounds which are more active through ingestion.
In the cloth-only assay the response to cypermethrin appeared to be more 
consistent at 34°C and 80% RH, and the compound appeared to be slightly 
more toxic under these conditions, though the results under the different 
conditions were not significantly different. The reason for greater consistency 
at the lower temperature is demonstrated by the enhanced survival of control 
lice, which was also reported by Levot and Hughes (1990), indicating that the 
toxic effects of cypermethrin are the major factor influencing mortality at this 
temperature. The higher toxicity at 34°C could be temperature related as 
pyrethroids generally have negative temperature coefficients (Corbett 1974). 
The response of MSD lice in the cloth-only assay agreed closely with an 
independent assessment, and indicated that this population was moderately
resistant to pyrethroids when compared with the most susceptible Peak Hill 
strain which has a LC50 of 0.30 mg/mL (Levot and Hughes 1990).
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The modified wool/skin /cloth assay cannot be directly compared with the 
cloth-only assay due to the incorporation of the wool/skin substrate.
However, the LC^ values were generally significantly higher (about three
times) under all conditions, and for three different strains. As the rate of kill 
did not vary greatly in the assays, i.e. extending the assay did not markedly 
lower the LC^, and mortality did not increase at 48 hours, the difference
between the two assays probably relates to the dilution effect of the added 
substrate.
With ivermectin the responses for the two assays were reversed; LC^ values 
were an order of magnitude lower in the cloth/wool/skin assay at 24 hours 
than those for the cloth-only assay. These were further lowered and more 
reproducible at 48 hours. The closely related compounds, abamectin and 
moxidectin produced similar results, though moxidectin was significantly less 
toxic (about six times) than the other two chemicals. Interestingly, abamectin 
was different to the other compounds in that there was only a slight lowering 
of LCgo values from 24 to 48 hours, rather than a significant difference.
The differences in the responses of B. ovisXo cypermethrin and ivermectin in 
the two assays reflects the differences between the two compounds. 
Cypermethrin is a relatively fast-acting contact insecticide, while ivermectin 
produces a slower kill and may be more effective through ingestion. For fast 
acting compounds the contact assay of Levot and Hughes (1990) is a quick 
and convenient method of comparative assessment. The modified assay 
produced results reflecting a similar pattern of responses to cypermethrin in 
the three strains, and thus is suitable for any compound, including slower- 
acting insecticides and those more effective through ingestion. Also, it may 
reflect more closely the in vivo situation since the selected conditions are 
similar to those at skin level of sheep.
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The MSD, Manildra, and Dewrang strains had been recently tested using the 
cloth contact assay by NSW Agriculture. For cypermethrin, their results were 
in close agreement with those achieved here for two of these strains. 
However, the response of the "susceptible" Manildra strain differed markedly 
(the LCgo in this study was about five times higher). In view of the
consistency of the other results it is probable that the Manildra strain may 
have been contaminated with more resistant lice while kept under culture.
Compared to the most susceptible Peak Hill strain (Levot and Hughes 1990) 
the four strains had resistance factors (relative LC50 values) ranging from
about five times for the MSD strain to over 20 times for Dewrang lice. While 
there was quite a range of responses in the four strains of lice to 
cypermethrin (up to a 4-fold difference at LC^), there was no real difference
between the responses of the four strains to ivermectin. Also, these 
responses did not correspond at all with the pattern for cypermethrin, 
indicating that all strains were susceptible to ivermectin and that there was no 
cross resistance from pyrethroid resistance.
The only anomaly was the response of the Tenterfield strain, which had a 
markedly steeper slope. Thus, while it had the highest LCgo value of the four 
strains it had a relatively low LC95 value, indicating a susceptible response. 
This steep slope of the concentration response probably related to the recent 
history of this strain . The strain was only lately obtained from the field, and 
the sheep had recently been treated with ivermectin. Therefore, the 
observed response could have been due to restriction of the variation of the 
population response due to the previous exposure. This resulted in 
constriction within the susceptible response rather than selection of tolerant 
individuals. However, this highlights an important consideration. The current 
registration of ivermectin is as a jetting fluid, primarily targeted for the
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prevention of blowfly strike, and application will probably result in incomplete 
coverage of the animal resulting in possible concentration gradients on the 
sheep. This could result in rapid selection of tolerant individuals, if they exist. 
Such a scenario has been proposed for the rise in pyrethroid resistance, 
which has resulted in reductions in the efficacy of pour-on formulations (Levot 
and Hughes 1990). This would warrant ongoing monitoring of louse 
populations for changes in susceptibility to detect any incipient resistance. 
Also, investigation of more efficient application methods, such as saturation 
dipping, is warranted to give more effective use of these chemicals and allow 
better management options when specifically treating for lice.
A strain of pyrethroid-resistant houseflies has been found also to be resistant 
to abamectin, and detoxification by monooxygenases has been proposed as 
a contributing factor (Scott 1989). In synergism experiments with piperonyl 
butoxide, Levot (1994) demonstrated that monooxygenases played a role in 
the metabolism of pyrethroids in B. ovis, and Kotze (1994) has reported 
enhanced monooxygenase activity in pyrethroid-resistant lice. There was no 
marked difference in susceptibility to ivermectin of the four strains examined 
here, indicating no cross resistance from pyrethroids in these populations. 
This suggests that the monooxygenase system implicated in pyrethroid 
resistance in B. ovis was not effective in detoxifying ivermectin. Under the 
same assay conditions (but of different durations) the two avermectins were 
about 20 times more toxic to lice than cypermethrin. Similarly, moxidectin 
was about four times more toxic than cypermethrin. Thus these compounds 
show considerable promise for the control of the sheep body louse, and as 
there is no indication of cross resistance from existing mechanisms, they 
could also play a valuable role in resistance management strategies for this 
pest.
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The major findings presented in this chapter have been published (Rugg and 
Thompson 1993).
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5. AVERMECTINS AND INSECTS ASSOCIATED WITH DUNG OF
LIVESTOCK.
5.1. Introduction.
As the main route of excretion of avermectins and related compounds is 
through the faeces and these are broad spectrum parasiticides, it would be 
expected that these compounds would have some significant effects on 
insects associated with dung of treated animals. Certainly there is a deal of 
controversy about the effects of these compounds on dung fauna and the 
related rates of dung degradation (see 2.1.4.). While there is little dispute 
that these parasiticides may be toxic to insects in dung, various authors 
dispute the effect of this on the rate of dung degradation.
The majority of work has focussed on cattle dung and introduced dung 
beetles, which in Australia are considered very important contributors to the 
degradation of cattle faeces (Bornemissza 1960, 1970). Wardhaugh and 
Mahon (1991) and Wardhaugh et al (1993) found that avermectin residues 
affected the insect fauna of both sheep and cattle dung, however, both these 
studies utilised artificial "pats" of sheep dung. Insects generally have a minor 
role in the degradation of sheep faeces as these are usually produced as 
small discrete pellets which dry rapidly and become unattractive to 
invertebrate dung decomposers (Cook 1993). The half-life of sheep dung on 
pasture has been determined to be in excess of 200 days (King 1993).
A number of authors have considered the effects of avermectins in sheep 
faeces on L. cuprina adults, which utilise fresh dung as a protein source, and 
have noted effects on reproductive development and behaviour, and survival 
(Cook 1991,1993, Mahon and Wardhaugh 1991, Mahon et al 1993). 
However, the major impact of avermectins in sheep dung on L  cuprina could
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relate to its effect on breech strike, as faecal staining in the breech area is 
considered a major predisposing factor for breech strike in sheep (Watts and 
Perry 1975, Morley et al 1976, Watts and Marchant 1977). As the faeces in 
the wool are the initial source of protein for the newly hatched larvae it is 
possible that avermectin residues in the faeces could prevent the 
establishment of breech strike.
To investigate some of these issues I assessed the dose responses of adults 
and larvae of the dung beetle, Onthophagus gazella F., and larvae of a dung 
feeding sarcophagid fly, Tricharea brevicornis Wiedemann, to cattle faeces 
spiked with avermectins and moxidectin. I also examined the effects of daily 
oral dosing of ivermectin at differing levels on the induction of breech strike in 
scouring sheep.
5.2. Materials and Methods.
5.2.1. Insects.
Dung beetles, O. gazella, were initially collected as adults in the field from in 
and under cow pats at MSDVRDL, and also from commercial cattle 
properties near Rockhampton and Innisfail, Queensland. Adults were 
identified using descriptions in Tyndale-Biscoe (1990), and sexed on the 
basis of foreleg morphology. Dung beetles were cultured in an insectary at 
27±2°C and 70% RH. Ten litre buckets were half-filled with sandy-loam soil 
which was then moistened with 300 mL of water; a 500 g pat of faeces, 
freshly collected from grass fed cattle, was then placed on top of the soil.
Five pairs of wild-caught adult beetles or cultured adults at least 5 days old 
were added to the buckets which were then covered with gauze. After 
10 days residual faeces were removed and the surviving adults were trapped 
in a 50 mL pot half-filled with faeces and soil, buried in the centre of the
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bucket. Adults were trapped for about 4 days, pooled and re-used to initiate 
further cultures. Approximately 20 days after setting up the buckets 150 mL 
of water was added to each bucket, and 30 days after initiation traps were 
reintroduced to collect emerging F1 adult beetles. Emergent beetles were 
held in 500 mL pots half-filled with soil and faeces for 5 to 10 days, before 
being used in experiments or added to cultures. Excess beetles were 
released at MSDVRDL.
A laboratory culture of the sarcophagid fly, T. brevicornis, was initiated from 
larvae collected from dung pats in the field at MSDVRDL, and identified using 
a key to immature stages of dung-breeding flies (Ferrar 1979), and on the 
basis of male genitalia (Lopes 1973). This non-pestiferous fly was introduced 
from South America (Ferrar 1987). They were cultured as per L. cuprina 
(see 3.2.1.) except for the following changes. A small pat of cattle faeces 
was used as the substrate for oviposition, following the liver protein feeds.
As these flies lay sheathed larvae that hatch immediately, the oviposition pat 
was transferred to a 1 kg pat of faeces on sand in a culture tray after 4 hours 
exposure to the adult flies. Pupae were removed from the sand and faeces 
by water flotation.
The L. cuprina used were the CFS89 strain (see 3.2.1. for source and culture 
details). When flies were released these were approximately 10 day old 
adults which had been liver fed 3 days previously.
5.2.2. Chemicals.
Chemicals were as described previously (see 3.2.2 and 4.2.2.). Danthron 
(1,8-Dihydroxyanthraquinone) used to induce diarrhoea in sheep (Watts and 
Marchant 1977) was obtained from Sigma Chemical Company, St Louis, Mo. 
(Crystalline 95%). Ivomec and Avomec Injection for Cattle (10 g/L ivermectin
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and abamectin, respectively), Ivomec Liquid for Sheep (0.8 mg/mL 
ivermectin) and Ivomec vehicle were obtained from Merck Sharp and Dohme 
Aust., Granville, NSW.
5.2.3. Spiking of Faeces
Stock solutions of the compounds to be tested were prepared by serial 
dilution in acetone from commercial injectable product (1% a.i.). Faeces less 
than 4 hours old were collected from cattle brought in from pasture and held 
in pens under reasonably insect free conditions. All faeces to be used were 
pooled and mixed to an even consistency. Faeces were spiked in either 1 kg 
or 100 g batches by addition of either 100 or 10 mL, respectively, of the 
required test solution. These were well mixed and then flattened on a sheet 
of aluminium foil and allowed to dry overnight in a well-ventilated, darkened 
room at 27°C. The spiked faeces were then re-weighed, and reconstituted 
with water to their original weight and mixed well prior to use. All 
concentrations in faeces are expressed per wet weight of faeces.
5.2.4. Dung Beetle Assays.
Adult assays were carried out in 500 mL plastic pots with ventilated lids.
Each 100 g pat of spiked faeces, plus untreated and acetone control pats, 
was split into two equal portions, each half was placed onto 2 cm of soil in 
each pot. An equal number of male and female beetles, selected randomly 
from a mixed sample of field-caught or at least 5 day old laboratory-reared 
adults, was added to each pot. The initial run included five or six 10-fold 
dilutions starting from a concentration of 1g/ kg, and mortality was assessed
N a r r o w e r
at 24 hour intervals for 4 days. In subsequent assays concentration 
ranges were utilised and mortality was assessed at from 3 to 5 days.
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Larval assays were carried out in 10 L buckets set up as for routine culture 
(see 5.2.1.), but using duplicate 500 g pats of spiked faeces. The initial 
range finding experiment again utilised 10-fold serial dilutions, and four pairs 
of beetles were added to each bucket. In the subsequent concentration- 
response assays five pairs were added to each bucket. Adults were left 
undisturbed in the buckets for 10 days, after which the remaining faeces and 
beetles were removed. Mortality was assessed on the basis of emergence of 
F1 beetles relative to controls. The weights of emergent beetles were also 
determined.
5.2.5. Fly Assays.
Fly assays were set up similarly to the adult beetle assays (see 5.2.4.). To 
add fly larvae to the test pats a portion of faeces was introduced to a suitable 
culture cage. This was visually inspected for oviposition and larvae, and then 
well mixed and divided into 0.5 or 1.0 g portions which were added to the 
spiked pat in each pot. Three portions were kept aside and the numbers of 
larvae counted under a dissecting microscope. The larvae were allowed to 
develop and after 7 days the pupae in each pot were weighed and counted. 
The number of flies that subsequently emerged in each pot was also 
counted. Mortality was assessed relative to control development.
In all of the above assays results were examined using probit analysis 
(Davies 1971). Significant differences between LC values were based on 
non-overlap of 95% Fiducial limits. Where results are presented as corrected 
% mortality these values are adjusted for control deaths using Abbott's 
(1925) formula. Apparent relationships between concentration and weight 
were examined using regression analysis (James 1985).
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5.2.6. Breech Strike Experiment.
One-hundred and fifty Romney sheep were used to assess the effect of daily 
dosing of ivermectin on the generation of breech strike. The sheep were 
weighed, ranked by weight and randomly allocated to six treatment groups of 
25 animals each. Ivermectin oral liquid for sheep was diluted 1:19 in vehicle, 
then a further four serial 1:1 dilutions were made, producing five 
concentrations of approximately 40, 20, 10, 5, and 2.5 pg/mL. Each group of 
sheep was dosed with one of the above concentrations or vehicle at a rate of 
0.5 mL/kg/day, thus giving dose rates ranging from 1.25 to 20.0 pg/kg/day. 
The highest dose therefore resulted in a daily dose of one tenth of the single 
oral therapeutic treatment (200 pg/kg). This determination was based on 
comparison with the commercial therapeutic doses of albendazole, where a 
controlled-release capsule delivers a daily dose of one tenth of the single oral 
therapeutic treatment (see Badewitz-Dodd 1994, pp. 265-290).
To simulate controlled-release administration, sheep were given their daily 
treatments as three divided doses, 25% at approximately 06:00, and again at 
approximately noon, and the remaining 50% at about 18:00. The animals 
were dosed orally using disposable 10 or 20 ml_ syringes. Sheep were 
dosed for a total of 9 days.
The sheep were held in a temperature-controlled insectary facility at 27±2°C 
for the duration of the experiment, with each treatment group held in a 
separate fly-proof pen. On the fifth day of dosing all sheep were given an 
oral dose of Danthron (5 g in 30 mL water), using a disposable syringe, to 
induce diarrhoea. Approximately 36 hours later about 5,000 adult protein-fed 
L. cuprina were released into each pen.
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Four hours after the release of the flies all sheep were inspected, faecal 
staining was assessed and the numbers and locations of egg masses were 
recorded. The sheep were inspected daily for the next 3 days and viability of 
larvae, and induction of fly strike (assessed as larvae actively feeding on the 
skin) were determined.
All procedures for the handling of sheep, dosing with danthron, and the 
induction and monitoring of breech strike were carried out following a protocol 
(MSD 104) approved by an accredited animal care and ethics committee.
5.3. Results
5.3.1. Adult Dung Beetle Assay.
In the initial experiments with both compounds there was little differentiable 
mortality at any concentration up to 48 hours. At 72 hours a number of 
beetles could be considered moribund (alive, but unable to move in a 
coordinated fashion) at higher concentrations. By 96 hours all beetles at the 
highest concentration for both moxidectin and ivermectin (1 g/kg) were dead. 
Ivermectin produced 90% mortality at 100 mg/kg, while there was little 
mortality in any of the concentrations of moxidectin lower than 1 g/kg.
Control survival was greater than 90% at 96 hours.
Concentration-response assays were assessed at 64, 88, 96 and 117 hours 
(Table 5.1.). At all time points ivermectin was about ten times more toxic 
than moxidectin. For both compounds the 64 hour LC values were at least 
one and a half times higher than those for later time points. The three later 
time points all produced relatively similar results for each compound.
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5.3.2. Dung Beetle Larvae Assays.
In the range finding experiment for ivermectin there were no differences in 
the numbers of beetles produced in control buckets and in any concentration 
up to 10 pg/kg. No beetles emerged from buckets with dung at a 
concentration of 100 pg/kg or higher. A similar pattern was observed for 
moxidectin except that no significant mortality was noted up to a 
concentration of 100 pg/kg. Emergence was reduced to 10% of controls at 1 
mg/kg and no beetles emerged in buckets with faeces at higher 
concentrations.
The concentration responses of larvae to both ivermectin and moxidectin had 
similar slopes (Table 5.2.). Ivermectin was about 16 times more toxic than 
moxidectin as determined by the emergence of beetles. The mean weights 
of beetles emerging from each bucket were similar to controls for each 
compound and concentration.
5.3.3. Fly Assays.
The initial range finding assays (using 10-fold dilutions) indicated that 
ivermectin was about ten times more toxic to T. brevicomis larvae than 
moxidectin. Ivermectin at 100 pg/kg resulted in approximately 70% reduction 
in the number of pupae, while moxidectin at 1 mg/kg produced a reduction of 
about 50%. Higher concentrations of both compounds resulted in 100% 
mortality and lower concentrations had no effect on the number of pupae 
produced.
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Definitive concentration responses of T. brevicornisXo ivermectin, moxidectin 
and abamectin were determined on the basis of both numbers of pupae and 
emergent flies relative to controls (Table 5.3.). The relationships between 
concentration, larval mortality, pupal weight, and emergence of flies for the 
three compounds are given in Table 5.4. While there was no apparent 
relationship between the concentration of ivermectin or abamectin and pupal 
weight, pupal weight was strongly negatively correlated with the log of the 
concentration of moxidectin (Table 5.5.).
5.3.4. Breech Strike Experiment.
Diarrhoea was induced in from 12 to 20 sheep in each group, and the 
majority of these animals had L. cuprina egg masses deposited in wool 
stained with faeces around the breech 4 hours after fly release (Table 5.6.). 
On the following day 17 control sheep had live larvae in breech wool. In the 
treated groups live larvae were found on from two to 18 sheep in each group; 
both the number of animals affected and the numbers of larvae observed 
tended to decrease with increasing ivermectin concentration. Over the next 
2 days active breech strikes developed on 12 control sheep, while none was 
observed on any treated sheep. Small numbers of live larvae were present in 
the breech wool of five sheep in the two groups treated at the lowest 
concentrations, but there were no strike lesions. On the next day there were 
no live larvae on any of these sheep.
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Table 5.5. Regression analysis of the relationship between the pupal 
weight of Tricharea brevicornis and the concentration of moxidectin in 
cattle faeces.
Assay# Number of 
X-Y pairs*
Slope Intercept r-squared
1 4 -0.044 1.89 0.92
2 7 -0.023 0.39 0.91
3 8 -0.027 0.87 0.79
4 7 -0.022 0.98 0.95
X = log of the concentration of moxidectin, Y = pupal weight, data taken in sequence from Table 5.4.
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5.4. Discussion.
5.4.1. Adult Dung Beetle Assay.
Adult O. gazella were relatively insensitive to both ivermectin and moxidectin,
and as seen in other species moxidectin was about ten times less toxic than 
ivermectin. The LC^ values for the two compounds were about four orders
of magnitude higher than those determined for L. cuprina larvae (see Chapter 
3) and more than ten times the values for B. ovis (see Chapter 4). It was also 
noticeable that the responses of the adult beetles to both compounds were 
much slower than those of the other species, with little response detected up 
to 48 hours and reproducible mortality only produced at 72 hours or greater.
This relative insensitivity in adult dung beetles has been reported previously 
with no significant effects on adult mortality in mature beetles fed dung from 
cattle treated with ivermectin (Ridsdill-Smith 1988, Wardhaugh and 
Rodriguez-Mendez 1988, Fincher 1992). However, newly emerged and 
sexually immature adults may be affected by ivermectin residues 
(Wardhaugh and Rodriguez-Mendez 1988, Houlding efa/1991), and the 
results of these and other workers certainly indicate that there is also a deal 
of variability in the responses of different species. Adult dung beetles 
emerge sexually immature and have an initial period of intense feeding. It is 
during this period that they would be most susceptible to residues in faeces 
(I. Dadour, W. A. Dept Ag., Pers. Comm.). Still, the relative insensitivity of 
adult dung beetles remains somewhat of a mystery, but possibly relates to 
the feeding behaviour of the beetles and the characteristics of the 
compounds. Adult dung beetles ingest only the liquid and colloidal 
constituents of dung; their mouthparts are unsuitable for solids (Bornemissza 
1970). Avermectins and similar compounds bind tightly to soil and organics, 
and are virtually insoluble in water (Halley et al 1989b). Thus, adults could
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be expected to ingest relatively low concentrations of these compounds when 
feeding.
The responses of O. gazella adults indicate that residues of either compound 
would be unlikely to cause severe toxic effects to mature adults following 
therapeutic treatment of cattle. Peak residue levels have been determined 
for ivermectin at about 0.9 mg/kg and 0.4 mg/kg (wet weight of faeces) for 
pour-on and injectable formulations, respectively (Sommer et al 1992, 
Sommer and Steffanson 1993, Lumaret et al 1993). These peaks are about 
50 times lower than the LC^ for ivermectin and are relatively transient,
generally lasting less than 24 hours.
This relative lack of toxicity to adult dung beetles, irrespective of the 
mechanism, may in part explain the divergencies of opinion on the effects of 
avermectin/milbemycin residues on dung degradation. As dung beetle adults 
are the stage primarily responsible for the visible degradation of dung, the 
expected residue levels would have little effect on this activity. Though while 
there may be no obvious overt toxic effects, one cannot discount possible 
sublethal effects which could disrupt behaviour or reproduction, or the covert 
effects on the next generation.
5.4.2. Dung Beetle Larvae Assay.
O. gazella larvae were highly susceptible to both ivermectin and moxidectin. 
The LC50 values for both compounds were three orders of magnitude less
than the respective adult values. Again there was the similar pattern with 
ivermectin about ten times more toxic than moxidectin. The result for 
moxidectin was in agreement with that of Doherty et al (1994), who compared 
moxidectin and abamectin in an in vitro experiment. They found that 
moxidectin produced about 30% and 90% mortality in O. gazella larvae at
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256 and 512 pg/kg, respectively, thus bracketing the LC^ value of 
328.4 pg/kg determined here. However, by contrast they determined that 
abamectin was about 64 times more toxic than moxidectin to both O. gazella 
and buffalo fly. I would have expected that abamectin should produce a 
similar response to ivermectin, and speculate that this divergence could 
possibly relate to the different methods used for spiking the faeces. In the 
Doherty et al (1994) study concentrations were prepared by serially diluting in 
dung, i.e. dung was spiked to the highest concentration, an aliquot of this was 
then mixed with an equal portion of fresh dung to produce a two times 
dilution, and this procedure was then repeated to give serial dilutions. As 
these compounds bind rapidly and tightly (but also possibly differently) to 
organic material (Halley et al 1989), I feel it would be difficult to ensure even 
and equivalent distribution of the compounds. While the method utilised here 
involved greater intervention with the dung, I am of the opinion that mixing 
with an equal volume of solvent at each level would ensure more accurate 
spiking and even distribution of the compounds.
While moxidectin is clearly less toxic to O. gazella larvae than ivermectin, 
these results and those of Doherty et al (1994) indicate that both compounds 
could disrupt dung beetle breeding by causing larval mortality following 
therapeutic treatment of cattle. While ivermectin residues are generally 
considered to be toxic to dung beetle larvae and fly larvae for some time after 
the treatment of cattle, there are differing reports for moxidectin. Strong and 
Wall (1994b) found that moxidectin residues had no toxic effects on the 
larvae of beetles and cyclorrhaphous flies in cattle dung, and similarly 
Fincher and Wang (1992) concluded that dung from moxidectin treated 
animals did not affect two species of dung beetles. However, Webb et al 
(1989) reported that faeces from cattle treated with a low, controlled-release 
dose of moxidectin were toxic to larvae of the face fly (Musca autumnalis De
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Geer) and concluded that the therapeutic injectable dose of moxidectin would 
be effective control for M. autumnalis larvae in dung. Miller et al (1994) 
reported significant mortality in horn fly larvae in dung for up to 28 days after 
oral or injectable treatment with moxidectin. Recently, a large trial was 
carried out in Western Australia, comparing ivermectin and moxidectin with 
50 animals in each treatment group, which demonstrated that residues of 
both chemicals had toxic effects on two species of dung beetles (D. Cook 
and I. Dadour, W. A. Dept Ag., Pers. Comm.).
On the basis of the toxicities reported here, and the fact that like ivermectin, 
moxidectin is primarily excreted in the faeces (Zulalian et al 1994) it would be 
expected that moxidectin residues would have some toxic effects on dung 
arthropods. The lower toxicity of moxidectin could in part explain some of the 
divergence in experimental results as residues may be close to a "threshold" 
level. If this is the case methodology must be examined as in studies using 
small numbers of treated animals (e.g. Fincher 1992, Fincher and Wang1992 
[only two treated animals]) the large inter-animal variation in 
pharmacokinetics (Marriner et al 1987) and therefore residues following 
treatment, could easily mask any toxic effects in the dung.
5.4.3. Fly Assays.
The responses of T. brevicornis larvae to ivermectin and moxidectin were 
remarkably similar to those for O. gazella larvae, and again ivermectin proved 
to be about ten times more toxic to the flies than moxidectin. Thus this fly 
could be used as an indicator species for dung beetle toxicity, reducing the
need for large time consuming beetle life cycle assays. Abamectin produced 
a response similar to that for ivermectin. All three compounds had lower LC50
values when the assays were assessed on the basis of number of flies
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produced indicating all three had some residual post-feeding effects causing 
mortality in the pupal stage.
The relationship between pupal weight and concentration was somewhat 
surprising. While there was no correlation for ivermectin and abamectin 
(mean pupal weight did not change as concentration and mortality 
increased), for moxidectin pupal weight was strongly negatively-correlated 
with concentration (r2 usually > 0.9). Further, this effect was noticeable well 
before any toxic signs were observed, with observable reductions in pupal 
weight even at concentrations below 100 pg/kg. The fact that mortality was 
not associated with the initial decreases in pupal weight indicates that 
moxidectin may have an anti-feedant effect with larvae avoiding the 
compound by reducing feeding or possibly a sub-lethal effect of intoxication 
disrupting feeding behaviour.
5.4.4. Breech Strike Experiment.
Faecal staining of wool is one of the main predisposing factors for breech 
strike in sheep, and this is currently controlled using surgical procedures 
(mulesing, tail docking), treatment for internal parasites, or labour intensive 
procedures, such as crutching and insecticide application (Watts and Perry 
1975, Watts and Marchant 1977, Wardhaugh and Morton 1990). The 
soiling of the breech is usually attributed to diarrhoea caused by dietary 
factors or internal parasitism (Morley et al 1976). While the latter cause may 
be minimised by effective control of gastro-intestinal parasites, dietary scours 
are dependent on external factors and generally less controllable.
Daily dosing of ivermectin was effective in preventing breech strike in 
scouring sheep, through the insecticidal effects of faecal residues. As all the 
dose rates used were likely to be at or below one suitable for control of
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intestinal parasites, it would be expected that any formulation developed for 
controlled-release delivery to control gastro-intestinal nematodes would also 
effectively reduce the incidence of breech strike.
5.4.5. General Considerations.
Feed-through compounds for the control of pestiferous Diptera in dung have 
been in use, especially in cattle for many years, yet little attention has been 
paid to the effects on non-target dung fauna (Strong 1992b). Similarly, most 
of the compounds used as external parasiticides for cattle have toxic effects 
on dung insects, and these effects appear greater for organophosphorus and 
pyrethroid compounds than avermectins (Bianchin et al 1992). Recently, 
however there has been a great deal of attention given to possible 
environmental consequences of systemic parasiticides, especially 
avermectins and related compounds with even entire journal volumes 
devoted to this subject (e.g. Vet. Parasitol. 48:1-344 1993).
Possibly this rise in interest could be related to the widespread use of these 
compounds. Their broad spectrum encompassing both nematodes and 
arthropods has resulted in their extensive use, and especially where gastro­
intestinal worms are the prime target, most arthropods could be considered 
non-target organisms. Certainly, in countries where the introduction of dung 
beetles to control dung build-up and dung breeding pests has occurred, any 
compounds with adverse effects on these bio-control agents will be expected 
to gain some attention. Also, the differing toxicities of related compounds 
marketed by different companies may be perceived as providing a 
commercial advantage. Hence, authors have reported the effects of 
ivermectin in controlling dung-breeding pestiferous Diptera (e.g. Meyer et al 
1980, Miller et al 1981, Marley et al 1993), or its toxicity to dung beetles (e.g. 
Ridsdill-Smith 1988, Sommer et al 1992, 1993), and that dung degradation
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may be retarded (e.g. Wall and Strong 1987, Sommer et al 1992) or not 
affected (e.g. Jacobs efa/1988, McKeand et al 1988, Wratten et al 1993). 
Recently, reports have appeared directly comparing the effects of 
avermectins and moxidectin on dung fauna (Fincher and Wang 1992,
Doherty et al 1994). Certainly it is an emotive issue and in some instances 
one must wonder about possible commercial pressures.
The investigations reported here indicate that avermectins and related 
compounds have the potential to affect dung inhabiting insects. There was 
however a deal of variation between the responses of species or life-cycle 
stages within species. Also the consistent result that moxidectin is an order 
of magnitude less toxic to insects than ivermectin seen with L. cuprina 
(Chapter 3) and B. ovis (Chapter 4) was repeated with the dung insects 
examined. This could indicate that moxidectin may have a lesser impact on 
some dung insects, but conversely would also have a lesser effect on 
pestiferous fly larvae. The use of these compounds should thus be evaluated 
on the basis of targets and environmental concerns. The use of ivermectin in 
a controlled-release device for sheep could provide added protection against 
breech strike, and residues in dung could possibly further affect the adult 
blowfly population which utilises sheep faeces as a source of protein (Cook 
1991,1993), while having little effect on the rate of degradation of sheep dung 
as insects play a relatively minor role in their breakdown (Cook 1993, King 
1993). If there was concern over possible adverse effects of treatment for 
gastro-intestinal worm infestation on cattle dung fauna, moxidectin could be 
the compound of choice (Strong and Wall 1994a), although a specific 
anthelminthic would be most preferable. If control of arthropod ectoparasites 
or their dung feeding stages is of importance (Marley et al 1993) ivermectin 
could be preferred because of its greater toxicity to insects. Even so, a 
recent study examining effects of commercial ivermectin use in cattle in
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South Africa (Scholtz and Kruger 1995) found that dung insect populations 
recovered rapidly, following an initial depression. They concluded that the 
long term effects on dung fauna may not be as severe as previous studies 
have claimed.
The debate over environmental consequences of the use of avermectins and 
similar compounds will no doubt continue, even though their effects may be 
less than many other compounds previously or currently in use. They will 
remain topical as they are the newest distinct class of parasiticides available 
and their usage will continue to increase, as will the commercial pressures to 
support different compounds within the macrocyclic lactone group as they 
reach the market. To date much research has focussed on identifying 
possible risks or benefits to individual fauna and extrapolating to worst case 
scenarios, and I expect that the debate will increase with the expected 
development and use of controlled-release devices. I would hope that 
research could be focussed to give an objective assessment of costs and 
benefits of the use of these chemicals, and that a more realistic approach 
could be taken to examine the whole picture, so that the ecology of use of 
these (and other) compounds could be determined under normal usage 
patterns. It should be possible to determine the best use of these 
compounds to ensure maximum efficacy, minimum risk to the environment, 
and to reduce the chance of development of resistance, for each use 
situation. Unfortunately, I cannot see this happening in a commerce driven 
world. While the debate continues I conclude with the closing comments 
from a recent paper by Lumaret et al (1993), which is probably also 
applicable to moxidectin "All available results show that the potential impact 
of ivermectin on the environment is variable and mainly depends on regions, 
climates, insects and probably even seasons."
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6. THE INTERACTIONS OF IVERMECTIN WITH THE FLEECE AND SKIN
OF SHEEP.
6.1. Introduction.
The unusual behaviour of insecticides in the fleece and skin of sheep has 
been considered both positively and negatively with regards to the application 
of ectoparasitfcides. The skin and fleece of sheep contains a number of 
organic substances which can affect applied insecticides. As well as the wool 
and hair itself the fleece and skin contain many other endogenous and 
exogenous substances (see Sinclair 1977).
The most important material of sheep origin, often termed "yolk", is a mixture 
of lipids (wool wax or lanolin) and organic salts (suints) produced by the 
sebaceous glands, sweat glands, and some epidermal cells. Common 
exogenous fleece contaminants include faeces, dirt, and vegetable matter. 
While insecticides may bind to either the endogenous or exogenous organics, 
it is generally considered that compounds bound to the latter (organic fleece 
contaminants) are often unavailable for activity against skin dwelling insects, 
while insecticide-yolk complexes are likely to be available for activity against 
ectoparasites (Sinclair 1977). Further, binding to yolk may result in the 
formation of insecticide depots (probably in the wool follicles) from which the 
compound may distribute into the fleece as the wool grows . Also it is 
possible that insecticide may move laterally in sheep skin via the yolk, which 
permeates the intercellular channels of the stratum corneum (Lloyd et al 
1979). This lateral movement could be due to transport of the compound by 
the yolk moving within the skin (Jenkinson and Lloyd 1979, Jenkinson et al 
1986), or the diffusion of the insecticide within the yolk itself (Pitman and 
Rostas 1983), or a combination of both methods.
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The major application of lateral movement of pesticides in the skin and fleece 
has been the use of pour-on applications of pyrethroids for the control of 
sheep body lice (Bayvel et al 1981 .Kettle et al 1983). In these applications a 
high concentration of insecticide is deposited along the backline of the sheep 
and translocation around the body results in differing though lethal 
concentrations around the body (Kettle et al 1983).
Vertical movement along the wool staple has been reported, mainly for the 
cyclodiene pesticide, dieldrin. Application of a fine mist to the tip of the fleece 
has been shown to result in effective concentrations at skin level 
(Brander 1957, Graham 1957).
Both lateral and vertical movement of pesticides in fleece are important in the 
sheep industry as they allow time saving methods of pesticide application. 
Pyrethroid pour-ons are widely used for louse control as they provide major 
time and labour savings over traditional saturation methods (Martin 1993). 
Any vertical translocation is useful when automatic jetting races are used for 
the application of insecticides for blowfly control, as while the use of these 
machines results in savings in time and effort, they are not as efficient in 
providing penetration to skin level as hand jetting (Herdegen et al 1989,
Lund 1993). The negative side of reliance on translocation of chemical to its 
site of action is the production of concentration gradients on the sheep's 
body. The possible exposure of insects to sublethal doses of pyrethroids is 
thought to have been a contributing factor to the relatively rapid rise of 
pyrethroid resistance in the sheep body louse (Levot and Hughes 1990). 
Varying insecticide residues following treatment for lice may also select for 
resistance in L. cuprina (McKenzie and Whitten 1984, Hughes and McKenzie 
1987).
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Ivermectin, like pyrethroids, is highly lipophilic, and would be expected to bind 
with the yolk and other organics in the fleece. In this chapter I report 
investigations of the interactions of ivermectin with the skin and fleece of 
sheep, examining lateral translocation across the skin, and vertical 
movement along the wool staple. I also carried out in vitro studies of the 
interaction of ivermectin and lanolin (wool fat). Ivermectin residues were 
detected using HPLC methods and bioassays.
6.2. Materials and Methods.
6.2.1. Chemicals.
Chemicals were as described previously (see 3.2.2 and 4.2.2.). HPLC grade 
solvents were obtained from Mallinckrodt Aust., Meadowbank, NSW. Lanolin 
(anhydrous wool fat) was supplied by David Craig & Co. Rocklea, Qld. 
Technical grade ivermectin powder (89.0%) and pure ivermectin B1a and B1b
(100%) were supplied by Merck and Co., Whitehouse Station, N. J.
6.2.2. HPLC.
Two separate HPLC systems were used, one supplied by ICI Instruments, 
Rydalmere, NSW, comprised an ETP Kortec gradient computer ( model K45) 
with two model K35D pumps, Rheodyne manual injector with 20 pL injection 
loop, ETP Kortec variable wavelength UV detector (model 95), and an 
Omniscribe D5000 chart recorder. This system was used with a 25 cm 
Spherisorb, 5 pm reverse phase C18 column (Alltech Associates, Baulkham 
Hills, NSW). The second system obtained from Varian Aust., Mt Waverly, 
VIC., consisted of a Marathon autosampler (20 pL injection loop), Star 9001 
isocratic pump, Star 9050 variable wavelength UV detector, and LC Star 
integrator; a similar type of column (Econosphere, 15cm Spherisorb, 5 pm
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reverse phase C18, Alltech Associates, Baulkham Hills, NSW) was used with 
this system.
The chromatographic conditions used for both systems were the same and 
are a slight modification of those of Oehler and Miller (1989); mobile phase: 
acetonitrile:methanol:water (53:35:7) 0.45 pm filtered and degassed, at 1.5 or 
2.5 mUmin; detection: UV at 245 nm. However, with the Varian system the 
column was held at 25°C, while the ICI system was run at ambient 
temperature. All samples and standards were prepared in methanol and 
0.45 pm filtered prior to injection. Results were determined by comparison 
with known standards on the basis of peak heights or areas.
6.2.3. Bioassays.
Bioassays for ivermectin residues were carried out with L. cuprina larvae, and 
followed the basic protocol outlined in section 3.2.3. Residues were 
extracted into methanol and triplicate 1 mL aliquots of 1 in 100 and 1 in 10 
dilutions, and undiluted extract were bioassayed. Mortalities were assessed 
at 48 hours, and relative toxicity of the extracts was determined by multiplying 
the percent mortality by the dilution factor.
6.2.4. Translocation on Sheep.
To examine the movement of ivermectin across the skin of sheep a skin plug 
biopsy technique was used. Sheep were restrained in a holding sling and the 
wool was shorn from the back of the animal. Technical grade ivermectin in a 
high concentration, usually in acetone, was applied to single, marked spots 
along the backline using a micro-pipette. Volatile solvents were used so that 
the solvent- driven spread on the sheep's skin would be minimised and pure 
compound would be rapidly deposited Also, this would minimise the 
possibility of transdermal penetration as native ivermectin does not penetrate
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intact skin. The commercial systemically active pour-on formulation for cattle 
is effective due to solvent-driven penetration of the skin (W. Back, Merck 
Sharp and Dohme Aust., Pers. Comm.). These origin spots and sites radially 
distal from the origin were then sampled with time using 6mm diameter skin 
biopsy punches (Stiefel Laboratories, Offenbach am Main, Ger.). The 
resultant skin/wool plugs were extracted in 5mL methanol for 24 hours; the 
extracts were then analysed on the ICI HPLC, with a mobile phase flow rate 
of 1.5 mLVmin. For each sheep, biopsy plugs were also taken prior to the 
application and used to assess spiked recoveries and act as blanks for 
analyses. These untreated plugs were placed in extraction tubes, some 
spiked with the same volume and concentration applied to the spots on the 
sheep, and the others left untreated. They were left uncapped and then 
extracted at the same time as the timed plugs. Standards were prepared by 
pipetting the applied volume into an extraction tube and adding methanol to 
5 mL. These were diluted serially in methanol. Sample extracts were 
compared with similar standards, and chromatograms were compared on the 
basis of peak height. Recovery was calculated as the percentage of the total 
theoretically applied, i.e. the first standard. The different variables examined 
using the above methods are outlined in Table 6.1.
To investigate differences in the translocation of the two components of 
ivermectin a trial was set up to evaluate movement on lousey sheep. Nine 
newly-shorn sheep were examined for louse infestation, by counting the lice 
in 20 10 cm partings from the neck to the rump, on each side of the sheep. 
These sheep were then ranked on these total louse counts and randomly 
allocated to three treatments; untreated controls, treated with ivermectin B1a, 
or B1b (both 1mg/mL in ethanol, applied at a dose rate of 0.75 mg/kg). The
doses (of approximately 30 mL) were applied using a pipette in two stripes
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either side of the back midline extending from the base of the head to the top 
of the tail, following pre-marked indelible lines.
The sheep were assessed for louse infestation at 7 days after treatment and 
then at 2 weekly intervals for 8 weeks using the standard counting procedure 
outlined above. However, in these later examinations a dewlap count was 
also carried out, with all lice observed in a parting running from the base of 
the jaw to the chest on either side of the animal's dewlap counted.
Two sheep from each treated group were selected at random, to be sampled 
for ivermectin residues using the skin/wool biopsy methods described above. 
On days 1 and 4 post treatment, plugs were taken from the application site 
and spots 2 and 4 cm lateral to the application line on each side of each 
sheep. On day 7 plugs were taken from the application line and 4 and 8 cm 
laterally. The final plugs were sampled 17 days after treatment from the 
application line and sites 4, 10 and 20 cm laterally. Plugs were taken from 
control animals for use as assay blanks. Biopsy extracts were analysed on 
the Varian HPLC with the mobile phase at 1.5 mL/min. Peak area counts 
were calculated for chromatogram comparisons.
Prior to taking skin plugs the immediate vicinity of the biopsy was 
anaesthetised with lignocaine (2%, lignocaine hydrochloride, Delta Veterinary 
Laboratories, Hornsby, NSW). The resultant wound was closed with a single 
stitch. Sheep were held in the sling for a maximum of 4 hours; if the 
experiment was of longer duration the sheep were kept in a single pen, and 
only held in the sling for the application of ivermectin and taking of biopsies.
To examine the disposition of ivermectin along the wool staple with time, 16 
merino sheep carrying about 8 months growth of wool were treated with a
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commercial formulation of ivermectin (Jetamec, Merck Sharp and Dohme, 
Granville, NSW). Eight were treated by hand jetting as per the maker's 
directions. The concentrate was diluted to 0.3 mg/mL with water and 4 litres 
was applied to each sheep at 80 psi with a hand wand, ensuring saturation of 
the fleece to skin level in a broad band down the back from the poll to the tail. 
The other eight sheep were treated (tip sprayed) with Jetamec diluted to 
1.2 mg/mL, and each sheep received 1 litre applied as a fine mist to a similar 
area as treated in the hand jetted animals. The application was carried out 
using a back-pack spray applicator with the nozzle held approximately 25 cm 
from the wool surface. Four other sheep were used as untreated controls.
Wool samples were taken from each sheep on days 1,7, 28, 57, 77, 98 and 
112 after treatment. On each occasion the wool from a 5 x 5 cm patch within 
the area treated was clipped as close as possible to the skin. The wool 
staples were cut into three equal portions; top, middle, and bottom thirds (1,
2, and 3 respectively, 3 being the closest to the skin), and 1g of each portion 
was extracted in 25 mL methanol for 24 hours. Extracts were bioassayed as 
described above (6.2.3.). The more sensitive, though less precise, bioassays 
were used rather than HPLC as the samples to be extracted were relatively 
large and dirty, and expected to contain low concentrations ivermectin.
All animal procedures were carried out under protocols (MSD 115, MSD 108) 
approved by an accredited animal care and ethics committee.
6.2.5. Interactions with Lanolin and Wool In Vitro.
To investigate the solubility/diffusion of ivermectin in lanolin, 1 mL aliquots of 
molten lanolin were poured into 10 mL centrifuge tubes and allowed to cool. 
250 pL of 100 pg/mL ivermectin in acetone was added to ten tubes, and 
250 pL of acetone only was added to 5 tubes to act as blanks. These tubes
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were then held in the dark under ambient conditions. At 2, 4, 6, 8, and 
24 hours two ivermectin treated tubes and one blank tube were rinsed for 
30 seconds with a total of 2.5 mL of methanol. Rinsates were analysed for 
ivermectin using HPLC and compared with a 10 pg/mL standard.
To examine more closely the responses of the two components of ivermectin, 
the basic experiment was repeated using 10 mg/mL solutions of ivermectin 
B1a and B1b. The same procedure was used, however only 25 pL was
applied to each tube and tubes were rinsed with 1 mL of methanol at 16 
hours only. Rinsates were compared with 25 pg/mL standards. For the 
HPLC analyses in this and the previous experiment, flow rate of the mobile 
phase was 2.5 mL/min on the Varian system.
To investigate if ivermectin diffused through lanolin with time, the compound 
was applied to wool cloths impregnated with lanolin. Squares (100 x 
100 mm) of a pure wool cloth (25 threads/inch) were saturated with 10 mL of 
a 5.6% solution of lanolin in acetone at 40°C, and allowed to dry, resulting in 
cloths containing approximately 25% (w/w) lanolin. A solution containing 0.5 
mg/mL ivermectin B1a and B1b was prepared in acetone, and a blue dye
(Brilliant Blue, Sigma, St Louis, Mo.) added. The cloth squares were 
supported on 20 x 20 mm stainless steel mesh and 100 pL of the ivermectin 
solution was added to the centre of each square, and two cloths were treated 
with acetone to act as blanks. All cloths were then placed in a darkened 
incubator held at 36.5°C and 70% RH. At selected time points three 
randomly selected treated cloths were removed, the central dyed spot was 
carefully cut out of two of these, and the dyed, undyed, and complete cloths 
were each extracted in 5 mL of methanol for 5 minutes. The resultant 
extracts were analysed using the Varian HPLC, and were compared with a
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standard containing both ivermectin B1a and B1b at 10 (jg/mL prepared from 
the solution used to dose the cloths. Mobile phase flow rate was 2.5 mLVmin.
6.3. Results.
6.3.1. Translocation on Sheep.
Representative chromatograms of analysis of wool/skin plug extracts are 
illustrated in Figs 6.1. - 6.4. The results of analyses for all sheep are given in 
Table 6.1. In this system ivermectin B1a and B1b eluted at about 5.4 and 4.4
minutes, respectively. The recovery of ivermectin from spiked plugs was
consistently reliable and generally approached 100% (see traces #3 and #5, 
Fig. 6.1. and Table 6.1.). Similarly, both ivermectin B1a and B1b were reliably
detected at plugs taken from the application site, however, recoveries were 
variable (see traces #8, #9 and #10, Fig. 6.1. and Table 6.1.). Analysis of 
blank plugs indicated that the extracts were reasonably clean, and there was 
no baseline interference at the points of interest (see trace #1, Fig. 6.2.), 
although there was an intermittent unknown peak eluting before ivermectin 
B1b at about 3.4 minutes (Traces #1a and #2a, Fig. 6.4.). This peak did not
interfere with either ivermectin component (Fig. 6.2.). Where ivermectin was 
detected in plugs away from the application site (in three of the seven 
animals) only the B1b component was recovered in significant amounts (see
traces #10a,b,c, and d, Figs 6.2. and 6.3.); the amounts detected ranging up 
to 5.4% of that applied (Table 6.1). Traces of ivermectin B1a were detected
away from the application site on a single animal only. Injection of diluted 
standard (trace #3/1000, Fig. 6.3.) indicated that ivermectin B1a should have
been easily detected at levels as low as one thousandth of that applied.
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Figure 6.1. HPLC traces of wool/skin biopsy plug extracts. ICI system, chart
speed 0.25 cm/min., attenuation 0.16 Abs. full scale. Vertical intersects mark 
injections. 1= ivermectin B1a, 2 = ivermectin B1b. #3: 750 pg/mL ivermectin
standard. #5: wool/skin biopsy spiked with 50 pL of 75 pg/mL ivermectin. #8, 
#9, and #10: wool/skin biopsies taken from application site immediately, 2 
hours, and 4 hours, respectively, after application of 50 pL of 75 pg/mL 
ivermectin.
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Figure 6.2. HPLC traces of wool/skin biopsy plug extracts. ICI system, chart
speed 0.5 cm/min., attenuation 0.0025 Abs. full scale. Vertical intersects 
mark injections. 1= ivermectin B1a, 2 = ivermectin B1b. #10a,b: wool/skin
biopsies taken 2 cm from application site 4 hours after application of 50 pL of 
75 pg/mL ivermectin. #3/50: 15 pg/mL ivermectin standard. #1: blank 
wool/skin biopsy.
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Figure 6.3. HPLC traces of wool/skin biopsy plug extracts. ICI system, chart 
speed 0.5 cm/min., attenuation 0.0025 Abs. full scale. Vertical intersects 
mark injections. 1= ivermectin B1a, 2 = ivermectin B1b. #10c,d: wool/skin
biopsies taken 4 cm from application site 4 hours after application of 50 pL of 
75 pg/mL ivermectin. #3/1000: 0.75 pg/mL ivermectin standard.
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Figure 6.4. HPLC traces of wool/skin biopsy plug extracts. ICI system, chart
speed 0.5 cm/min., attenuation 0.0025 Abs. full scale. Vertical intersects 
mark injections. 1= ivermectin B1a, 2 = ivermectin B1b. #1 a: blank wool/skin
biopsy. #9/50: 15 pg/mL ivermectin standard. #2a: acetone blank wool/skin 
biopsy .
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Five of the six lousey sheep treated with either ivermectin B1a or B1b showed
fairly rapid decreases in louse numbers (Table 6.2.). This was most evident 
in two of the sheep treated with B1b in which standard louse counts were
zero, and very few lice were found on the dewlap from 7 days after treatment 
onwards. However, the third animal in this group showed no major reduction 
in louse numbers at all. By contrast, louse numbers on the B1a-treated sheep
were reduced gradually, with zero body counts first recorded 28 days after 
treatment.
Area counts from HPLC analysis of ivermectin B1a and Blb residues in
wool/skin biopsy plug extracts are given in Table 6.3. Both ivermectin 
components were reliably recovered from the application sites. Although it is 
apparent that sheep and sampling variation probably masked any temporal 
trends away from the application sites both components were detected some 
distance from the treatment origin. The amounts recovered from the 
application sites were markedly reduced by 17 days after treatment. Peak 
area counts for 10 pg/mL ivermectin B1a and B1b standards were 72270 and
86793 respectively.
Representative HPLC traces are given in Figures 6.5. - 6.13. In the Varian 
system ivermectin B1a and B1b eluted at about 14.0 and 10.6 minutes
respectively. Analysis of untreated wool/skin biopsies indicated that there 
was no significant baseline interference. Again in these analyses there was 
an earlier eluting (at about 5.8 minutes) intermittent unknown peak (denoted 
Ivm x). This unknown peak was detected in some blanks (Fig. 6.6.) and in 
some biopsies taken immediately after application (Fig. 6.9.) as well as in 
samples where neither ivermectin component was recovered (Fig. 6.11.), but 
was never observed in the standards prepared from the solutions applied to 
the sheep.
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Title i DayO #4211
Run File : C:\STAR\DATA\AVB002.RUN
Hethod File : IVM2.HTH
Sample ID : Manual Sample
Injection Date: 25-JUN-92 9:49 AM Recalculation Date: 25-JUN-92 6:29 PH
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A - A
Detector Type 
Bus Address 
Sample Rate 
Run Time
ADCB (10 Volts 
16
10.00 Hz 
15.002 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed 
Start Time
Figure 6.5. HPLC trace of blank wool/skin biopsy plug extract, taken prior to 
treatment.
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Title ! DayO 3908
Run File : C:\STAR\DATA\AVB1001.RUN
Hethod File > IVM2.HTH
Sample ID . Manual Sample
Injection Date. 26-JUN-92 10.42 AM Recalculation Date. 29-JUN-92 4.20 PH
Operator . Number 1 
Workstation.
Instrument . Varian Star 
Channel . A - A
Detector Type. ADCB (10 Volts)
Bus Address . 16
Sample Rate . 10.00 Hz
Run Time . 15.002 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed - 
Start Time
I vmX
1.30 cm/min Attenuation
0.000 min End Time
23
15.002 min
Zero Offset 
Min / Tick
12%
1 . 0 0
Figure 6.6. HPLC trace of blank wool/skin biopsy plug extract, taken from a 
control animal.
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Workstation :
Instrument : Varian Star 
Channel : A - A
Bus Address : 16
Sample Rate : 10.00 Hz
Run Time : 15.002 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed « 
Start Time
IvmBla _
1.30 cm/min Attenuation •=
0.000 min End Time
10
15.002 min
Zero Offset « 5\ 
Hin / Tick ■= 1.00
<WI*= 2.0
<WI=4.0 
<WI«8.0
< WI ■= 4.0
<W I ■= 8.0 
<W I ■= 4.0
< W I ■= 8 . 0
< WI •= 2.0
13.92
< WI ■= 4 . 0
Figure 6.7. HPLC trace of 10 pg/mL ivermectin B1a standard.
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Injection Date: 25-JUN-92 10:38 AH
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A = A
Recalculation Date: 25-JUH-92 4:22 PH
Detector Type: ADCB (10 Volts)
Bus Address : 16
Sample Rate : 10.00 Hz
Run Time : 15.002 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed = 
Start Time
IvmB 1 b
1.30 cm/min Attenuation ■= 14
0.000 min End Time = 15.002 min
Zero Offset - 3\ 
Hin / Tick ■= 1.00
<WI-2.0 
<WI-4.0
< WI *= 8 .0
<WI=16.0
-- :==> 10.7
<WI=8.0
Figure 6.8. HPLC trace of 10 pg/mL ivermectin B1b standard.
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Title : TO #3441
Run File i C .\STAR\DATA\AVB003.RUN
Method File i IVM2.MTH
Sample ID i Manual Sample
Injection Date. 25-JUN-92 10.05 AM
Operator . Number 1 
Workstation.
Instrument . Varian Star 
Channel . A - A
*********** Varian Star Workstation
Recalculation Date. 25-JUN-92 6:33 PM
Detector Type. ADCB (10 Volts)
Bus Address . 16
Sample Rate . 10.00 Hz
Run Time . 15.002 min
............... Rev. c 08/20/90 *****
Chart Speed - 
Start Time
IvmX
IvmBla
1.30 cm/min Attenuation - 36 Zero Offset - 21
0.000 min End Time - 15.002 min Min / Tick - 1.00
Figure 6.9. HPLC trace of extract of wool/skin biopsy plug taken from the 
application site immediately following treatment with ivermectin B1a.
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Injection Date: 2S-JUN-92 10:55 AH Recalculation Date: 25-JUN-92 4:39 PH
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A ■= A
Detector Type 
Bus Address 
Sample Rate 
Run Time
ADCB (10 Volts) 
16
10.00 Hz 
15.002 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed - 1.30 cm/rain Attenuation = 29 Zero Offset ■= 2X
Start Time = 0.000 min End Time = 15.002 min Hin / Tick = 1.00
I vmX
IvmBla
< W I - 2.0 
-  1.099
1.714
<WI«4 . 0
< K I = 8.0
< W I = 1 6 . 0
< W I = 8.0
< W I = 1 6.0
Figure 6.10. HPLC trace of extract of wool/skin biopsy plug taken from the 
application site 1 day after treatment with ivermectin B1a.
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Injection Date: 25-JUN-92
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A *= A
11:12 AM Recalculation
Detector Type 
Bus Address 
Sample Rate 
Run Time
Date: 25-JUN-92 4:42 PH
ADCB (10 Volts)
16
10.00 Hz 
15.002 min
Varian Star Workstation Rev. C 08/20/9C
Chart Speed - 1 . 30 cm/min Attenuation = 73 Zero Off
Start Time 0.000 min End Time 15.002 min Min / Ti
<WI«2.0 
<WI=4.0
—  1 . 1 2 6
<WI=8.0
<WI = 16.0
<WI«8.0
<WI«4.0
Figure 6.11. HPLC trace of extract of wool/skin biopsy plug taken from 2 cm 
lateral to the application site 1 day after treatment with ivermectin B1a.
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injection Date, 25-JUN-92 11=45 AH 
Operator « Humber 1
Workstation,
Instrument = Varian Star 
Channel , A - A
...«..***** Varian Star Workstation
Recalculation Date. 25-JUH-92 4.40 PH
Detector Type. ADCB (10 Volts)
Bus Address , 16
Sample Rate , 10.00 Hz
Run Time = 15-002 min
............. . Rev. C 08/20/90 ....
Chart Speed 
Start Time
1.30 cm/min Attenuation
0.000 min En<3 Time
18
15.002 min
Zero Offset - 4*t 
Hin / Tick - 1-00
< W I “ 2 . 0
Figure 6.12. HPLC trace of extract of wool/skin biopsy plug taken from the 
application site 1 day after treatment with ivermectin B1b.
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Injection Date: 25-JUN-92 12:01 PH Recalculation Date: 25-JUN-92 4:51 PH
Operator : Number 1 Detector Type: ADCB (10 Volts)
Workstation : Bus Address : 16
Instrument : Varian Star Sample Rate : 10.00 Hz
Channel : A ■= A Run Time : 15.002 min
Varian Star Workstation *************** Rev. C 08/20/90
Chart Speed ■= 1 . 30 cm/m i n Attenuation = 20 Zero Offset « 51
Start Time 0.000 min End Time 15.002 min H in /Tick - 1.00
<wI - 2 . 0 
1 . 0 7 6
- . 6 9 6  
< W I *= 4 0
< WI = 8 .0
<WI ■= 1 6 .0
< W I - 8 .0
Figure 6.13. HPLC trace of extract of wool/skin biopsy plug taken from 2 cm 
lateral to the application site 1 day after treatment with ivermectin B1b.
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The relative toxicities of wool staple portions from sheep hand jetted or tip 
sprayed with ivermectin are given in Table 6.4. There was a high degree of 
variation between sheep within groups as indicated by the relatively high 
standard deviations. However, there were a number of obvious trends. 
Firstly, it was obvious that both treatments resulted in an even distribution of 
ivermectin along the entire length of the staple. Secondly, there appeared to 
be little change in the distribution or amounts of chemical in the fleece over 
the first 4 weeks. Thirdly, residues appeared to slowly decline over the next 
2 months, this decline possibly being the greatest in the wool closest to the 
skin (staple portion 3). Lastly, ivermectin residues declined rapidly after 11 
weeks after treatment, but the highest concentrations were in the middle 
staple portion in both groups.
The relative toxicities can be related to actual ivermectin residues as follows. 
The LCsq for L. cuprina in this bioassay is approximately 5 pg/L, therefore a
relative toxicity of 50 equates with an extract concentration of 5 pg/L, a 
relative toxicity of 500 equals 50 pg/L and so on. As 1g of wool was 
extracted in 25 mL of methanol these concentrations are divided by 40 to get 
actual concentrations in wool (pg/g). Thus relative toxicities of 50, 500 and 
5000 approximate ivermectin wool residues of 0.125, 1.25 and 12.5 pg/g, 
respectively.
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6.3.2. Interactions with Lanolin and Wool In Vitro.
Less ivermectin B1b was recovered in surface rinses of lanolin than B1a at all 
time points in both experiments and the amounts of each component 
recovered decreased with time (Table 6.5.). Baselines were clean and 
ivermectin peaks were well defined in these analyses (Figs 6.14. - 6.19.).
This was especially noticeable in the second experiment when higher 
concentrations and lower application and rinse volumes were used (Figs 
6.18. and 6.19.).
When the ivermectin B1a and B1b solution was applied to the wool squares it 
rapidly spread to form a central dyed circle with a diameter of around 2 - 
3 cm in a matter of minutes. However, these dyed circles did not increase in
size with time after this initial spread. In the analyses of the lanolin 
impregnated wool cloth, ivermectin B1a and B1b eluted at about 6.0 and 5.5
minutes respectively (Fig. 6.20.), and interference from the dye appeared to 
be restricted to the first 3 minutes after injection prior to the solvent peak 
(Figs 6.20. and 6.21.). The blank baseline (Fig. 6.21.) was noisy, but 
relatively clean around the elution time of both ivermectin components. 
Ivermectin B1a and B1b were detected in the whole cloths and the dyed
portions only. Neither compound was detected in any of the undyed portions 
(Figs 6.22. - 6.24., Table 6.6.). There was little difference between the 
recoveries of the B1a and B1b components at any time point and the amounts
detected in the dyed portions were generally similar to those of the whole 
cloths. The amounts extracted from the cloths indicated good recoveries with 
75% or better recovered out to 5 days after application, and at least 50% at 
50 days.
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Table 6.5. Recoveries of ivermectin B1a and B1b by surface rinsing lanolin at 
various times after application.
Rinse time 
after application 
(hours)
Ivermectin recovered
B ,a B1b
Peak area 
(counts)
% of standard Peak area 
(counts)
% of standard
10 pg/mL 148614 100.0 17481 100.0
ivermectin
2 127659 85.9 10803 61.8
129146 86.9 10034 57.4
4 68065 45.8 4598 26.3
59743 40.2 4073 23.3
6 28980 19.5 2325 13.3
44287 29.8 4108 23.5
8 13970 9.4 1276 7.3
17536 1 1 .8 1521 8.7
24 21698 14.6 2010 11.5
11889 8.0 1136 6.5
25 pg/mL 211333 100.0 218136 100.0
B,a and B,b
16 183523 86.8 119649 54.9
135587 64.2 102300 46.9
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Title : IVH std lOppm
Run File i C:\STAR\DATA\AAF001.RUN
Method File : IVM2.HTH
Sample ID : Manual Sample
Injection Date: 5-AUG-92 11:39 AM Recalculation Date: 5-AUG-92 4:48 PM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A - A
Detector Type 
Bus Address 
Sample Rate 
Run Time
ADCB (10 Volts) 
16
5.00 Hz 
6.067 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed 
Start Time
3.21 cm/min Attenuation - 59
0.000 min End Time *= 6.067 min
Zero Offset - 2\ 
Min / Tick ■= 1.00
i :
<WI-8.C 
<WI«4.C
- 4 . 6 ¿ 5
Figure 6.14. HPLC trace of 10 [jg/mL ivermectin standard.
138
Injection Date: 5-AUG-92 1:10 PM Recalculation Date: 5-AUG-92 5:41 PH
Operator
Workstation
Instrument
Channel
Chart Speed 
Start Time
Figure 6.15.
Number 1
Varian Star 
A *= A
Detector Type: ADCB (10 Volts)
Bus Address : 16
Sample Rate : 5.00 Hz
Run Time : 6.003 min
Varian Star Workstation Rev. C 08/20/90
HPLC trace of blank lanolin rinsate (2.5 mL methanol).
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Injection Date: 5-AUG-92
Operator : Humber 1 
Workstation :
Instrument : Varian Star 
Channel : A ■ A
12:48 PM Recalculation
Detector Type 
Bus Address 
Sample Rate 
Run Time
Date: 6 - AUG - 9 2 9:27 AM
ADCB (10 Volts)
16
5.00 Hz 
6.003 min
Varian Star Workstation Rev. C 08/20/9C
Chart Speed 
Start Time
3.25 cm/min Attenuation
0.000 rain End Time
9
6.003 min
Zero Offset = 161 
Min / Tick = 1.00
1 1
>
(
I
C
S
Figure 6.16. HPLC trace of 2.5 mL methanol rinsate of lanolin 8 hours after 
application of 250 pL of 100 pg/mL ivermectin.
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Injection Date: 7-AUG-92 3:05 PH Recalculation Date: 10-AUG-92 10:16 AM
Operato r 
Workstation 
Instrument 
Channe1
Chart Speed 
Start Time
IvmB 1 a
Figure 6.17
Number 1
Varian Star 
A - A
Varian Star Workstation
Detector Type: ADCB 
Bus Address : 16
Sample Rate : 5.00
Run Time : 6.003
Re v .
113
6.003 min
(10 Volts)
Hz
min
C 08/20/90 ........
Zero Offset ■= 0% 
Min / Tick ■= 1.00
♦ II
3.25 cm/min Attenuation =
0.000 min End Time *=
. HPLC trace of 25 pg/mL ivermectin B1a standard.
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Injection Date: 7-AUG-92 2:57 PM Recalculation Date: 10-AUG-92 10=16 AH
Operator 
Workstation 
Instrument 
C h a n n e 1
Chart Speed 
Start Time
Figure 6.18.
Number 1 Detector T y p e : ADCB (10 Volts)
Bus Address : 16
Varian Star Sample Rate : 5.00 Hz
A - A Run Time : 6.003 min
Varian Star Work sta ti on *************** Re v. C 08/20/90 ..........
“ 3.25 cm/rain Attenu at io n « 75 Zero Offset ■= li
- 0.000 min End Time ■= 6.003 min Min / Tick = 1.00
- ~~ -II
- L
HPLC trace of blank lanolin rinsate (1.0 mL methanol).
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Injection Date: 7-AUG-92 3:20 PM Recalculation Date: 10-AUG-92 10:30 AM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A - A
Detector Type: ADCB (10 Volts)
Bus Address : 16
Sample Rate : 5.00 Hz
Run Time : 6.003 min
Varian Star Workstation Rev. C 08/20/90
Chart Speed - 
Start Time
IvmBla
3.25 cm/min Attenuation - 93
0.000 min End Time « 6.003 min
Zero Offset = 0% 
Min / T i c k  - 1 . 0 0
+ 11
-II
< W I = 8 . 0
Figure 6.19. HPLC trace of 1.0 mL methanol rinsate of lanolin 16 hours after 
application of 25 pL of 10 mg/mL ivermectin B1a.
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Injection Date: 2-JUN-93 12:56 PM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A = A
Detector Type: ADCB (10 Volts) 
Bus Address 16 
Sample Rate : 5.00 Hz 
Run Time : 8.003 min
* * * * ******* Varian Star Workstation ****«*.»<....... Rev C 0 8 / 2 0 / 9 0  '*
Chart
Start
Speed
Time
CM 
• O
Il 
II .72 c m / m i n  Attenuation = 0 0 0  m i n  End Time =
3 5 8
8 . 0 0 3  m i n
Zero Offset 
Kir. / Tick
I
Figure 6.20. HPLC trace of ivermectin B1a and B1b standard, each 10 pg/mL
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Injection Date: 2-JUN-93 1:06 PM
Operator Number 1 Detector Type : ADCB (10 Volts)
Workstation Bus Address : 16
Instrument Varian Star Sample Rate : 5.00 Hz
Channel A « A Run Time : 8.003 mi n
Varian Star Workstation ************* *- Rev. C 08/20/90 ***
Chart Speed = 2.72 cm/min Attenuation «= 128 Zero Offset
Start Time = 0.000 min End Time = 8. 003 min Min / Tick
Figure 6.21. HPLC trace of methanol extract of blank lanolin impregnated 
wool cloth.
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Injection Date: 7-JUN-93 11:59 AM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A <■ A
Detector Type 
Bus Address 
Sample Rate 
Run Time
ADCB (10 Volts) 
16
5.00 Hz 
10.003 mi n
*********** Varian Star Workstation ******«*»«***** Rev . C 08/20/90
Chart Speed 
Start T ime
2.18 cm/'min 
0.000 min
Attenuation 
End Time
128
10.003 min
Zero Offset = 
Min / Tick
Figure 6.22. HPLC trace of methanol extract of whole lanolin impregnated 
wool cloth 5 days after application of 100 pL of 0.5 mg/mL ivermectin B1a and 
B1b-
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Infection Date: 7-JUN-93 12:10 PM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A = A
Detector Type: ADCB (10 Volts)
Bus Addr ess : 16
Sample Rate : 5.00 Hz
Run Time : 10.003 min
Varian Star Workstation *************** Rev. C 08/20/90
Chart Speed = 
Start Time =
2.18 cm/min Attenuation
0.000 min End Time
128
10.003 nun
Zero Offset 
Min / Tick
10%
1.00
Figure 6.23. HPLC trace of methanol extract of dyed portion of lanolin 
impregnated wool cloth 5 days after application of 100 pL of 0.5 mg/mL 
ivermectin B1a and B1b.
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Injection Date: 7-JUN-93 12:22 PM
Operator : Number 1 
Workstation :
Instrument : Varian Star 
Channel : A *= A
Detector Type 
Bus Address 
S amp 1 e Ra t e 
Run Time
ADCB (10 Volts) 
16
5.00 Hz 
10.003 mi n
Varian Star Workstation *************** Re v . C 08/20/90
Chart Speed 
Starr. Time
2.18 cm/min Attenuation
0.000 min End Time
128
10.003 min
Zero Offset 
Min / Tick
10%
1.00
Figure 6.24. HPLC trace of methanol extract of undyed portion of lanolin 
impregnated wool cloth 5 days after application of 100 pL of 0.5 mg/mL 
ivermectin B1a and B1b.
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Table 6.6. Ivermectin extracted from lanolin impregnated wool cloths after 
application of 100 pL of ivermectin B1a and ivermectin B1b, each at 0.5 mg/mL, 
in acetone containing dye.
Time
after
application
(days)
Sample* Ivermectin B1a Ivermectin B1b
Peak height 
(counts)
% of
Standard
Peak height 
(counts)
% of 
Standard
0.2 10 pg/mL 11197 100.0 12039 100.0
Whole 9482 84.7 10005 83.1
Dyed 8486 75.8 9115 75.7
8553 76.4 9208 76.5
Undyed n.d. 0.0 n.d. 0.0
n.d. 0.0 n.d. 0.0
1 10 pg/mL 11030 100.0 11898 100.0
Whole 9519 86.3 9803 82.4
Dyed 9714 88.1 10584 89.0
9967 90.4 10755 90.4
Undyed n.d. 0.0 n.d. 0.0
n.d. 0.0 n.d. 0.0
2.3 10 pg/mL 11233 100.0 12090 100.0
Whole 11197 99.7 11706 96.8
Dyed 9069 80.7 9776 80.9
8963 79.8 9487 78.5
Undyed n.d. 0.0 n.d. 0.0
n.d. 0.0 n.d. 0.0
* 10 pg/mL = standard (1 in 50 dilution of solution applied), Whole = whole cloth, Dyed and Undyed = respective portions of 
cut cloths.
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Table 6.6.(Ctd) Ivermectin extracted from lanolin impregnated wool cloths 
after application of 100 pL of ivermectin B1a and ivermectin B1b, each at 0.5 
mg/mL, in acetone containing dye.
Time
after
application
(days)
Sample* Ivermectin B1a Ivermectin B1b
Peak height 
(counts)
% of
Standard
Peak height 
(counts)
% of
Standard
5 10 pg/mL 10949 100.0 11915 100.0
Whole 7118 65.0 7261 60.9
Dyed 8628 78.8 9335 78.3
9077 82.9 9837 82.6
Undyed n.d. 0.0 n.d. 0.0
n.d. 0.0 n.d. 0.0
13 10 pg/mL 11430 100.0 12423 100.0
Whole 8199 71.7 8630 69.5
Dyed 7080 61.9 7769 62.5
Undyed n.d. 0.0 n.d. 0.0
50 10 pg/mL 10402 100.0 11319 100.0
Whole 6467 62.2 7931 70.1
Dyed 6295 60.5 7111 62.8
5049 48.5 5681 50.2
Undyed n.d. 0.0 n.d. 0.0
n.d. 0.0 n.d. 0.0
* 10 |jg/mL = standard (1 in 50 dilution of solution applied), Whole = whole cloth, Dyed and Undyed = respective portions of 
cut cloths.
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6.4. Discussion.
6.4.1. Translocation on Sheep.
The wool/skin biopsy method used for the detection of lateral movement 
appeared sound. The intermittent unknown baseline peak was probably of 
sheep origin as this was detected in blanks and origin plugs taken 
immediately after application but never in standards prepared from the 
applied solutions. This was probably due to interference from blood 
components, which varied widely from biopsy to biopsy. Recoveries from 
spiked samples were generally good, and both ivermectin components were 
reliably detected at the application sites. The recovery of significant amounts 
of ivermectin B1b only, from wool/skin biopsies taken away from a discrete
application site indicates that there could be a significant difference between 
the behaviours of the two components on newly shorn sheep. Also, this 
implies that the observed movement was independent of dispersal due to the 
solvent, as this would be expected to distribute both components. However, 
this phenomenon was highly variable and animal dependent with movement 
detected on only three of the seven animals treated with discrete 
applications. Neither the volume of the application nor the solvent used 
appeared to affect this pattern. Jenkinson et al (1986) proposed that the 
lateral movement of topically applied cypermethrin at a rate of 11 cm/hour 
was probably due to its carriage in the intercellular sweat/sebum emulsion of 
the stratum corneum, and likely to be highly variable between animals. If this 
were the case for ivermectin, or if movement was simply due to diffusion 
through the lipid, the results would indicate that the B1b component was 
probably more soluble in yolk (wool grease) than B1a.
This result was corroborated to some extent in the experiment using lousey 
sheep. Sheep to sheep variation was dramatically demonstrated by one of
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the B1b-treated animals in which louse numbers were only slightly reduced 
(animal 3908, Table 6.2.), while lice were rapidly killed on the other five 
treated animals. The untreated animals maintained their louse burdens. The 
difference between the two ivermectin components was again apparent with 
the louse numbers on the two B1b-treated animals (on which reductions 
occurred) declining more rapidly than those for the B1a-treated animals.
However, louse numbers were reduced to virtually zero by day 56 on all five 
animals.
HPLC analyses of wool/skin biopsies from four of these animals indicated 
that both ivermectin components spread laterally over the longer time period 
of this experiment. The high variability between sampling times masked any
real temporal trends, although there was possibly an indication of more rapid 
spread of the B1b component. Comparison with the results for the louse
counts show that the in vivo biological data was much more sensitive than 
analytical residue analysis.
The relative toxicities of wool staple portions indicated that both application 
methods deposited ivermectin evenly along the wool staple. For the tip- 
sprayed sheep, it is probable that the solvent penetrated the fleece and 
descended the staple by wicking or capillary action following application. The 
trends with time in both groups indicated that the ivermectin tended to remain 
at its deposition site. The fact that residues remained highest in the middle 
portion, was probably a result of UV breakdown of ivermectin in the upper 
portion and possibly a dilution effect of new wool growth in the portion closest 
to the skin. That ivermectin depleted most rapidly from this lower portion of 
the staple indicates that there was little if any diffusion of ivermectin up or 
down the staple.
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6.4.2. Interactions with Lanolin and Wool In Vitro.
Avermectins are highly lipohilic (Fisher and Mrozick 1989), and this was 
supported by the rapid absorption of ivermectin into lanolin. The ivermectin 
B1b component appeared to be noticeably more labile than the Bia
component as its recoveries were more rapidly decreased. However, with 
time absorption appeared to cease and equilibrate for the two components. 
After 8 hours in the first experiment recoveries were similar for the two 
components and equivalent amounts were recovered at the next time point. 
This indicates that the ivermectin may possibly bind with the lanolin rather 
than diffuse into or solubilise in the lanolin, as the cessation of absorption 
could be due to saturation of the exposed lanolin. This conjecture is 
supported by the higher recoveries at a later time in the second experiment 
implying that the rate of absorption/binding was not concentration dependent. 
The difference in fat lability of ivermectin B1a and B1b has rarely been 
commented on in the literature, however, Chiu and Lu (1989) found that B1b 
depleted faster than B1a from all rat tissues examined after subcutaneous 
treatment. Interestingly the residues of B1b were markedly lower for all 
tissues at all time points except for fat at the first time point when the B1a and 
B1b residues were equivalent.
There were no apparent differences in the recoveries of either component 
from the lanolin impregnated cloths. This was probably due to the diffuse 
spread of the application solution over the matrix and the relatively long 
extraction. The high initial recoveries achieved indicated that the ivermectin 
was not tightly bound to the lanolin. The lower recoveries at later times 
probably reflected degradation of the compounds.
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from the area of deposition with time. This further supports the notion that 
ivermectin binds with lanolin, rather than being soluble in lanolin. Certainly 
there was no evidence of any diffusion of either the B1a or B1b component
through lanolin.
6.4.3. General Considerations.
The pyrethroids, cypermethrin and deltamethrin have been shown to spread 
laterally across the skin of newly-shorn sheep after backline or pour-on 
application (Jenkinson et al 1986, Kettle et al 1983). However, this spread is 
highly variable within and between sheep. The in vivo results for ivermectin 
residues presented a similar pattern and showed that ivermectin could
disperse laterally after discrete application, but this was highly variable both 
on sheep and between sheep. Interestingly the B1b component appeared to 
spread more rapidly than the B1a component. This was apparent from both
residue analyses and also biological data, as lice were more rapidly killed on 
sheep treated with the B1b component. However, louse kill though slower on
the B1a-treated sheep was possibly more complete than for the B1b-treated 
sheep.
Examination of the disposition of ivermectin along the wool staple after 
saturation application indicated that there was little if any movement of 
ivermectin along the wool fibres after deposition. Changes in concentrations 
with time for different staple portions probably related to the breakdown of 
ivermectin exposed to light and a dilution effect with the growth of new wool.
The in vitro studies with pure lanolin showed that both ivermectin 
components permeated into or bound with lanolin, and demonstrated that the 
B1b component was more labile in or had a greater affinity to lanolin. The
application of ivermectin to lanolin impregnated wool cloths indicated that
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neither component would diffuse passively through lanolin. All dispersal was 
purely solvent driven and no ivermectin was detected away from the 
application site even after 50 days. Thus ivermectin bound tightly where it 
was deposited, a result that supports the conclusions drawn from the 
observations of the disposition of ivermectin along the wool staple.
The actual treatment of sheep using a backline application in ethanol (a 
solvent which would not be expected to give wide solvent driven spread) 
resulted in marked reductions in lice numbers on most sheep, giving 
apparent eradication in five of the six sheep. This indicated that both 
ivermectin components were spread laterally to most parts of the sheep and 
also that the biological indicator was probably much more sensitive than 
residue analyses. The failure to achieve a marked reduction in numbers of 
lice on one of the B1b-treated sheep highlights the between sheep variation.
The facts that ivermectin did not diffuse through lanolin in vitro, nor along the 
staple on sheep indicates that the lateral movement on shorn sheep was 
purely due to passive carriage in the yolk (lipid sweat mixture) as it moves 
through the stratum corneum. This mode of transport was considered the 
most probable for cypermethrin on sheep by Jenkinson et al (1989). The 
differences in rate of spread of the two components of ivermectin therefore 
probably relate to their different affinities to lanolin. Ivermectin B1b with its
more rapid binding would be expected to be dispersed more rapidly by 
movement of the yolk. B1a with a lower affinity may possibly spread at a
slower rate, but this lower binding rate may possibly result in a more even 
dispersal of the chemical. Certainly dispersal via carriage in the yolk would 
be expected to be highly variable, and animal dependent. This was clearly 
demonstrated by the markedly different results achieved on each animal.
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While the result of apparent eradication of lice on five of six animals, using 
what was possibly a most inefficient backline delivery system, could indicate 
that avermectins could possibly be a candidate for lice control in a backline 
formulation, one must consider the implications of the translocation method 
and past experience with pyrethroids. The strong affinity of ivermectin to 
lanolin is highly likely to result in strong and defined concentration gradients 
on sheep, and these will probably be accentuated by individual sheep 
variation. These are probably identical conditions to those which are 
considered to have contributed to the rapid rise of pyrethroid resistance in the 
sheep body louse (Levot and Hughes 1987). An effective backline treatment 
that would not be expected to result in the rapid rise of resistance would have 
to be formulated so that the solvent actually delivers an even spread of the 
chemical.
However, the quite markedly different affinities of the two components of 
ivermectin to lanolin resulted in obviously different behaviour on the sheep. 
This was despite the fact that there is only a minor structural difference 
between the two compounds. Thus, other avermectins could behave 
differently and possibly be more suitable for backline use on sheep, though 
firstly a much greater understanding of the way in which yolk disperses along 
the skin is required. The strong binding of these compounds could make 
them useful for studying the nature of the movement of yolk along the skin. 
Future studies could possibly utilise radiolabelled avermectins which would 
allow much more sensitive detection of residues to elucidate this mechanism.
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7. GENERAL DISCUSSION.
Avermectins and related compounds are highly potent insecticides, and as 
they appear to have a different mode of action to other insecticide classes 
they are a very important resource. However, their broad spectrum, including 
activity against nematodes and mites, has resulted in the relatively 
non-specific introduction of these chemicals for commercial use. Their 
activity against both nematodes and arthropods has also given rise to new 
terminology with macrocyclic lactones generically referred to as 
"endectocides", compounds effective against both internal and external 
parasites (Shoop 1993). The primary use of these compounds has been 
veterinary, where a single host species may have a broad spectrum of 
susceptible parasites. It is possible that commercial focus on this broad- 
spectrum activity may have retarded development of specific insecticides and 
nematicides. While avermectins have been in use as endectocides and 
miticides for over ten years, it is only recently that ivermectin has been 
introduced as a specific insecticide for L. cuprina. Yet, for many years 
ivermectin has been known as a highly potent insecticide against L. cuprina 
(James et al 1980), and it is an order of magnitude more toxic to early instars 
of L. cuprina than diazinon was when first introduced for control of fly strike 
(Hughes and Levot 1990).
Ivermectin has been widely used for nematode control of sheep in Australia 
since 1987, and thus would certainly have been available for exposure to 
field populations of L. cuprina and B. ovis. Larvae of L. cuprina, especially, 
could have been exposed to sublethal (and possibly selective) doses of 
ivermectin in blood. In fact the LC^ of ivermectin to L. cuprina larvae
corresponds to the plasma level in sheep at about 5 days after therapeutic 
dosing. B. ovis would be less likely to be exposed to residues as they feed
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on the skin only and ingest little blood. Thus it was promising for this group 
of chemicals that the field responses of both L  cuprina and B. ovis to 
ivermectin were those of susceptible populations. Further, the lack of any 
marked increase in tolerance to ivermectin following intense selection in the 
laboratory provided evidence that there was no specific mechanism for 
ivermectin resistance in the field population of L. cuprina.
Where high level resistances to avermectins have been selected in the 
laboratory for house flies (Scott 1991) and mites (Campos et al 1995), these 
have arisen rapidly and probably reflect selection of existing mechanisms. 
Similarly, field resistances in thrips (Immaraju et al 1992) and nematodes 
(Shoop 1993) have resulted from intensive use, resulting in a high selection 
pressure. Where the mechanisms of resistance have been investigated it is 
suggested that reduced penetration plays a major role and altered active site 
binding a minor role in houseflies (Konno and Scott 1991). Resistance due to 
enzymatic metabolism has been proposed for some low level resistances in 
insects (Scott 1989, Argentine et al 1992) or considered to have no role 
(Scott et al 1991). Similarly, there is divergence over cross resistance to 
avermectins from other chemical groups. Though some workers have 
reported cross resistance to avermectins in pyrethroid-resistant insects (Scott 
1989, Geden et al 1990), others have reported no evidence of any significant 
cross resistance from pyrethroids or other insecticides (Roush and Wright 
1986, Campanhola and Plapp 1989, Argentine and Clark 1990, Cochran 
1990).
The field strains of L. cuprina and B. ovis I examined are resistant to 
organophosphates and carbamates, and pyrethroids, respectively, yet all field 
strains (including L. cuprina strains with enhanced monooxygenase levels) 
produced a susceptible response to ivermectin. Also, highly-selected
158
laboratory strains of L. cuprina resistant to organophosphates or pyrethroids 
showed only minor increases in tolerance to ivermectin, probably consistent 
with increased vigour or a strain difference due to long term laboratory 
culture and selection. Esterase metabolism is considered to be the major 
mechanism in organophosphate resistance in L. cuprina (Hughes 1982, 
Hughes and Devonshire 1982), and monooxygenases have been implicated 
in pyrethroid resistances in laboratory selected L. cuprina (Kotze 1993) and in 
B. ovis (Kotze 1994). Thus it was apparent that neither of these existing 
mechanisms are likely to interfere significantly with the effectiveness of 
avermectins against L. cuprina or B. ovis.
The selection of L. cuprina larvae with ivermectin resulted in a slight increase 
in tolerance which stabilised at less than ten times that of the susceptible 
parental strain. This resistance appeared to be reasonably specific as the 
only significant cross resistance was to the macrocyclic lactone, moxidectin. 
Low level tolerance to other insecticides was similar to the level the strain 
reverted to after relaxation of selection pressure (about two times that of the 
parental strain), indicating that the selection procedure had resulted in a 
generalised increase in fitness. Synergists produced a slight decrease in the 
tolerance of the selected strain implying that enzymatic detoxification may 
have been playing a role, however, this was non-specific and generalised. 
The monooxygenase levels of the selected strain were significantly higher 
(about three times) than those of the parental strain, but field strains with 
similar levels were susceptible to ivermectin. Also, induction of the 
susceptible strain with phénobarbital markedly increased tolerance to 
diazinon but had no effect on susceptibility to ivermectin. Thus there were no 
specific enzymatic mechanisms that could be implicated in the observed 
tolerance, and monooxygenase-mediated metabolism of ivermectin appeared 
to be of little importance.
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Allowing for the increase in fitness, the slight tolerance (less than five times) 
in the selected strain could not be ascribed to any specific mechanism, and 
factors such as metabolism, decreased penetration, behavioural avoidance 
etc. could have been involved. However, none was suitable for selection of 
high level resistance. This coupled with the lack of any significant cross 
resistance from existing tolerances to other insecticides, indicates that a 
mechanism capable of conferring high-level resistance to avermectins is not 
currently present in field populations of L. cuprina.
The intensity of the debate over environmental consequences of the use of 
avermectins and related compounds is probably not surprising when their 
broad spectrum of activity, and marketing as endectocides are considered. 
While specific external parasiticides may have a greater systemic effect on 
dung fauna than avermectins (Bianchin et al 1992), the fact that these are 
targeted at arthropods may have resulted in acceptance of adverse affects 
on non-target dung fauna. The avermectin endectocides are primarily aimed 
at internal nematode parasites, thus toxic effects on dung-feeding insects 
may be perceived as beneficial (when larvae of pest species are affected) or 
adverse (when beneficial species are affected), but both of these are 
generally seen as side effects of treatment for nematodes.
My studies basically confirmed expected results, that the macrocyclic 
lactones are highly toxic to insects as well as nematodes. However, I feel 
that the focus of debate should be on the positive aspects of the differences 
in activities of similar compounds, and a more ecologically based approach to 
the assessment of so called adverse effects. Moxidectin is less toxic to 
insects than ivermectin or abamectin, generally by at least one order of 
magnitude, whilst probably having similar activity against nematodes. All
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three compounds are marketed as endectocides. The former would be 
expected to have a lesser toxic effect on non-target dung fauna (though it 
may have significant sub-lethal effects), but would be likely to be less 
effective against target ectoparasites and dung breeding pests. In view of the 
marked differences in the activities of the three compounds I would speculate 
that there could easily be closely related compounds with more specific 
activities against either nematodes or arthropods. Also, the presumption 
could be made that these entities were selected for development because of 
the commercial benefits of their broad spectrum. Little thought was probably 
given to the possible impact of the effects of residues on non-target species, 
from the points of view of selection for resistance and adverse effects on 
beneficial insects. Both of these aspects would be better served by use of 
compounds with specific activities against either arthropods or nematodes.
However, benefits can be gained from the broad spectrum of these 
compounds as demonstrated by the effective reduction of breech strike in 
scouring sheep using daily dosing with ivermectin. Again, this benefit would 
have to be balanced against the possible environmental effects of dung 
residues. Fortunately, insects play a minor role in the degradation of sheep 
faeces and thus such detrimental effects are likely to be minimal. However, it 
is essential that emphasis should be placed on ecological studies to actually 
determine the effects of these and other compounds on dung fauna. While 
toxicity studies will give information on direct lethal and sub-lethal effects, in- 
depth studies are required on the effects on field population dynamics under 
normal usage patterns and conditions. In most studies aspects such as 
untreated refugia and dispersal and immigration of insects are ignored.
My in vivo and in vitro studies of the behaviour of ivermectin on the wool and 
skin of fleece and in lanolin indicated that avermectins bind tightly to lanolin
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(and therefore the wool fats) and do not appear to actively disperse through 
lanolin. Thus the observed movement of ivermectin around the body of 
shorn sheep is probably due to its carriage in the yolk as it moves through the 
intercellular spaces of the stratum corneum, similar to one of the proposed 
methods of translocation of topically applied pyrethroids (Jenkinson et al 
1989). The differences in the rates of movement of the two components of 
ivermectin probably related to their respective rates of binding or their 
different affinities to lanolin.
These properties of the avermectins are very important factors when
considering their application for control of ectoparasites of sheep. In long
wool the fleece will restrict access to the skin surface; also the secretion and
movement of yolk is considerably less than that of newly shorn sheep. Thus
it is likely that these chemicals will not translocate significantly from the site of
application. Therefore, it is probable that the method used to apply the
insecticide will have a significant effect upon its efficacy and also the resultant
residues which may select for resistance. These differences have been
observed in field trials where hand jetting with ivermectin was noticeably
more effective than machine jetting in preventing fly strike (Thompson et al 
As
1994^ 7- Also hand jetting with ivermectin for louse control in long-woolled 
sheep only results in a greater than 98% reduction in louse numbers, not 
eradication (Eagleson et al 1993a). These results reflect in part the limited 
distribution of chemical during the jetting process, but also demonstrate the 
lack of movement of chemical into untreated areas. While careful hand 
jetting ensures saturation of the predilection sites for blowfly strike, it is 
extremely difficult to completely cover the animal's body for louse control; 
thus pockets of lice may survive the initial treatment and be exposed to 
sub-lethal concentrations as the chemical degrades.
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In newly shorn sheep there was movement of ivermectin around the sheep's 
body, however this was highly variable and dependent on transport in the 
yolk secretions of the sheep. From a back-line application this process is 
likely to lead to a situation where a concentration gradient will develop around 
the sheep's body with resultant exposure of lice to sub-lethal concentrations. 
This is identical to the process which is considered to have led to the rapid 
development of resistance to pyrethroids in B. ovis (Levot and Hughes 1990). 
In view of this it is probable that even an effective back-line formulation using 
an avermectin in typical low volume application would be unlikely to achieve 
complete eradication of lice on all sheep, and would possibly select for 
chemical resistance. Unless a back-line formulation or delivery method that 
distributes the chemical evenly can be devised, the most responsible use of 
an avermectin for louse control would be using a saturation method (eg. 
dipping) where complete coverage is obtained.
In summary, my studies showed that while there has been exposure to 
ivermectin of the major ectoparasites of sheep for some years, there is no 
indication of resistance in field populations of L. cuprina or B. ovis, nor is 
there any indication of any significant cross resistances from other 
insecticides in field or laboratory-selected strains. Laboratory selection with 
ivermectin did not markedly increase the tolerance of L. cuprina to ivermectin. 
Experiments with L. cuprina and dung-feeding insects confirmed that there 
are significant differences in the toxicities of the macrocyclic lactones to 
insects. Lastly, investigations of the interactions of ivermectin with the skin 
and fleece of sheep, and lanolin, demonstrated that the compound binds 
tightly to lanolin on the skin and fleece, and that any translocation on the 
sheep is due to passive carriage in the yolk. These findings introduce many 
interesting avenues for future research.
163
The recent introduction of ivermectin as a specific ectoparasiticide for sheep 
must be welcomed as an alternative to existing chemicals, however, external 
application is likely to result in much greater selection pressure on both 
sheep blowflies and lice. Ongoing monitoring of field populations will be 
important to detect the onset of resistance. Further modification of the 
methods used for the louse assay may also allow maintenance of laboratory 
cultures of B. ovis and allow for laboratory selection of this species. Thus 
allowing the potential for resistance in this species to be examined more 
closely. The increasing use of avermectins and like compounds is inevitable 
in the near future. While their toxicity to non-target dung fauna is obvious, 
further study of their environmental effects is sorely needed to clarify any 
adverse effects. However, I would prefer that research is undertaken on an 
ecological basis examining effects on population dynamics under normal 
usage patterns over realistic time frames. The highly lipophilic nature of 
these compounds make the study of their interactions with the skin and skin 
covering of the animals to be treated very important. Examination of 
application methods and formulations is required to maximise effective 
spread over the body to increase efficacy, but most importantly to reduce 
selection pressure due to the development of concentration gradients or 
variable residues. Finally, this group of compounds contains entities with 
varying potencies against different organisms. Focus on the development of 
specific insecticides and nematicides rather than broad spectrum agents 
could produce worthwhile compounds that could easily alleviate many of the 
problems associated with environmental toxicity, and also reduce the risk of 
development of resistance due to effects of residues on non-target pest 
organisms.
164
8. REFERENCES.
Abalis, I. M. and Eldefrawi, A. T. 1986. [3H]Muscimol binding to a putative 
GABA receptor in honey bee brain and its interaction with avermectin B1a.
Pestic. Biochem. Physiol. 25:279-287.
Abbott, W. S. 1925. A method of computing the effectiveness of an 
insecticide. J. Econ. Entomol. 18:265-267.
Abro, G. H., Dybas, R. A., Green, A. St. J. and Wright, D. J. 1988. Toxicity 
of avermectin B, against a susceptible laboratory strain and an insecticide-
resistant strain of Plutella xylostella (Lepidoptera: Plutellidae). J. Econ. 
Entomol. 81:1575-1580.
Agee, H. R. 1985. Neurobiology of the bollworm moth: effects of abamectin 
on neuronal activity and on sensory systems. J. Agric. Entomol. 2:325-336.
Agosin, M. 1985. Role of microsomal oxidations in insecticide degradation. 
In Kerkut, G. A. and Gilbert, L. I. (Eds). Comprehensive Insect Physiology, 
Biochemistry and Applied Pharmacology. Vol. 12. pp. 647-712. Pergamon. 
Oxford.
Albert, J., Lingle, D. H., Marder, E. and O'Neill, M. B. 1986. A GABA- 
activated chloride conductance not blocked by picrotoxin on spiny lobster 
neuromuscular preparations. Brit. J. Pharmacol. 87:771-779.
165
Anderson, T. E., Babu, J. R., Dybas, R. A. and Mehta, H. 1986.
Avermectin ingestion and contact toxicity against Spodoptera eridania
and Heliothis virescens (Lepidoptera: Noctuidae). J. Econ. Entomol. 79:197- 
201 .
Argentine, J. 1991. Two abamectin-resistant strains of Colorado potato 
beetle. Resist. Pest Manag. 3:30-31.
Argentine, J. A. and Clark, J. M. 1990. Selection for abamectin resistance 
in Colorado potato beetle (Coleoptera: Chrysomelidae). Pestio. Sci. 28:17- 
24.
Argentine, J. A., Clark, J. M. and Lin, H. 1992. Genetics and biochemical 
mechanisms of abamectin resistance in two isogenic strains of Colorado 
potato beetle. Pestio. Biochem. Physiol. 44:191-207.
Arundel, J. H. and Sutherland, A. K. 1988. Ectoparasitic Diseases of Sheep, 
Cattle, Goats and Horses. Australian Bureau of Animal Health/ Australian 
Government Publishing Service. Canberra. (Animal Health in Australia, voi. 
10 ).
Badewitz-Dodd, L. H. (Ed.). 1994. Index of Veterinary Specialities. 
Australian Edition. Mimms Australia. Sydney.
Bayvel, A. C. D., Keiran, P. J. and Townsend, R. B. 1981. Technical details 
of a new treatment for external parasites in sheep. Wool Technol. Sheep 
Breeding. 29:17-24.
166
Beeman, R. W. and Stuart, J. J. 1990. A gene for lindane + cyclodiene 
resistance in the red flour beetle (Coleoptera: Tenebrionidae). J. Econ. 
Entomol. 83:1745-1751.
Bianchin, I., Honer, M. R., Gomes, A. and Koller, W. W. 1992. Effect of 
some antitick compounds/insecticides on Onthophagus gazella. EMBRAPA 
Comunicado Technico, No 45:1-7. ISSN 0100-7807.
Bloomquist, J. R. 1993. Toxicology, mode of action and target site-mediated 
resistance to insecticides acting on chloride channels. Comp. Biochem. 
Physiol. 106:301-314.
Bogan, J. A. and McKellar, Q. A. 1988. The pharmacokinetics of ivermectin 
in sheep and cattle. J. Vet. pharmacol. Therap. 11:260-268.
Boray, J. C., Levot, G. W., Plant, J. W., Hughes, P. B. and Johnson, P. W.
1988. Resistance of the sheep body louse, Damalinia ovis, to synthetic 
pyrethroids. In Outteridge, P. M. (Ed.) Australian Advances in Veterinary 
Science, pp. 130-136. Australian Veterinary Association. Sydney.
Bornemissza, G. F. 1960. Could dung eating insects improve our pastures? 
J. Aust. Inst. Agric. Sci. 26:54-56.
Bornemissza, G. F. 1970. Insectary studies on the control of dung breeding 
flies by the activity of the dung beetle, Onthophagus gazella F. (Coleoptera: 
Scarabaeinae). J. Aust. Entomol. Soc. 9:31-41.
167
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein dye binding. 
Anal. Biochem. 72:248-254.
Brander, G. C. 1957. The movement of dieldrin in the sheep's fleece. Aust. 
Vet J. 33:247.
Bull, D. L. 1986. Toxicity and pharmacodynamics of avermectin in the 
tobacco budworm, corn earworm, and fall armyworm (Noctuidae: 
Lepidoptera). J. Agric. Food Biochem. 34:74-78.
Bull, D. L. and Pryor, N. W. 1991. Interactions of carbaryl with susceptible 
and multirésistant house flies (Diptera: Muscidae). J. Econ. Entomol. 
84:1145-1153.
Burg, R. W., Miller, B. M., Baker, E. E., Birnbaum, J., Currie, S. A., 
Hartman, R., Kong, Y-L, Monaghan, R. L, Olsen, G., Putter, I., Tunac, J. 
B., Wallick, H., Stapley, E. O., Oiwa, R. and Omura, S. 1979. 
Avermectins, new family of potent antihelminthic agents: producing organism 
and fermentation. Antimicrob. Agents Chemother. 15:361-367.
Campanhola, C. and Plapp, F. W. Jr. 1989. Toxicity and synergism of 
insecticides against susceptible and pyrethroid-resistant neonate larvae and 
adults of the tobacco budworm (Lepidoptera: Noctuidae). J. Econ. Entomol. 
82:1527-1533.
Campbell, W. C. (Ed.). 1989. Ivermectin and Abamectin. Springer-Verlag. 
New York.
168
Campbell, W. C., Fischer, M. H., Stapley, E. O., Albers-Schonberg, T. and 
Jacob, T. A. 1983. Ivermectin: a potent new antiparasitic agent. Science. 
221:923-928.
Campbell, W. C., Burg, R. W., Fischer, M. H. and Dybas, R. A. 1984. The 
discovery of ivermectin and other avermectins. In Magee, P. S., Kohn, G. K. 
and Menn, J. J. (Eds). Pesticide Synthesis Through Rational Approaches. 
pp. 5 -20. American Chemical Society. Washington DC.
Campos, F., Dybas, R. A. and Krupa, D. A. 1995. Susceptibility of 
twospotted spider mite (Acari: Tetranychidae) populations in California to 
abamectin. J. Econ. Entomol. 88:225-231.
Chiu, S-H. L. and Lu, A. Y. H. 1989. Metabolism and tissue residues. In 
Campbell, W. C. (Ed.). Ivermectin and Abamectin. pp. 131-143. Springer- 
Verlag. New York.
Chiu, S-H. L., Green, M. L., Bayliss, F. P., Eline, D., Rosegay, A., 
Meriwether, H. and Jacob, T. A. 1990. Absorption, tissue distribution, and 
excretion of tritium-labelled ivermectin in cattle, sheep and rat. J. Agric. Food 
Chem. 38:2072-2078.
Cochran, D. G. 1985. Mortality and reproductive effects of avermectin B1a 
fed to German cockroaches. Entomologia Exp. Appl. 37:83-88.
Cochran, D. G. 1990. Efficacy of abamectin fed to German cockroaches 
(Dictyoptera: Blattellidae) resistant to pyrethroids. J. Econ. Entomol. 
83:1243-1245.
169
Conder, G A., Thompson, D. P. and Johnson, S. S. 1993. Demonstration 
of co-resistance of Haemonchus contortus to ivermectin and moxidectin. Vet 
Rec. 132:651-652.
Cook, D. F. 1991. Ovarian development in females of the Australian sheep 
blowfly Lucilia cuprina (Diptera: Calliphoridae) fed on sheep faeces and the 
effects of ivermectin residues. Bull. Entomol. Res. 81:249-256.
Cook, D. F. 1993. Effect of avermectin residues in sheep dung on mating of 
the Australian sheep blowfly Lucilia cuprina. Vet. Parasitol. 48:205-214.
Corbett, J. R. 1974. The Biochemical Mode of Action of Pesticides. 
Academic Press. London.
Corbitt, T. S., Green, A. S. J. and Wright, D. J. 1989. Relative potency of 
avermectin B  ^ against larval stages of Spodoptera littoralis and Heliothis
virescens. Crop Prot. 8:127-132.
Davies, R. G. 1971. Program 45 in Computer Programming in Quantitative 
Biology. Academic Press. New York.
De Azambuja, P., Gomes, J. E. P. L., Lopes, F. and Garcia, E. S. 1985. 
Efficacy of ivermectin against the bloodsucking insect, Rhodnius prolixus 
(Hemiptera, Triatominae). Mem. Inst. Oswaldo Cruz. 80: 439-442.
Deng, Y. and Casida, J. E. 1992. House fly head GABA-gated chloride 
channel: Toxicologically relevant binding site for avermectins coupled to site 
for ethynylbicycloorthobenzoate. Pestic. Biochem. Physiol. 43:116-122.
170
Doherty, W. M., Stewart, N. P., Cobb, R. M. and Keiran, P. J. 1994. In- 
vitro comparison of the larvicidal activity of moxidectin and abamectin against 
onthophagus gazella (F.) (Coleoptera: Scarabaeidae) and Haematobia 
irritans exigua De Meijere (Diptera: Muscidae). J. Aust. Entomol. Soc. 
33:71-74.
Drexler, G. and Sieghart, W. 1984a. Properties of high affinity binding site 
for tritium-labelled avermectin B1a. Eur. J. Pharmacol. 99:269-277.
Drexler, G. and Sieghart, W. 1984b. Evidence for association of a high 
affinity avermectin binding site with benzodiazepine receptor. Eur. J. 
Pharmacol. 101:201 -207.
Drexler, G. and Sieghart, W. 1984c. Sulphur-35-labelled tert-butyl- 
bicyclophosphorothionate and avermectin bind to different sites associated 
with the gamma-aminobutyric acid-benzodiazepine receptor complex. 
Neurosci. Let. 50:273-277.
Duce, I. R. and Scott, R. H. 1983. GABA sensitivity in the distal bundles of 
the locust extensor tibia muscle. J. Physiol. 343:32.
Duce, I. R. and Scott, R. H. 1985. Actions of dihydroavermectin B1a on 
insect muscle. Brit. J. Pharmacol. 85:395-401.
Eagleson, J. S., Thompson, D. R., Scott, P. G., Cramer, L. G. 1993a. 
Efficacy of ivermectin jetting fluid for control of the sheep biting louse 
(Damalinia ovis). Aust. J. Exp. Agric. 33:843-845.
171
Eagleson, J. S., Thompson, D. R., Scott, P. G., Cramer, L. G. and Barrick,
R. A. 1993b. Field trials to confirm the efficacy of ivermectin jetting fluid for 
control of blow fly strike in sheep. Vet. Parasitol. 51:107-112.
East, I. J., Kerlin, R. L. and Eisemann, C. H. 1992. Reduced growth of 
Lucilia cuprina larvae fed serum from sheep treated with anthelminthics.
Aust. Vet. J. 69:286-287.
Egerton, J. R., Ostlind, D. A., Blair, L. S., Eary, C. H., Suhayda, D., Cifelli,
S. , Reik, R. F. and Campbell, W. C. 1979. Avermectins, new family of 
potent antihelminthic agents: efficacy of the B1a component. Antimicrob.
Agents Chemother. 15:372-378.
Ewert, K. M., Di Pietro, J. A., Danner, C. S. Jr and Lawrence, L. M. 1991. 
Ivermectin treatment of horses: effect on proportion of faecal-fouled areas in 
pastures. Vet. Rec. 129:140-141.
Ferrar, P. 1979. The immature stages of dung-breeding muscoid flies in 
Australia, with notes on the species, and keys to larvae and puparia. Aust. J. 
Zool. Suppl. Ser. 73:1-106.
Ferrar, P. 1987. A Guide to the Breeding Habits and Immature Stages of 
Diptera Cyclorrhapha. E. J. Brill. Leiden.
Fincher, G. T. 1992. Injectable ivermectin for cattle: effects on some dung- 
inhabiting insects. Environ. Entomol. 21:871-876.
172
Fincher, G. T. and Wang, G. T. 1992. Injectable moxidectin for cattle: 
effects in two species of dung burying beetles. Southwest Entomol. 
17:303-306.
Fink, D. W. and Porras, A. G. 1989. Pharmacokinetics of ivermectin in 
animals and humans. In Campbell, W. C. (Ed.). Ivermectin and Abamectin. 
pp. 113-130. Springer-Verlag. New York.
Fischer, M. H. and Mrozik. H. 1989. Chemistry. In Campbell, W. C. (Ed.). 
Ivermectin and Abamectin. pp. 1-23. Springer-Verlag. New York.
Fritz, L. C., Wang, C. C. and Gorio, A. 1979. Avermectin B1a irreversibly
blocks presynaptic potentials at the lobster neuromuscular junction by 
reducing muscle membrane resistance. Proc. Nat Acad. Sci. 76:2062-2066.
Fukami, J. 1980. Metabolism of several insecticides by glutathion S- 
transferase. Pharmacol. Therap. 10:473-514.
Fuller, M. E. 1934. The insect inhabitants of carrion: a study in animal 
ecology. Bull. Coun. Sci. Indust. Res. Aust. No. 195.
Geden, C. J., Steinkraus, D. C., Long, S. J., Rutz, D. A. and Shoop, W. L. 
1990. Susceptibility of insecticide-susceptible and wild house flies (Diptera: 
Muscidae) to abamectin on whitewashed and unpainted wood. J. Econ. 
Entomol. 83:1935-1939.
Graham, N. P. H. 1957. Control of flystrike. The use of light surface sprays 
as a means of controlling body strike. Aust. Vet. J. 33:137-140.
173
Halley, B. A.f Jacob, T. A. and Lu, A. Y. H. 1989a. The environmental 
impact of the use of ivermectin: environmental effects and fate. 
Chemosphere. 18:1543-1563.
Halley, B. A., Nessel, R. J. and Lu, A. Y. H. 1989b. Environmental aspects 
of ivermectin usage. In Campbell, W. C. (Ed.). Ivermectin and Abamectin. 
pp. 162-172. Springer-Verlag. New York.
Harrison, I. R. 1967. The development of organophosphate insecticide 
resistance in the Australian sheep blowfly, Lucilia cuprina (Wied.). Vet. Rec. 
80:205.
Harrison, P. M. and Rundle, J. C. 1983. The mechanism and importance of 
larvicide translocation on wool. In National symposium on the Sheep Blowfly 
and Flystrike in Sheep, Sydney, December 1983. pp. 180-185. Department 
of Agriculture of NSW. Sydney.
Hart, R. J. 1969. Recent developments in sheep blowfly control. N.S.W.
Div. Aust. Vet. Ass. Proc. 5:14-15.
Herdegen, J. W., Simpson, I. H. and Ridings, H. I. 1989. Jetting technique 
evaluation. Wool Tech. Sheep Breeding. 37:123-129.
Hopkins, D. E. 1970. In vitro colonization of the sheep biting louse, Bovicola 
ovis. Ann. Entomol. Soc. Am. 63:1196-1197.
174
Hotson, I. K. 1983. The development of ivermectin as an antiparasitic agent 
in sheep. In Proceedings of the symposium "Recent Developments in the 
Control of Animal Parasites". pp. 42-55. XXII World Veterinary Congress, 
Perth, Australia.
Houlding, B., Ridsdill-Smith, T. J. and Bailey, W. J. 1991. Injectable 
ivermectin causes a delay in Scarabaeinae dung beetle egg-laying in cattle 
dung. Aust. Vet. J. 68:185-186.
Hoy, M. A. and Conley, J. 1987. Selection for abamectin resistance in 
Tetranychus urticae and T. pacificus (Acari: Tetranychidae). J. Econ. 
Entomol. 80:221-225.
Hoy, M. A. and Ouyang, Y-L. 1989. Selection of the western predatory mite, 
Metaselulus occidentalis (Acari: Phytoseiidae), for resistance to abamectin.
J. Econ. Entomol. 82:35-40.
Hughes, P. B. 1981. Spectrum of cross-resistance to insecticides in field 
samples of the primary sheep blowfly, Lucilia cuprina. Int. J. Parasitol. 
11:475-479.
Hughes, P. B. 1982. Organophosphorus resistance in the sheep blowfly, 
Lucilia cuprina (Wiedemann) (Diptera: Calliphoridae): A genetic study 
incorporating synergists. Bull. Entomol. Res. 72:573-582.
Hughes, P. B. and Devonshire, A. L. 1982. The biochemical basis of 
resistance to organophosphorus insecticides in the sheep blowfly, Lucilia 
cuprina. Pestic. Biochem. Physiol. 18:289-297.
175
Hughes, P. B. and Levot, G. W. 1990. Toxicity of three avermectins to 
insecticide susceptible and resistant larvae of Lucilia cuprica (Wiedemann) 
(Diptera: Calliphoridae). J. Aust. Entomol. Soc. 29:109-111.
Hughes, P. B. and McKenzie, J. A. 1987. Insecticide resistance in the 
Australian sheep blowfly, Lucilia cuprica: speculation, science and strategies. 
In Ford, M. G., Holloman, D. W., Khambay, B. P. S. and Sawicki, R. M. 
(Eds). Biological acd Chemical Approaches to Combaticg Resistacce ic 
Xecobiotics. pp. 162-177. Ellis Horwood. Chichester.
Hughes, P. B., Green, P. E. and Reichmann, K. G. 1984. Specific 
resistance to malathion in laboratory and field populations of the Australian 
sheep blowfly, Lucilia cuprica (Diptera: Calliphoridae). J. Ecoc. Ectomol. 
77:1400-1404.
Immaraju, J. A. and Morse, J. G. 1990. Selection for pyrethroid resistance, 
reversion, and cross-resistance with citrus thrips (Thysanoptera: Thripidae).
J. Ecoc. Ectomol. 83:698-704.
Immaraju, J. A., Paine, T. D., Bethke, J. A., Robb, K. L. and Newman, J. P. 
1992. Western flower thrips (Thysanoptera: Thripidae) resistance to 
insecticides in coastal California greenhouses. J. Ecoc. Ectomol. 85:9-14.
Ismail, F. and Wright, D. J. 1991. Cross-resistance between acylurea insect 
growth regulators in a strain of Plutella xylostalla L. (Lepidoptera: 
Yponomeutidae) from Malaysia. Pestic. Sci. 33:359-370.
Jackson, H. C. 1989. Ivermectin as a systemic insecticide. Parasitol. Today. 
5:146-156.
176
Jacobs, D. E., Pilkington, J. G., Fisher, M. A. and Fox, M. T. 1988. 
Ivermectin therapy and degradation of cattle faeces. Vet. Rec. 123:400.
James, P. J., Saunders, P. E., Cockrum, K. S. and Munro, K. J. 1993. 
Resistance to synthetic pyrethroids in South Australian populations of sheep 
lice (Bovicola ovis). Aust. Vet. J. 70:105-108.
James, P. S.t Picton, J. and Riek, R. F. 1980. Insecticidal activity of the 
avermectins. Vet. Rec. 106:59.
James, T. 1985. Parastat, parametric statistical analyses programmed for 
the IBM PC. Dept, of Environmental Biology, University of Guelph.
Jenkinson, D. McEwan and Lloyd, D. H. 1979. The topography of the skin 
surface of cattle and sheep. Br. Vet. J. 135:376-379.
Jenkinson, D. McEwan, Hutchinson, G., Jackson, D. and McQueen, L.
1986. Route of passage of cypermethrin across the surface of sheep skin. 
Res. Vet. Sc. 41:237-241.
Johnson, P. W., Boray, J. C. and Dawson, K. L. 1992. Resistance to 
synthetic pyrethroid pour-on insecticides in strains of the sheep body louse 
Bovicola (Damalinia) ovis. Aust. Vet. J. 69:213-217.
Kass, I. S., Stretton, A. O. W. and Wang, C. C. 1984. The effects of 
ivermectin and drugs related to acetylcholine and 4-aminobutyric acid on 
neurotransmission in Ascaris summ. Molec. Biochem. Parasitol. 
13:213-225.
177
Kass, I. S., Wang, C. C., Walrond, J. P. and Stretton, A. O. W. 1980. 
Avermectin B1a a paralysing anthelminthic that affects interneurons and
inhibitory motoneurons in Ascaris. Proc. Natl. Acad. Sci. 77:6211-6215.
Kerlin, R. L. and East, I. J. 1992. The survival and fecundity of buffalo flies 
after treatment of cattle with three anthelminthics. Aust. Vet. J. 69:283-285.
Kettle, P. R., Watson, A. J. and White, D. A. 1983. Evaluation of a 
deltamethrin formulation as a back-line treatment of sheep for the control of 
the sheep body louse (Damalinia ovis). N. Z. J. Exp. Agrie. 11:321 -324.
Keys, R. G., Toohey, L. A. and Arul Thilakan, T. 1993. Survival by sheep 
body lice (Bovicola ovis) after plunge dipping in synthetic pyrethroid 
lousicides. Aust. Vet. J. 70:117.
Kieran, P. J. 1994. Moxidectin against ivermectin-resistant nematodes - a 
global view. Aust. Vet. J. 71:18-20.
King, K. L. 1993. Methods for assessing the impact of avermectins on the 
decomposer community of sheep pastures. Vet. Parasitol. 48:87-97.
Konno, Y. and Scott, J. G. 1991. Biochemistry and genetics of abamectin 
resistance in the house fly. Pestic. Biochem. Physiol. 41:21-28.
Kotze, A. C. 1993. Cytochrome P450 monooxygenases in larvae of 
insecticide susceptible and resistant strains of the Australian sheep blowfly, 
Lucilia cuprina. Pestic. Biochem. Physiol. 46:65-72.
178
Kotze, A. C. 1994. Enhanced monooxygenase activity in pyrethroid-resistant 
strains of Bovicola ovis (Schrank) (Phthiraptera: Trichodectidae). J. Aust. 
Entomol. Soc. 33:275-278.
Kotze, A. C. 1995. Induced insecticide tolerance in Lucilia cuprina (Diptera: 
Calliphoridae) larvae following dietary phénobarbital treatment. J. Aust. 
Entomol. Soc. In Press.
Kotze, A. C. and Sales, N. 1994. Cross resistance spectra and effects of 
synergists in insecticide-resistant strains of Lucilia cuprina (Wiedemann) 
(Diptera: Calliphoridae). Bull. Entomol. Res. 84:355-360.
Kotze, A. C. and Sales, N. 1995. Elevated in vitro monooxygenase activity 
associated with insecticide resistances in field strain larvae of the Australian 
sheep blowfly (Diptera: Calliphoridae). J. Econ. Entomol. In Press.
Lamoureux, G. L. and Rusness, D. G. 1986. Tridiphane [2-(3,5- 
dichlorophenyl)-2-(2,2,2-trichloroethyl)oxirane] an atrazine synergist: 
enzymatic conversion to a potent glutathione-S-transferase inhibitor. Pestic. 
Biochem. Physiol. 26:323-342.
Lasota, J. A. and Dybas, R. A. 1991. Avermectins, a novel class of 
compounds: implications for use in arthropod pest control. Annu. Rev. 
Entomol. 36:91-117.
Levot, G. W. 1990. Dose response and selection for propetamphos 
resistance in field populations of Lucilia cuprina (Wiedemann) (Diptera: 
Calliphoridae). J. Aust. Entomol. Soc. 29:295-300.
179
Levot, G. W. 1991. Resistance to organophosphorus insecticides in the 
sheep body louse, Damalinia ovis. Annual Scientific Meeting of The 
Australian Society for Parasitology. Lome, Vic. Abstract.
Levot, G. W. 1992. High level resistance to cypermethrin in the sheep body 
louse. Aust. Vet. J. 69:120.
Levot, G. W. 1994. Pyrethroid synergism by piperonyl butoxide in Bovicola 
ovis (Schrank) (Phthiraptera: Trichodectidae). J. Aust. Entomol. Soc. 
33:123-126.
Levot, G. W. and Hughes, P. B. 1990. Laboratory studies on resistance to 
cypermethrin in Damalinia ovis (Schrank) (Phthiraptera: Trichodectidae).
J. Aust Entomol. Soc. 29:257-259.
Lloyd, D. H., Amakiri, S. F. and Jenkinson, D. McEwan. 1979. Structure of 
the sheep epidermis. Res. Vet. Sc. 26:180-182.
Lopes, H. S. 1973. Contribution to the knowledge of the genus Tricharea 
Thompson, 1869. (Diptera, Sarcophagidae). Rev. Brazil. Biol. 33:143-152.
Lumaret, J. P., Galante, E., Lumberas, C., Mena, J., Bertrand, M., Bernal, 
J. L., Cooper, J. F., Kadiri, N. and Crowe, D. 1993. Field effects of 
ivermectin residues on dung beetles. J. appl. Ecol. 30:428-436.
Lummis, C. R. and Sattelle, D. B. 1985. GABA and benzodiazepine binding 
sites in insect CNS. Pestic. Sci. 16:61-65.
180
Lund, R. D. 1993. The efficacy of chemical application devices for sheep 
blowfly and lice control. Proc. 1993 NSW Sheep and Wool Refresher 
Course, pp. 20-32.
Madsen, M., Overgaard Nielsen, B., Holter, P., Pedersen, O. C., Brochner 
Jespersen, J., Vagn Jensen, K. M., Nansen, P. and Gronvold, J. 1990. 
Treating cattle with ivermectin: effects on the fauna and decomposition of 
dung pats. J. Appi Ecol. 27:1-15.
Mahon, R. J. and Wardhaugh, K. G. 1991. Impact of dung from ivermectin- 
treated sheep on oogenesis and survival of adult Lucilia cuprina. Aust. Vet.
J. 68:173-177.
Mahon, R. J., Wardhaugh, K. G., van Gerwen, A. C. M. and Whitby, W. A.
1993. Reproductive development and survival of Lucilia cuprina Wiedemann 
when fed sheep dung containing ivermectin. Vet. Parasitol. 48:193-204.
Marley, S. E., Hall, R. D. and Corwin, R. M. 1993. Ivermectin cattle pour- 
on: duration of a single late spring treatment against horn flies, Haematobia 
irritans (L.) (Diptera: Muscidae) in Missouri, USA. Vet. Parasitol.
51:167-172.
Marriner, S. E., McKinnon, I. and Bogan, J. A. 1987. The pharmacokinetics 
of ivermectin after oral and subcutaneous administration to sheep and 
horses. J. Vet. Pharmacol. Therap. 10:175-179.
Martin, P. J. 1993. The development of high synthetic pyrethroid resistance 
in Bovicola (Damalinia) ovis and the implications for resistance management. 
Aust. Vet. J. 70:209-211.
181
Martin, R. and Pennington, A. J. 1988. Effect of dihydroavermectin B1a on 
Cl single-channel currents in Ascaris muscle. Neurotox. '88 Abstr. 141.
McKeand, J., Bairden, K. and Ibarra-Silva, A. M. 1988. The degradation of 
bovine pats containing ivermectin. Vet Rec. 122:587-588.
McKenzie, J. A. and Whitten, M. J. 1984. Estimation of the relative 
viabilities of insecticide resistance genotypes of the Australian sheep blowfly, 
Lucilia cuprina. Aust. J. Biol. Sc. 37:45-52.
Mellin, T. N., Busch, R. D. and Wang, C. C. 1983. Postsynaptic inhibition of 
invertebrate neuromuscular transmission by avermectin B1a. Neuropharm.
22:89-96.
Meyer, J. A., Simco, J. S. and Lancaster, J. L. 1980. Control of face fly 
larval development with ivermectin, MK-933. Southwest Entomol.
5:207-209.
Miller, J. A., Kunz, S. E., Oehler, D. D. and Miller, R. W. 1981. Larvicidal 
activity of Merck MK-933, an avermectin, against the horn fly, stable fly, face 
fly and house fly. J. Econ. Entomol. 74:608-611.
Miller, J. A., Oehler, D. D. and Scholl, P. J. 1994. Moxidectin: 
pharmacokinetics and activity against horn flies (Diptera: Muscidae) and 
trichostrongyle nematode egg production. Vet. Parisitol. 53:133-143.
182
Miller, J. A., Oehler, D. D.t Siebenaler, A. J. and Kunz, S. E. 1986. Effect 
of ivermectin on survival and fecundity of horn flies and stable flies (Diptera: 
Muscidae). J. Econ. Entomol. 79:1564-1569.
Morcombe, P. W. and Young, G. E. 1993. Persistence of the sheep body 
louse, Bovicola ovis, after treatment. Aust.Vet.J. 70:147-150.
Morley, F. H. W., Donald, A. D., Donnelly, J. R., Axelsen, A. and Waller, P. 
J. 1976. Blowfly strike in the breech region of sheep in relation to helminth 
infection. Aust. Vet. J. 52:325-329.
Morse, J. G. and Brawner, O. L. 1986. Toxicity of pesticides to Scirtothrips 
citri (Thysanoptera: Thripidae) and implications to resistance management.
J. Econ. Entomol. 79:565-570.
Mrozik. H., Eskola, P., Reynolds, G. F., Arison, B. H., Smith, G. M. and 
Fisher, M. H. 1988. Photoisomers of avermectins. J. Org. Chem. 53:1820- 
1823.
Murray, M. D. 1978. The species of flies reared from struck sheep in 
Western Australia. Aust. Vet. J. 54:262.
Nicholson, R., Robinson, P. S., Palmer, P. J. and Casida, J. E. 1988. 
Ivermectin-stimulated release of neurotransmitter in the insect central 
nervous system: modulation by external chloride and inhibition by a novel 
trioxabicyclooctane and two polychlorocycloalkane insecticides. Neurotox. 
'88 Abstr. 96.
183
O'Brien, R. D. 1967. Insecticides Action and Metabolism. Academic Press. 
New York.
O'Flynn, M. and Green, P. E. 1980. Insecticide resistance in field strains of 
Lucilia cuprina. Aust. Vet. J. 56:67-69.
Oehler, D. D. and Miller, J. A. 1989. Liquid chromatographic determination 
of ivermectin in bovine serum. J. Assoc. Off. Anal. Chem. 72:59.
Orton, C. J., Watts, J. E. and Rugg, D. 1992. comparative effectiveness of 
avermectins and deltamethrin in suppressing oviposition in Lucilia cuprina 
(Diptera: Calliphoridae). J. Econ. Entomol. 85:28-32.
Ostlind, D. A., Cifelli, S. and Lang, R. 1979. Insecticidal activity of the 
antiparasitic avermectins. Vet. Rec. 105:168.
Parella, M. P. 1983. Evaluation of selected insecticides for control of 
permethrin-resistant Liriomyza trifolii (Diptera: Agromyzidae) on 
chrysanthemums. J. Econ. Entomol. 76:1460-1464.
Pitman, I. H. and Rostas, S. J. 1981. Topical drug delivery to cattle and 
sheep. J. Pharm. Sc. 70:1181-1194.
Pomroy, W. E. and Whelan, N. C. 1993. Efficacy of moxidectin against an 
ivermectin-resistant strain of Ostertagia circumcincta in young sheep. Vet. 
Rec. 132:416.
184
Pong, S-S. and Wang, C. C. 1982. Avermectin B1a modulation of gamma- 
aminobutyric acid receptors in rat brain membranes. J. Neurochem. 
38:375-379.
Pong, S-S., Wang, C. C. and Fritz, L. C. 1980. Studies on the mechanism 
of action of avermectin B1a: stimulation of release of gamma-aminobutyric
acid from brain synaptosomes. J. Neurochem. 34:351-358.
Pritchard, R. K., Steel, J. W., Lacey, E. and Henessy, D. R. 1985. 
Pharmacokinetics of ivermectin in sheep following intravenous, intra- 
abomasal or intraruminal administration. J. Vet. Pharmacol. Therap. 
8:88-94.
Putter, I., MacConnell, J. G., Preiser, F. A., Haidri, A. A., Ristich, S. S. and 
Dybas, R. 1981. Avermectins: Novel insecticides, acaracides and 
nematicides from a soil microorganism. Experentia. 37:963-964.
Raftos, D. A. and Hughes, P. B. 1986. Genetic basis of a specific 
resistance to malathion in the Australian sheep blowfly, Lucilia cuprina 
(Diptera: Calliphoridae). J. Econ. Entomol. 79: 553-557.
Ridsdill-Smith, T. J. 1988. Survival and reproduction of Musca vetustissima 
Walker (Diptera: Muscidae) and a scarabaeinae dung beetle in dung of cattle 
treated with avermectin B1. J. Aust. Entomol. Soc. 27:175-178.
Rohrer, S. P., Birzin, E. T., Eary, C. H., Schaeffer, J. M. and Shoop, W. L. 
1994. Ivermectin binding sites in sensitive and resistant Haemonchus 
contortus. J. Parasitol. 80:497-499.
185
Roncalli, R. A. 1984. Efficacy of ivermectin against Oestrus ovis in sheep. 
Vet. Med. Small Anim. Clinic. 79:1095-1097.
Roush, R. T. 1990. Genetics and management of insecticide resistance: 
lessons for resistance in internal parasites? In Boray, J. C., Martin, P. J. 
and Roush. R. T. (Eds). Resistance of Parasites to Antiparasitic Drugs. 
pp. 197-211. MSD Agvet. New Jersey.
Roush, R. T. and Daly, J. C. 1990. The role of population genetics in 
resistance research and management. In Roush, R. T. and Tabashnik, B. E. 
(Eds). Pesticide Resistance in Arthropods, pp. 97-152. Chapman and Hall. 
New York.
Roush, R. T. and McKenzie, J. A. 1987. Ecological genetics of insecticide 
and acaricide resistance. Ann. Rev. Entomol. 32:361-380.
Roush, R. T. and Wright, J. E. 1986. Abamectin toxicity to houseflies 
(Diptera: Muscidae) resistant to synthetic organic insecticides. J. Econ. 
Entomol. 79:562-564.
Roxburgh, N. A. and Shanahan, G. J. 1973a. Carbamate resistance in the 
sheep blowfly, Lucilia cuprina (Wied.). Vet. Rec. 93:467.
Roxburgh, N. A. and Shanahan, G. J. 1973b. A method for the detection 
and measurement of insecticide resistance in larvae of Lucilia cuprina 
(Wied.) (Diptera: Calliphoridae). Bull. Entomol. Res. 63:99-102.
186
Rugg, D. and Thompson, D. R. 1993. A laboratory assay for assessing the 
susceptibility of Damalinia ovis (Schrank) (Phthiraptera: Trichodectidae) to 
avermectins. J. Aust. Entomol. Soc. 32:1-3.
Rugg, D., Sales, N., Kotze, A. C. and Levot, G. W. 1995. Susceptibility to 
ivermectin of pyrethroid-resistant Lucilia cuprina (Wiedemann) (Diptera: 
Calliphoridae). J. Aust. Entomol. Soc. 34:69-70.
Rugg, D., Thompson, D. R., Scott, P. G., Cramer, L. G. and Barrick, R. A. 
1993. Efficacy of ivermectin jetting fluid against strike by some primary and 
secondary blowflies of sheep. Aust. Vet. J. 70:180-182.
Sales, N., Levot, G. W. and Hughes, P. B. 1989. Monitoring and selection 
of resistance to pyrethroids in the Australian sheep blowfly, Lucilia cuprina. 
Med. Vet. Entomol. 3:287-291.
Schaeffer, J. M. and Bergstrom, A. R. 1988. Identification of gamma- 
aminobutyric acid binding sites in Caenorhabditis elegans. Life Sci. 
43:1701-1706.
Schaeffer, J. F. and Haines, H. W. 1989. Avermectin binding in 
Caenorhabditis elegans a two-state model for the avermectin binding site. 
Biochem. Pharmacol. 38:2329-2338.
Schaper, R. and Liebisch, A. 1991. Einflus eines systemisch wirkenden 
antiparasitikums (ivermectin) auf die dungfauna und den dungabbau der 
rinder bei weidhaltung. Tierärztliche Umschau. 46:12-18.
187
Schmidt, C. D. 1983. Activity of an avermectin against selected insects in 
ageing manure. Environ. Entomol. 12:455-457.
Schmidt, C. D. and Kunz, S. E. 1980. Testing immature laboratory-reared 
stable flies and horn flies for susceptibility to insecticides. J. Econ. Entomol. 
73:702-703.
Scholtz, C. H. and Krüger, K. 1995. Effects of ivermectin residues in cattle 
dung on dung insect communities under extensive farming conditions in 
South Africa. In Stork, N. E. and Harrington, R. (Eds) Insects in a changing 
environment, pp. 465-471. Academic Press. London.
Scott, E. W.f Kinabo, L. D. and McKellar, Q. A. 1990. Pharmacokinetics of 
ivermectin after oral or percutaneous administration to adult milking goats.
J. Vet. Pharmacol. Therap. 13:432-435.
Scott, J. G. 1989. Cross resistance to the biological insecticide abamectin in 
pyrethroid resistant strains of house flies. Pestic. Biochem. Physiol. 
34:27-31.
Scott, J. G., Roush, R. T. and Liu, N. 1991. Selection of high-level 
abamectin resistance from field-collected house flies, Musca domestica. 
Experentia. 47:288-291.
Scott, M. T. 1952. Observations on the bionomics of the sheep body louse 
(Damalinia ovis). Aust. J. Agric. Res. 3:60-67.
Shanahan, G. J. 1958a. Resistance to dieldrin and aldrin in Lucilia cuprina 
Wied. J. Aust. Inst. Agric. Sci. 24:157.
188
Shanahan, G. J. 1958b. Resistance to dieldrin in Lucilia cuprina Wied., the 
Australian sheep blowfly. Nature 181:860-861.
Shanahan, G. J. 1965. Susceptibility tests with organophosphates against 
Lucilia cuprina Wied., the primary blowfly of sheep in Australia. Agric. Gaz. 
N.S.W. 76:180-182.
Shanahan, G. J. 1967. The sheep blowfly's tolerance of insecticides. Agric. 
Gaz. N.S.W. 78:444-445.
Shanahan, G. J. and Hart, R. J. 1966. Change in response of Lucilia 
cuprina to organophosphorus insecticides in Australia. Nature 
212:1466-1467.
Shanahan, G. J. and Roxburgh, N. A. 1974. Effect of diazinon selection 
upon two organophosphorus-resistant field strains of Lucilia cuprina (Wied.) 
(Diptera: Calliphoridae). Bull. Ent. Res. 63:567-571.
Shoop, W. L. 1993. Ivermectin resistance. Parasitol. Today. 9:154-159.
Shoop, W. L, Haines, H. W., Michael, B. F. and Eary, C. H. 1993. Mutual 
resistance to avermectins and milbemycins: oral activity of ivermectin and 
moxidectin against ivermectin-resistant and susceptible nematodes. Vet. 
Rec. 133:445-447.
Sinclair, A. N. 1977. The unusual nature of sheep fleece in relation to 
applied insecticide. Vet. Rev. 24:95-101.
189
Sommer, C. and Overgaard Nielsen, B. 1992. Larvae of the dung beetle 
Onthophagus gazella Fabricus (Coleóptera: Scarabaeidae) exposed to lethal 
and sublethal ivermectin concentrations. J. Appl. Entomol. 114:502-509.
Sommer, C. and Steffanson, B. 1993. Changes with time after treatment in 
the concentrations of ivermectin in fresh cow dung and in cow pats aged in 
the field. Vet. Parasitol. 48:67-73.
Sommer, C., Steffanson, B., Overgaard Nielsen, B., Gronvold, J., Vagn 
Jensen, K. M., Brochner Jespersen, J., Springborg, J. and Nansen, P. 
1992. Ivermectin excreted in cattle dung after subcutaneous injection or 
pour-on treatment: concentrations and impact on dung fauna. Bull. Entomol. 
Res. 82:257-264.
Spradbery, J. P., Tozer, R. S., Drewett, N. and Lindsay, M. J. 1985. The 
efficacy of ivermectin against larvae of the screw-worm fly (Chrysomya 
bezziana). Aust. Vet. J. 62:311-314.
Standfast, H. A., Muller, M. J. and Wilson, D. D. 1984. Mortality of 
Culicoides brevitarsis (Díptera: Ceratopogonidae) fed on cattle treated with 
ivermectin. J. Econ. Entomol. 77:419-421.
Strong, L. 1992a. Avermectins: a review of their impact on insects of cattle 
dung. Bull. Entomol. Res. 82:256-274.
Strong, L. 1992b. The use and abuse of feed-through compounds in cattle 
treatments. Bull. Entomol. Res. 82:1-4.
190
Strong, L. and Brown, T. A. 1987. Avermectins in insect control and 
biology: a review. Bull. Entomol. Res. 77:357-389.
Strong, L. and Wall, R. 1994a. Ecological impacts of the avermectins: 
recent developments. Pestic. Outlook. 13-16.
Strong, L. and Wall, R. 1994b. Effects of ivermectin and moxidectin on the 
insects of cattle dung. Bull. Entomol. Res. 84:403-409.
Tackiguchi, Y., Mishima, H., Okuda, M., Terao, M., Aoki, A. and Fukuda,
R. 1980. Milbemycins, a new family of macrolide antibiotics: fermentation, 
isolation and physico-chemical properties. J. Antibiot. 33:1120-1127.
Tanaka, K. 1987. Mode of action of insecticidal compounds acting at 
inhibitory synapse. J. Pestic. Sci. 12:549-560.
Tanaka, K. and Matsumura, F. 1985. Action of avermectin B1a on the leg 
muscles and nervous system of the American cockroach. Pestic. Biochem. 
Physiol. 24:124-135.
Terras, M. A., Rose, H. A. and Hughes, P. B. 1983. Aldrin epoxidase 
activity in larvae of a susceptible and a resistant strain of the sheep blowfly, 
Lucilia cuprina (Wiedemann). J. Aust. Entomol. Soc. 22:256.
Thompson, D. R., Eagleson, J. S., Rugg, D., Scott, P. G., Cramer, L. G. 
and Barrick, R. A. 1994a. The efficacy of ivermectin jetting fluid for control of 
blowfly strike on sheep under field conditions. Aust Vet. J. 71:44-46.
191
Thompson, D. R., Rugg, D., Scott, P. G., Cramer, L. G. and Barrick, R. A.
1994b. Efficacy of ivermectin jetting fluid for the curative treatment of blowfly 
strikes in sheep. Aust Vet. J. 71:42-43.
Thompson, D. R., Rugg, D., Scott, P. G., Cramer, L. G. and Barrick, R. A. 
1994c. Rainfall and breed effects on the efficacy of ivermectin jetting fluid for 
the prevention of fly strike and treatment of infestations of lice in long-woolled 
sheep. Aust Vet J. 71:161-164.
Turner, M. J. and Schaeffer, J. M. 1989. Mode of action of ivermectin. In 
Campbell, W. C. (Ed.). Ivermectin and Abamectin. pp. 73-88. Springer- 
Verlag. New York.
Tyndale-Biscoe, M. 1990. Common Dung Beetles in Pastures of South- 
Eastern Australia. CSIRO. Australia.
Uribe, L. F., McMullin, P. F., Cramer, L. C. and Amaral, N. K. 1989. 
Topically applied ivermectin: efficacy against torsalo (Diptera: Cuterebridae). 
J. Econ. Entomol. 82:847-849.
Wall, R. and Strong, L. 1987. Environmental consequences of treating 
cattle with the antiparasitic drug ivermectin. Nature 327:418-421.
Wardhaugh, K. G. and Mahon, R. J. 1991. Avermectin residues in sheep 
and cattle dung and their effects on dung-beetle (Coleoptera: Scarabaeidae) 
colonization and dung burial. Bull. Entomol. Res. 81:333-339.
192
Wardhaugh, K. G. and Rodriguez-Mendez, H. 1988. The effects of the 
antiparasitic drug, ivermectin, on the development and survival of the dung 
breeding fly, Orthelia cornicina (F.) and the scarabaeine dung beetles, Copris 
hispanus L.f Bubas bubalus (Oliver) and Onitis belial F. J. Appl. Entomol. 
106:381-389.
Wardhaugh, K. G. and Morton, R. 1990. The incidence of flystrike in sheep 
in relation to weather conditions, sheep husbandry, and the abundance of the 
Australian sheep blowfly, Lucilia cuprina (Wiedemann) (Diptera: 
Calliphoridae). Aust. J. Agric. Res. 41:1155-1167.
Wardhaugh, K. G., Mahon, R. J., Axelsen, A., Rowland, M. W. and 
Wanjura, W. 1993. Effects of ivermectin residues in sheep dung on the 
development and survival of the bushfly, Musca vetustissima Walker and a 
scarabaeine dung beetle, Euoniticellus fulvus Goeze. Vet. Parasitol. 
48:139-157.
Waterhouse, D. F. 1947. The relative importance of live sheep and carrion, 
as breeding grounds of the Australian sheep blowfly, Lucilia cuprina. Bull. 
Coun. Sci. Indust. Res. Aust. No. 217.
Watts, J. E. and Marchant, R. S. 1977. The effects of diarrhoea, tail length 
and sex on the incidence of breech strike in modified mulesed merino sheep. 
Aust. Vet. J. 53:118-123.
Watts, J. E. and Perry, D. A. 1975. Observations on breech strike in 
scouring sheep. Aust. Vet. J. 51:586-587.
193
Watts, J. E., Muller, M. J., Dyce, A. L. and Norris, K. R. 1976. The species 
of flies reared from struck sheep in south-eastern Australia. Aust. Vet. J. 
52:488-489.
Webb, J. D., Burg, J. G. and Knapp, F. W. 1991. Moxidectin evaluation 
against Solenoptes capillatus (Anoplura: Linognathidae), Bovicola bovis 
(Mallophaga: Trichodectidae), and Musca autumnalis (Diptera: Muscidae) on 
cattle. J. Econ. Entomol. 84:1266-1269.
Whitten, M. J. and McKenzie, J. A. 1982. The genetic basis for pesticide 
resistance. In Lee, K. E. (Ed.). Proceedings of the 3rd Australasian 
Conference on grassland invertebrate ecology, pp. 1 -16. Australian 
Government Printer. Adelaide.
Wilkinson, F. C., de Chaneet, G. C. and Beetson, B. R. 1982. Growth of 
populations of lice, Damalinia ovis, on sheep and their effects on production 
and processing performance of wool. Vet. Parasitol. 9:243-252.
Wislocki, P. G., Grosso, L. S. and Dybas, R. A. 1989. Environmental 
aspects of use in crop protection. In Campbell, W. C. (Ed.). Ivermectin and 
Abamectin. pp.182-214. Springer-Verlag. New York.
Wratten, S. D., Mead-Briggs, M., Gettinby, G., Ericsson, G. and Baggot, D. 
G. 1993. An evaluation of the potential effects of ivermectin on the 
decomposition of cattle dung pats. Vet. Rec. 133:365-371.
194
Wright, D. E. 1986. Biological activity and mode of action of avermectins. In 
Ford, M. D., Lunt, G. G., Deay, R. C. and Usherwood, P. N. R. (Eds). 
Neuropharmacology and Pesticide Action, pp 174-202. Ellis Horwood. 
Chichester.
Wright, J. E. 1984. Biological activity of AVMB1 against the boll weevil 
(Coleóptera: Curculionidae). J. Econ. Entorno!. 77:1029-1032.
Wright, J. E., Jenkins, J. N. and Villavaso, E. J. 1985. Evaluation of 
avermectin B  ^ (MK-936) against Heliothis spp. in the laboratory and in field
plots and against the boll weevil in field plots. Southwest Entomol. 
Supplement. 7:11-16.
Zulalian, J., Stout, S. J., da Cunha, A. R., Garces, T. and Miller, P. 1994. 
Absorption, tissue distribution, metabolism, and excretion of moxidectin in 
cattle. J. Agrie. Food Chem. 42:381-387.
195
